Steroid Estrogens and Estrogenic Activity in Farm Dairy Shed Effluents by Gadd, Jennifer Bronwyn
  
STEROID ESTROGENS AND ESTROGENIC 
ACTIVITY IN FARM DAIRY SHED EFFLUENTS 
A thesis 
submitted in partial fulfilment 
of the requirements for the degree 
of 
Doctor of Philosophy in Chemistry 
in the 
University of Canterbury 
by 
Jennifer Bronwyn Gadd 
 
March 2009 
  
  i 
Table of Contents 
 
Acknowledgements ........................................................................................................................ v 
Abstract...........................................................................................................................................vii 
Abbreviations.................................................................................................................................. ix 
Chapter 1: Introduction .................................................................................................................. 1 
1.1 Background ........................................................................................................................................... 1 
1.2 Endocrine System and Endocrine Disruption .................................................................................. 2 
1.2.1 Endocrine System .......................................................................................................................... 2 
1.2.2 Steroid Metabolism and Excretion .............................................................................................. 2 
1.2.3 Endocrine Disruption.................................................................................................................... 5 
1.3 Agriculture as a Potential Source of Estrogens................................................................................. 7 
1.3.1 Potential Loads Estimated from Excretion................................................................................. 7 
1.3.2 Measured Concentrations in Agricultural Wastes.................................................................... 8 
1.3.3 Potential Loads from New Zealand Agricultural Sources..................................................... 11 
1.3.4 Treatment and Disposal of Agricultural Wastes ..................................................................... 12 
1.4 Thesis Rationale and Objectives ....................................................................................................... 13 
1.5 Thesis Structure .................................................................................................................................. 14 
Chapter 2: Review of Methods to Analyse Estrogens in Wastewaters.................................. 15 
2.1 Introduction......................................................................................................................................... 15 
2.2 In vitro Bioassays................................................................................................................................. 16 
2.3 Chemical Analysis of Free Estrogens............................................................................................... 17 
2.4 Chemical Analysis of Conjugated Estrogens.................................................................................. 19 
2.4.1 Sample Handling and Preservation .......................................................................................... 19 
2.4.2 Sample Extraction........................................................................................................................ 20 
2.4.3 Purification of Extracts................................................................................................................ 22 
2.4.4 LC-MS Analysis ........................................................................................................................... 22 
2.4.5 Hydrolysis Methods.................................................................................................................... 23 
2.4.6 Alternative Methods ................................................................................................................... 24 
2.4.7 Limitations in Analytical Methods............................................................................................ 25 
2.5 Summary.............................................................................................................................................. 25 
ii   
Chapter 3: Development of an analytical procedure for determination of estrogens and 
conjugated estrogens in dairy shed effluent and environmental water samples................. 27 
3.1 Introduction .........................................................................................................................................27 
3.2 Materials and Methods.......................................................................................................................28 
3.2.1 Materials ........................................................................................................................................28 
3.2.2 SPE Procedures.............................................................................................................................29 
3.2.3 Sample Clean-Up Procedures for Free Estrogens....................................................................30 
3.2.4 Sample Clean-Up Procedures for Conjugated Estrogens .......................................................31 
3.2.5 LC-MS Determination of Conjugated Estrogens .....................................................................33 
3.2.6 GC-MS Determination of Free Estrogens..................................................................................35 
3.2.7 Sample Preservation Experiments .............................................................................................37 
3.2.8 Matrix Spike Experiments...........................................................................................................38 
3.3 Results and Discussion.......................................................................................................................40 
3.3.1 Analysis of Free and Conjugated Estrogens by LC-MS..........................................................40 
3.3.2 Comparison of SPE Methods......................................................................................................45 
3.3.3 Clean-up of Free Estrogens.........................................................................................................47 
3.3.4 Clean-up of Conjugated Estrogens ............................................................................................50 
3.3.5 Comparison of Sample Preservation Methods.........................................................................53 
3.3.6 Method Detection Limits.............................................................................................................55 
3.3.7 Variation in Replicate Samples...................................................................................................56 
3.3.8 Recovery in Different Matrices...................................................................................................57 
3.3.9 Comparison to Standard Addition Method .............................................................................59 
3.4 Conclusions..........................................................................................................................................59 
Chapter 4: Survey of steroid estrogens and estrogenic activity in New Zealand farm dairy 
effluents .......................................................................................................................................... 61 
4.1 Introduction .........................................................................................................................................61 
4.2 Materials and Methods.......................................................................................................................63 
4.2.1 Sampling Locations......................................................................................................................63 
4.2.2 Sampling and Extraction.............................................................................................................63 
4.2.3 Chemical Analysis........................................................................................................................64 
4.2.4 E-Screen Analysis.........................................................................................................................65 
4.2.5 Model Compounds and Calculation of Predicted Estrogens.................................................67 
4.2.6 Nutrient analysis ..........................................................................................................................68 
4.3 Results and Discussion.......................................................................................................................68 
4.3.1 Response of Free and Conjugated Estrogens in the E-Screen ................................................68 
  iii 
4.3.2 Steroid Estrogen Concentrations ............................................................................................... 72 
4.3.3 Estrogenic Activity ...................................................................................................................... 76 
4.3.4 Comparison to Literature Data.................................................................................................. 81 
4.4 Conclusions ......................................................................................................................................... 84 
Chapter 5: Assessing the Efficacy of Two-Pond and Advanced Pond Treatment Systems to 
Remove Estrogens from Dairy Shed Effluent ........................................................................... 85 
5.1 Introduction......................................................................................................................................... 85 
5.2 Methods ............................................................................................................................................... 87 
5.2.1 Study Sites .................................................................................................................................... 87 
5.2.2 Sampling and Extraction ............................................................................................................ 89 
5.2.3 Laboratory Biodegradation Experiment................................................................................... 91 
5.2.4 Chemical Analysis ....................................................................................................................... 91 
5.2.5 Enzymolysis and solvolysis procedure to assess conjugated estrogens .............................. 92 
5.2.6 E-Screen Analysis ........................................................................................................................ 94 
5.2.7 Fractionation of Samples for E-Screen Analysis...................................................................... 94 
5.2.8 Nutrient analysis ......................................................................................................................... 94 
5.3 Results and Discussion ...................................................................................................................... 95 
5.3.1 Two-pond System........................................................................................................................ 95 
5.3.2 Advanced Pond System............................................................................................................ 104 
5.3.3 Biodegradation of 17α-Estradiol in Laboratory Test ............................................................ 114 
5.3.4 Comparison of Treatment Systems and Potential Improvements for Estrogen Removal117 
5.4 Conclusions ....................................................................................................................................... 119 
Chapter 6: Evaluation of Three In Vitro Bioassays to Estimate the Estrogenic Activity of 
Dairy Shed Effluents ................................................................................................................... 121 
6.1 Introduction....................................................................................................................................... 121 
6.2 Methods ............................................................................................................................................. 122 
6.2.1 Sample Preparation ................................................................................................................... 122 
6.2.2 E-Screen....................................................................................................................................... 123 
6.2.3 Two-hybrid Yeast Assay........................................................................................................... 123 
6.2.4 Calculation of EEQs based on Chemical Analysis ................................................................ 124 
6.2.5 Statistical Analyses .................................................................................................................... 124 
6.3 Results and Discussion .................................................................................................................... 124 
6.3.1 Performance of Assays.............................................................................................................. 124 
6.3.2 Comparison of EEQs of DSE Samples in Each Assay........................................................... 125 
6.3.3 Comparison of Bioassay and Predicted Estrogenic Activity ............................................... 127 
iv   
6.4 Conclusions........................................................................................................................................131 
Chapter 7: Investigation of Steroid Estrogens and Estrogenic Activity in Aquatic 
Receiving Environments of Dairy Catchments ....................................................................... 133 
7.1 Introduction .......................................................................................................................................133 
7.2 Methods..............................................................................................................................................135 
7.2.1 Sampling Sites.............................................................................................................................135 
7.2.2 Sample Collection and Extraction............................................................................................141 
7.2.3 Chemical Analysis......................................................................................................................141 
7.2.4 E-Screen Analysis.......................................................................................................................142 
7.2.5 Quality Assurance and Quality Control .................................................................................142 
7.2.6 Statistical Methods .....................................................................................................................143 
7.3 Results and Discussion.....................................................................................................................143 
7.3.1 Catchment Sampling .................................................................................................................143 
7.3.2 Border-Dyke Irrigation Catchment..........................................................................................145 
7.3.3 Waikato Regional Survey..........................................................................................................146 
7.3.4 Comparison to Literature Values.............................................................................................147 
7.3.5 Sources and Routes of Estrogen Contamination....................................................................149 
7.3.6 Potential for Effects on Wildilife ..............................................................................................151 
7.4 Conclusions........................................................................................................................................152 
Chapter 8: Final Conclusions ..................................................................................................... 155 
8.1 Overview ............................................................................................................................................155 
8.2 Implications For Aquatic Biota of DSE Discharges to land and water ......................................155 
8.2.1 Water............................................................................................................................................155 
8.2.2 Land .............................................................................................................................................157 
8.3 Thesis objectives Revisited...............................................................................................................158 
8.4 Key Research Findings .....................................................................................................................160 
8.5 Recommendations for Future Research .........................................................................................162 
References..................................................................................................................................... 163 
Appendix A: DSE Composition………………………………………………………………..175 
Appendix B: Stream Sampling Locations and Catchment Characteristics………………..177 
 
  v 
Acknowledgements 
 
First and foremost I would like to thank my external supervisors, Dr Louis Tremblay and 
Dr Grant Northcott. To Louis for his direction, encouragement and support, without 
which this thesis would have been impossible. To Grant, for all that and for sharing his 
vast expertise in the laboratory (and sometimes in the kitchen). I would also like to thank 
Assoc. Professor Andrew Abell and Dr Andy Pratt for their guidance and willingness to 
supervise a project outside of their usual field. 
Thank you to Janine Cooney and Dwayne Jensen of HortResearch for allowing me access 
to their expensive instruments and for happily sharing their expertise. Thank you to 
Katherine Trought of Landcare Research for teaching me the E-Screen assay and always 
being fun to work with. Thanks to many of the staff at HortResearch and Landcare 
Research for their assistance, hospitality and entertaining lunchtime discussions. 
I would also like to thank Kingett Mitchell Ltd (now Golder Associates) for their support 
by way of an Enterprise Scholarship and for being extremely flexible and understanding 
employers as I undertook this thesis. Acknowledgement also goes to the University of 
Canterbury Evans’ Fund for the provision of funds which allowed me to travel to 
conferences and for expenses during the numerous trips to Hamilton. 
I would also like to thank the past and present members of the Marine Group for 
welcoming me into their office and laboratory, despite the occasional odours my research 
produced. I would especially like to thank Annabel for her friendship, support and 
company during long nights in the laboratory and (not so long) tea breaks. 
Thanks very much to Rishi & Meenal and Phil & Jenn for regularly letting me stay at their 
homes in Hamilton for weeks on end. Finally, a big thank you goes to my family and 
friends for their support over the too many years of undertaking this thesis.  
vi   
   vii 
Abstract 
 
Estrogenic contamination of waterways is of world-wide concern due to the adverse 
effects observed in aquatic biota. Recently, wastes from agricultural activities have been 
identified as likely sources of steroid estrogens released into the environment. Wastes 
from dairying activities are of particular concern in New Zealand. This project included 
development of analytical methods to measure free and conjugated estrogens, 
measurement of estrogens from the source to receiving environments and an investigation 
of effluent treatment technologies.  
The analytical method developed in this study was based on GC-MS measurement of free 
estrogens (17α-estradiol (17α-E2), 17β-estradiol (17β-E2) and estrone (E1)) and LC-IT-MS 
measurement of their sulfate-conjugates (17α-E2-3S, 17β-3S, E1-3S) in raw and treated 
farm dairy shed effluents (DSE). Effluents from farms in the Canterbury and Waikato 
Regions, two regions where dairy farming is the dominant land-use, were collected and 
analysed. All effluents demonstrated high concentrations of steroid estrogens, particularly 
17α-E2 (median 760 ng/L). Estrogenic activity was also elevated, at up to 500 ng/L 17β-E2 
equivalents using the E-Screen, an in vitro cell proliferation bioassay. Comparison to the 
chemical data indicated that for most samples, the highest proportion of estrogenic 
activity was derived from steroid estrogens naturally excreted by dairy cows. Conjugated 
estrogens were measured in several raw effluent samples, at similar concentrations to 
those of free estrogens, particularly E1. 
Dairy effluent treatment systems reduced free estrogen concentrations by 63-99% and 
reduced estrogenic activity by up to 89%. In spite of high removal efficiencies, estrogens 
remained elevated in the treated effluents that are discharged into waterways. Steroid 
estrogens and estrogenic activity were detected in streams and groundwater in areas 
impacted by dairy farming. Although concentrations were generally low, in two streams 
the concentrations were above levels regarded as safe for aquatic biota (<1 ng/L). The 
results demonstrate that dairy effluents are indeed a major source of estrogens to the 
environment and to waterways.      
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Chapter 1:  Introduction 
1.1 BACKGROUND 
Estrogenic compounds have been linked to a wide range of effects in wildlife, particularly 
in aquatic environments. As early as 1978, a high prevalence of intersex fish (having both 
male and female gonadal characteristics) was discovered in a sewage effluent lagoon and 
downstream of a sewage treatment plant (STP) discharge in the River Lea, United 
Kingdom (Thames Water Authority, unpublished report cited in (1)). Further 
investigations showed that male rainbow trout and carp produced the egg-yolk protein 
vitellogenin when exposed to sewage treatment plant effluents, whereas fish in control 
waters did not (2). Although male fish have the gene for this protein, they do not usually 
produce it as the female sex hormone estrogen is required to express the gene (3). These 
‘estrogenic effects’ persisted in receiving waters downstream of effluent discharge 
locations, as demonstrated by elevated vitellogenin concentrations and lower gonad 
weight in wild and caged male fish compared to control fish (4,5); and by a high incidence 
of intersex in wild fish (6). 
These observations led to investigations into the cause of this ‘feminizing’ effect of the 
effluent. Initially the synthetic estrogen ethynylestradiol (in the contraceptive pill) and 
nonylphenols (degradation products of nonylphenol ethoxylate detergents) were 
postulated as potential causes of this feminising effect of effluent (7). Nonylphenols had 
been shown to act in a similar way to estrogen in biological assays (8). However, toxicity 
identification evaluation procedures suggested that the natural estrogen hormones 17β-
estradiol and estrone excreted in human urine and faeces were equally likely to cause the 
observed estrogenic effects from sewage effluents (9,10). Subsequently, numerous studies 
have examined natural and synthetic estrogens in STP influents, effluents and 
downstream receiving environments. 
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1.2 ENDOCRINE SYSTEM AND ENDOCRINE DISRUPTION 
1.2.1 Endocrine System 
All multi-cellular organisms require intercellular communication mechanisms which 
allow them to respond to their environment and maintain homeostasis (11). The 
endocrine (or hormone) system is a cell signalling system that plays a critical role in the 
key processes of development, growth, reproduction, behaviour, and metabolism (11,12). 
This system consists of several glands (e.g., adrenal, pituitary, gonads) that synthesise and 
secrete hormones which are then transported via the circulatory system to target cells. On 
reaching a target cell, the hormone binds to a specific hormone receptor, and then the 
receptor/hormone complex attaches to a specific segment of DNA called the response 
element to activate or inhibit gene expression, ultimately leading to protein synthesis. 
Figure 1.1 shows that the hormone 17β-estradiol binds to the estrogen receptor (ER), then 
the ligand-ER activated complex binds to the estrogen response element (ERE) as a dimer 
to up or down regulate genes that are modulated by estrogens.  
1.2.2 Steroid Metabolism and Excretion 
The most active form of the endogenous estrogen hormone is the steroid 17β-estradiol 
(17β-E2) which is found in the circulatory system of all vertebrates. Less active forms of 
estrogen are also present in vertebrates, including estrone (E1), estriol (E3) and 17α-
estradiol (17α-E2) (Figure 1.2), though each varies in importance between species. 
Hormones that do not reach target cells or have completed their task of receptor binding 
and protein synthesis are inactivated, primarily via the liver and kidneys, before excretion 
(11). Estrogens are inactivated by conversion to weaker forms; or by conversion to more 
water soluble compounds that can be readily excreted by the addition of sulfate or 
glucuronide groups. These groups can be attached at either the 3 or 17 position, or both 
and are referred to as conjugated estrogens (Figure 1.3).  
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Figure 1.1: Simplified process of estrogen receptor binding and protein synthesis. The steroid hormone 17β-
estradiol enters the cell and binds to the receptor. The ligand-ER complex enters the nucleus and forms a 
homodimer that binds to the estrogen response element (ERE) on the DNA chain. This initiates gene 
transcription and subsequently production of new proteins.  
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Figure 1.2: Structures of steroid estrogens and conjugated steroid estrogens. Carbon atom numbers indicated 
on 17β-estradiol.     
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Figure 1.3: Inactivation of 17β-estradiol through oxidation to estrone and conjugation to glucuronide and sulfate groups. Glucuronidation and sulfation reactions 
catalysed by UDP-glucuronosyltransferase enzyme (UGT) and sulfotransferases (SULTs) respectively. Deglucuronidation and desulfation reactions catalysed by β-
glucuronidase and sulfatase enzymes respectively. 
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Daily excretion rates of estrogens depend on gender and reproductive state. Pregnant 
women can excrete more than 30 mg of E3 per day as conjugated forms in urine (13), 
whereas usual cycling (menstruating) levels of E3 in urine are 5-14 µg/day with similar 
levels of E1 (8-21 µg/day) and 17β-E2 (3-11 µg/day) (14). Males excrete lower levels at 
1.5 µg/day for E1, 1.5 µg/day for 17β-E2 and 4 µg/day for E3 (14). Although 
predominantly excreted as conjugates, the sulfate and glucuronide groups can be 
removed through hydrolysis reactions to reform the ‘free’ estrogen. This process has been 
demonstrated in sewage (15,16) and results in the presence of the free estrogens in sewage 
effluents. 
Likewise, other mammals excrete estrogen in urine and faeces and rates may be much 
higher: for example, cows excrete ~200 µg/day of total estrogens in urine when cycling 
(17), and 43-100 mg/day in urine at the end of pregnancy (18,19). These rates do not 
include faecal excretion, which is an equally or more important excretion route for cattle 
(20). Estrogen excretion from some species is lower, such as chickens, where layer hens 
excrete ~3.3 µg/day of E1 and ~3.0 µg/day of 17β-E2 while non-laying hens excrete 
0.93 µg/day of E1 and 2.3 µg/day of 17β-E2 (21). Livestock excretion results in their 
presence in agricultural wastes (e.g., manures) and potentially increases estrogenic 
contamination of aquatic receiving environments through discharges of agricultural 
wastes. 
1.2.3 Endocrine Disruption 
Endocrine disrupters interfere with the normal process of hormone/receptor binding and 
protein synthesis, predominantly via interaction with the hormone receptors (11). 
Endocrine disrupting compounds (EDCs) can bind to receptors and activate gene 
expression analogous to the endogenous hormone (an agonist). Alternatively, a 
compound can bind to the receptor without activating gene expression and in doing so, 
prevent binding and gene expression by endogenous hormones (antagonists). Non-
receptor mediated mechanisms are also possible, including alterations in the synthesis, 
metabolism or transport of endogenous hormones (22); alterations in the synthesis or 
binding affinity of hormone receptors; alteration of post-receptor activation (23) and by 
disrupting ‘cross-talk’ between different hormone receptors (11). Although endocrine 
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disruption has been most clearly demonstrated for reproductive hormones, particularly 
estrogen and testosterone, and thyroid hormones (11,12), it is likely that other hormones 
will be similarly susceptible (24). 
A wide range of adverse effects in wildlife and humans were linked to an endocrine 
disruption mechanism by Colburn et al. (25). Wildlife effects include imposex in marine 
gastropods caused by the anti-foulant tributyltin; masculinisation of fish downstream of 
bleached Kraft pulp and paper mills; intersex and vitellogenin induction in fish 
downstream of sewage effluents (as described earlier); and abnormalities in steroid 
hormone levels, decreased penis size and poor reproductive success in alligators in a 
pesticide contaminated lake (25,26). 
The form of endocrine disruption most studied to date is mediated through the estrogen 
receptor, with a wide range of compounds identified as estrogen agonists (also known as 
estrogenic compounds). Estrogenic compounds are defined not by a common chemical 
structure, but by their common action. In most cases, this is through interaction with the 
estrogen receptor,  however there is also evidence of cross-talk and non-ER mediated 
mechanisms (12). The definition proposed by Hertz (27), that ‘estrogens are substances 
which elicit the proliferative activity of the organs of the female genital tract’ has been 
used in this thesis as it relates most appropriately to the bioassay method predominantly 
used (the E-Screen, Chapters 4-7).  
These structurally diverse compounds include natural and synthetic hormones, 
compounds produced by plants and fungi (phyto- and myco-estrogens respectively) and 
the so-called xenoestrogens. Xenoestrogens are anthropogenic estrogenic compounds 
such as nonylphenols, bisphenol A and some phthalates and pesticides (Table 1.1). 
Xenoestrogens tend to bind only weakly to the estrogen receptor, reflected in their low 
binding affinities compared to the synthetic and natural hormones, and their low potency 
in a prolilferation assay (Table 1.1). The wide range in binding affinities and estrogenic 
potencies are coupled with a wide range in environmental concentrations of estrogenic 
compounds. Industrial compounds, such as nonylphenol, can be present at sub µg/L to 
low µg/L in riverine waters while the more potent hormones are present only at sub to 
low ng/L concentrations (28). 
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Table 1.1: Known estrogenic compounds and their relative potencies in ER binding assays and a cell 
proliferation assay. 
Compound Chemical Class / Use 
Relative ER 
binding affinity  
(29-31) a 
Relative potency in 
cell proliferation assay 
(E-Screen) (29,31,32) b 
17β-estradiol 
Endogenous sex 
hormone 1 1 
Estrone 
Endogenous sex 
hormone 0.007-0.60 0.01-0.012 
Estriol 
Endogenous sex 
hormone 0.03-0.75 0.071-0.1 
17α-ethynyl estradiol Synthetic hormone 1.2-8.7 1-1.25 
DES Synthetic hormone 1.3-4.7 2.5-10 
Zearalenone Mycoestrogen 0.05 0.01 
Coumestrol Phytoestrogen 0.0012-0.93 0.00001-0.00011 
Genistein Phytoestrogen 0.0001-0.14 0.000013 
p-nonylphenol Industrial chemical 0.00007-0.00018 0.000013-0.00008 
4-octylphenol Industrial chemical 0.0003-0.0019 0.0001-0.0002 
Bisphenol A (BPA) Plasticiser 0.00023-0.0023 0.00001-0.000025 
Benzylbutylphthalates Plasticiser 0.00003 0.000003 
2’,4’,6’-trichloro-4-
hydroxybiphenol PCB 0.054 0.0001 
Kepone Pesticide 0.0019 0.000001 
p,p′-DDT Pesticide 0.0000054 0.000001 
o,p′-DDT Pesticide 0.00003-0.00089 0.000001 
Note: a ER binding affinity relative to 17β-estradiol, unitless. b Potency in E-Screen assay relative to 17β-
estradiol, unitless.  
1.3 AGRICULTURE AS A POTENTIAL SOURCE OF 
ESTROGENS 
1.3.1 Potential Loads Estimated from Excretion 
Urinary and faecal excretion rates have been used by several authors to estimate and 
evaluate the potential load of estrogens from different human and livestock sources. 
Estimates for human and livestock populations in the UK (33), the Netherlands (34), the 
EU and the US (35) indicate the importance of livestock as a source of steroid estrogens 
(Table 1.2). For the UK, the estimated total estrogen (E1 plus 17β-E2) excretion from the 
human population was 365 kg/year, while excretion from farm animals was 1520 
kg/year, with the majority of this from dairy cattle (1058 kg/year, 70% of livestock load) 
(33). This is despite substantially fewer dairy cattle (2.2. million) than people (59 million) 
and reflects the higher daily excretion rates from cattle compared to that from humans 
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(33). In the Netherlands, the relative livestock contribution is even higher at 94% of the 
total estimated estrogen excretion, and dairy cattle are again the dominant source (63% of 
total livestock emissions) (34). Dairy cattle were also estimated to be the largest 
contributors of estrogens in the EU and USA compared to pigs, sheep and chickens (35). 
These loading calculations are at best an estimate of the potential load that may enter the 
environment and must be supported by actual data from analyses of agricultural wastes. 
Table 1.2: Estimated loads of estrogens from livestock from various countries/ regions (kg/year). 
 UK (33) a Netherlands (34) EU (35) US (35) 
Humans 365 1,170 NC NC 
Dairy cattle 1,058 11,700 24,600 45,000 
Laying hens NC b 440 2,700 2,400 
Broiler chickens 49 NC 93 280 
Pigs 386 3,900 3,000 830 
Sheep 27 NC 1,300 92 
Total Livestock 1,520 16,900 31,700 48,600 
Total 1,885 18,000 31,700 48,600 
Notes: a Sum of 17β-E2 and E1. b NC: Not calculated. 
1.3.2 Measured Concentrations in Agricultural Wastes 
Steroids were in fact identified in agricultural wastes as early as 1978, when estrogenic 
activity was measured in poultry litter processed for livestock feed (36). Despite this, and 
another early study highlighting potential issues with estrogens administered to animals 
subsequently entering the environment (37), there was little research in this field. In the 
late 1990s, widespread publicity regarding endocrine disrupting chemicals and their 
effects on wildlife (38) rekindled research into the presence of estrogens in agricultural 
wastes as potential sources of environmental estrogens. Most of the research reviewed has 
been published only in the last 5 years, highlighting the novelty of this research area. 
These recent studies demonstrate high concentrations of steroid estrogens in agricultural 
wastes, including dairy wastewaters and manures, swine wastewaters, slurries and 
manures and poultry litter (Table 1.3). These concentrations are well above those found in 
sewage treatment plant effluents, indicating the potential magnitude of dairy wastes as a 
source of estrogens. Nevertheless, most studies are limited to a small number of samples 
from a small number of agriculture operations, with the exception of a comprehensive 
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study by Raman et al. (39), who analysed triplicate samples collected from multiple 
locations (up to eight) within a range of animal waste facilities. 
Table 1.3: Estrogen concentrations in agricultural wastewaters (ng/L, mean reported where n>1). 
Agricultural operation Country E1 17α-E2 17β-E2 E3 N a Ref. 
Piggery/Swine Facilities        
Farm NZ 27.3 8.0 10.9 BDL 1 (40) 
Farm WWTP Japan 5300 665 1250 2600 2 (41) 
Nursery US 392 NM 48 208 4 (42) 
Nursery US 731 63 37 351 3 (43) 
Finisher US 74,700 NM 125 302 1 (42) 
Finishing lagoon b,c US 10,000 3000 3000 NM 24 (39) 
Finishing hoop structure b,c US 54,000 3000 40,000 NM 9 (39) 
Finisher US 1547 179 123 1543 3 (43) 
Farrowing sows US 14,124 NM 1971 7831 5 (42) 
Farrowing facility d US 6100 NM 1300 700 2 (44) 
Farrowing lagoon b,c US 6000 3000 4000 NM 8 (39) 
Farrowing pit b,c US 56,000 6000 18,000 NM 16 (39) 
Farrowing sows US 9940 1197 194 6288 3 (43) 
Dairy Facilities        
Shed effluents NZ 1164 356 159 ND 6 (40) 
Drain with shed effluent Australia 38 NM 8.6 NM 1 (45) 
Dry stack manure sludge b,c US 48,000 84,000 22,000 NM 18 (39) 
Dry stack manure solids b,c US 30,000 28,000 12,000 NM 12 (39) 
Holding ponds b,c US 8000 3000 2000 NM 16 (39) 
Wastewater US 70 224 148 <8 3 (43) 
Flushed manure wastewater 
c 
US 672 NM 344 NM 2 (46) 
Flushed manure wastewater 
c 
US 551 2114 672 BDL 5 (47) 
Wastewater ponds US ~300 ~2200 ~200 NM 6 (48) 
Other Livestock Facilities        
Beef feedlot US 17 6 <20 <8 3 (43) 
Poultry US 2246 265 40 340 3 (43) 
Goat NZ 157 47.1 172 BDL 1 (40) 
Notes: a N = Number of samples. b Estimated from chart to nearest whole number. c Data for whole samples, 
not pre-filtered. d Estimated from chart to nearest 100 ng/L. 
Wastes from different species have different steroid profiles, with 17β-E2 and E1 
dominating in swine and poultry wastes while 17α-E2 and E1 dominate in dairy wastes. 
The mean results of Raman et al. (39) for 17β-E2, 17α-E2 and E1 are substantially higher 
than results reported by many other authors (Table 1.3). Their data were confirmed by 
comparing results obtained by GC-MS, ELISA and an estrogenic assay (YES). Fine et al. 
(42) similarly reported very high concentrations of E1 in swine wastewaters, with a mean 
concentration of 14.1 µg/L for wastewaters from farrowing sows and a concentration of 
74.7 µg/L in a wastewater sample from a piggery finishing facility. Both authors (39,42) 
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reported higher steroid estrogen concentrations in samples containing comparatively 
higher solids. Heterogeneity between samples, sites and facilities is a likely cause of the 
observed variation in reported concentrations by different authors (Table 1.3). Piggery 
wastes typically contain higher estrogen concentrations than dairy wastes and may be due 
to lower dilution of piggery wastes compared to dairy wastes, due to different on-farm 
waste management practices.  
The estrogenic activity of the agricultural wastes has also been analysed using biological 
assays to provide an integrated estimate of potential effects. This is limited to just four 
studies, again with typically a small number of samples (Table 1.4). These preliminary 
data with 17β-estradiol equivalents (EEQ) of 33-3100 ng/L further demonstrate the 
potential risk from agricultural wastes in the environment. 
Table 1.4: Estrogenic activity in agricultural wastewaters (ng/L) and solid wastes (ng/g, mean reported 
where n>1). 
Agricultural Operations Country EEQ N Ref. 
Wastewaters     
Dairy farms NZ 341 6 (40) 
Goat farm NZ 61 1 (40) 
Piggery NZ 33 1 (40) 
Piggery operations Japan 650 & 3100 2 (41) 
Piggery – farrowing facility US 843 & 858 2 (44) 
Solid wastes     
Piggery operations Canada ~4000 25 (49) 
Dairy & veal manure Canada ~3000 7 (49) 
Dairy cow manure Canada ~850 6 (49) 
Beef cattle faecal pats Canada ~6 6 (49) 
Chicken litter Canada ~150 24 (49) 
 
In spite of conjugated estrogens being the dominant forms of estrogens excreted in urine, 
only one study has measured these compounds in agricultural wastes, possibly due to a 
lack of available analytical methods. Hutchins et al. (43) analysed conjugated estrogens in 
wastes from a range of concentrated animal feeding operations in the United States. For 
most animal facilities, concentrations of estrogen sulfate conjugates were at low ng/L in 
wastes and glucuronide conjugates were not detected (Table 1.5). In contrast, wastes from 
dairy facilities contained sulfate conjugates at concentrations of 39-174 ng/L, within the 
range of concentrations measured for free estrogens in the same samples. This illustrates 
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the potential importance of conjugated estrogens, if they can hydrolyse to free bioactive 
forms under environmental conditions or within effluent treatment systems. 
Table 1.5: Range in conjugated estrogens concentrations in agricultural wastes (ng/L, n=3, from ref (43)). 
Source E1-3S 17α-E2-3S 17β-E2-3S 17β-E2-17S 
Swine sow 1.7-2.0 <1.0 <1.0 72.0-84.3 
Swine farrowing <1.0 <1.0 <1.0 <1.0 
Swine nursery <1.0 <1.0 <1.0 <1.0 
Poultry operation 1 2.0-3.8 <1.0 8.0-13.9 <1.0 
Poultry operation 2 0.0-2.2 <1.0 <1.0 <1.0 
Dairy farm 85.0-91.0 141-174 39-44 <1.0 
Beef feedlot <1.0 <1.0 <1.0 <1.0 
1.3.3 Potential Loads from New Zealand Agricultural Sources 
Livestock are likely to be an important source of estrogens in New Zealand, due to the 
predominance of agriculture and in particular, dairy farming. Although agriculture is 
widespread throughout New Zealand, the Waikato Region is the largest dairying region, 
with 1,669,000 dairy cattle, 32% of the national dairy herd. The Canterbury region of the 
South Island has fewer dairy cattle, but numbers have increased substantially, almost 
tripling in less than 10 years, from 275,000 in 1999 to 755,000 in 2007. 
The estimated loads from different livestock sources have been calculated for New 
Zealand from excretion rates used for previously published estimates of estrogen loads 
(33-35). As each author used a different method and different daily excretion rates in their 
estimated loads, each method has been used to estimate the New Zealand loads (Table 
1.6). The total load of estrogens calculated based on the Blok and Wosten (34) method is 
substantially higher than estimated based on the Lange et al. (35) and Johnson et al. (33) 
methods; however both indicate that dairy cattle are by far the most important 
contributors of estrogens to the environment. The estimated load from the human 
population is minor by comparison. 
On New Zealand dairy farms, the majority of animal excreta is deposited onto paddocks 
during free range grazing and is not subject to any treatment. However, 10-20% of excreta 
is deposited within the farm dairy shed or yard area during milking (50), where it is 
captured as farm dairy shed effluent (DSE), which also contains wash-down water and 
chemical products used to clean the milking plant (50). This effluent is then either applied 
Introduction 
12   
to land, or treated and discharged into waterways. Discharge of treated effluents to 
waterways represents a potential risk for aquatic biota downstream. 
Table 1.6: Estimated loads of estrogen excreted from New Zealand livestock and human populations 
based on different emission rates. 
   Estimated total estrogen excretion (kg/yr) based on: 
Animal  
Population 
(000s)  Lange et al. (35) 
Johnson et al. 
(33) 
Blok & Wosten 
(34) 
Pig  356 a  16 27 72 
Laying hens  3,325 b  24 11 8,561 
Dairy cattle c  5,110 d  4,202 2,281 43,995 
Broiler chicken  12,513 b  2.6 5.5 937 
Sheep  35,897 d  619 124 NC 
Total livestock  60,514  4,918 3,928 54,896 
Humans  4,135 e  NC 26 391 
Total humans & 
livestock  64,649  4,918 3,953 55,286 
Note: a Data from 2003 agricultural production census (51). b Data from 2002 agricultural production census 
(52). c Dairy cattle estimate does not include contribution from calves as this was not included by 
Johnson et al. (33). d Data from 2007 agricultural production census (53). e Data from 2006 census (54). 
1.3.4 Treatment and Disposal of Agricultural Wastes 
Removal of steroid estrogens in sewage treatment plants (STPs) has been well-
characterised over the past ten years, with the primary removal processes identified as 
sorption to solids and aerobic degradation (55). Conjugated estrogens are removed by 
initial hydrolysis to free forms within the sewerage system and in sewage treatment 
plants (55), and are then removed as free estrogens. Removal in agricultural waste 
treatment systems is not as well-characterised, particularly for liquid wastes. 
Furthermore, the treatment of agricultural wastes is typically more rudimentary than 
treatment of sewage. Initial studies indicate 44-99% of steroid estrogens in swine or dairy 
wastewaters are removed following anaerobic sludge treatment or passage through 
lagoons or wetlands (41,44,48). Initial studies in New Zealand (40) demonstrated the 
presence of steroid estrogens in DSE treated through pond systems, suggesting removal is 
not as good in these systems. 
Approximately one-third of farms in the Waikato Region, the largest dairy farming region 
in New Zealand, continue to discharge treated DSE to waterways. If estrogens are not  
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adequately removed during treatment, as suggested from preliminary data, DSE 
discharged into waterways potentially represent the major source of estrogens to New 
Zealand’s aquatic environments and a high risk to aquatic biota downstream.  
1.4 THESIS RATIONALE AND OBJECTIVES 
As described in the preceding sections, endocrine disruption and the presence of 
estrogenic compounds in aquatic environments is of world-wide concern. Much of the 
research to date has investigated sewage treatment plants as major contributors of steroid 
estrogens and xenoestrogens. Recently agricultural effluents have been identified as likely 
sources of steroid estrogens into the environment and this is of particular concern in New 
Zealand, a country whose economy largely depends on agriculture. Initial investigations 
in New Zealand (40,56) indicate that significantly higher concentrations of steroid 
estrogens are likely be found in dairy effluents when compared to concentrations in STP 
effluents. 
Based on this, the overall aim of this thesis was to assess whether dairy shed effluents 
contribute significant amounts of steroid estrogens to New Zealand’s aquatic 
environment. 
Specific objectives were as follows:  
1. To develop a method to enable the analysis of free and conjugated estrogens in dairy 
shed effluents and environmental samples.  
2. To determine levels of free and conjugated estrogens in dairy effluents and compare 
results with those generated using biological assays. 
3. To assess whether estrogens are removed in dairy effluent treatment systems used 
prior to discharge of effluents to aquatic receiving environments. 
4. To investigate the presence of steroid estrogens and estrogenic activity in aquatic 
receiving environments in catchments with a high proportion of dairy land use.  
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1.5 THESIS STRUCTURE 
This thesis is presented in six chapters following this introduction. Because each chapter, 
with the exceptions of this introduction and the final chapter, is presented as a stand-
alone paper, there is some repetition between chapters particularly with respect to 
experimental methods. 
Chapter 2 reviews analytical methods for analysis of free and conjugated estrogens in 
wastewaters. 
Chapter 3 describes the development of analytical methods to detect and quantify steroid 
estrogens and conjugated estrogens in dairy shed effluents and environmental samples. 
Chapter 4 presents the results of a survey of estrogens and estrogenic activity in dairy 
shed effluents from farms in the Canterbury and Waikato regions of New Zealand. 
Chapter 5 presents an investigation of estrogen removal comparing a traditional two-
pond based system with an advanced pond system used to treat dairy effluents in the 
Waikato Region of New Zealand. 
Chapter 6 compares the estrogenic activity of DSE samples measured in the E-Screen 
assay with that in receptor-reporter gene yeast based assays. 
Chapter 7 describes preliminary investigations into the presence of steroid estrogens and 
estrogenic activity in aquatic receiving environments in catchments with predominantly 
dairy land use. 
Chapter 8 combines the findings of this thesis, discusses overall conclusions with 
reference to the objectives of the research and presents recommendations for future 
research. 
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Chapter 2:  Review of Methods to Analyse 
Estrogens in Wastewaters 
2.1 INTRODUCTION 
The steroid estrogens 17β-E2, E1, E3 and 17α-E2 can be measured either biologically 
utilising their common mechanism of action, or by targeted chemical analysis. The classic 
biological method for measuring estrogen induction of cell proliferation is an increase in 
rat uterine wet weight (23). Due to the length of time and ethical considerations with this 
in vivo test, a range of in vitro assays have been developed and have since been used to 
screen compounds and environmental samples for estrogenic activity. The mechanisms, 
advantages and disadvantages of in vitro bioassays are briefly discussed in this chapter. 
Chemical methods for the analysis of free estrogens in sewage influents and effluents, and 
in some agricultural wastes have been published. These methods are typically based on  
GC-MS or LC-MS and these are briefly reviewed. 
The analysis of conjugated estrogens is very challenging, and is particularly demanding in 
wastewaters due to their high complexity. There are far fewer published studies of these 
compounds. Nonetheless, there are a growing number of studies analysing conjugated 
estrogens in addition to free estrogens in sewage (16,57-64), surface waters and river 
sediments (65,66). Additionally, a recent paper has assessed conjugated estrogens in 
agricultural wastewaters (43). 
Historically, analysis of conjugated estrogens (e.g., in urine or plasma) used methods 
based on the hydrolysis of conjugated estrogens into the free form followed by analysis as 
free estrogens. These hydrolysis methods have been used to measure conjugated 
estrogens in STP influents and effluents. However, these polar compounds are well-suited 
to analysis by LC-MS and these instruments are now widely available. The methods 
reviewed in this chapter focus on those utilising LC-MS(MS) analysis. In addition to 
analysis, sample preservation and preparation procedures are reviewed. 
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2.2 IN VITRO BIOASSAYS 
In general, in vitro assays tend to be very sensitive, repeatable and low cost, and can 
provide information on mechanisms of estrogen action (67). In vitro bioassays measure all 
estrogenic compounds present in environmental samples based on their biological 
activity, and do not require prior knowledge of the chemical constituents. Measurements 
include the contribution from any steroid estrogens, phytoestrogens, mycoestrogens and 
xenoestrogens present in a sample. In this way they provide an integrated measurement 
of estrogenic activity that organisms may be exposed to. In environmental samples, 
results are typically expressed as 17β-estradiol-equivalents (EEQ, usually in ng/L) by 
comparison to the response of pure 17β-estradiol in that assay. 
The in vitro assays can be classified into three groups: receptor binding assays, receptor-
reporter gene assays and cell proliferation assays. The mechanisms, advantages and 
disadvantages of these groups are summarised briefly below. These aspects, specific 
examples of assays, and their protocols have been previously reviewed in detail (67-70). 
Receptor binding assays are based on the primary mechanism of action of estrogenic 
compounds, which is binding to the estrogen receptor (ER). Typically, samples are added 
to a preparation of estrogen receptors along with radiolabelled 17β-E2 and the amount of 
17β-E2 competitively displaced is determined. Estrogen receptors for these assays have 
been isolated from mammalian tissues, such as rat (71,72) or sheep (31) uteri, and fish 
tissues such as rainbow trout livers (73,74). A more novel method is to extract receptors 
produced by recombinant E. coli (75) or human liver cancer cells (76). A disadvantage of 
receptor binding assays for environmental samples is that they merely indicate the 
presence of compounds able to bind to the estrogen receptor. This does not imply that 
they can elicit an ER-mediated response, as the compounds may be either estrogen 
agonists or antagonists. Furthermore, as these assays are extra-cellular, they cannot 
account for differences in cell uptake or metabolism of chemicals. 
Receptor-reporter gene assays require not only that a compound bind to the estrogen 
receptor, but that they induce receptor-mediated transcription and therefore measure 
agonists only. Reporter gene assays are usually based on yeast, fish or mammalian cells, 
genetically modified by adding a reporter gene sequence that encodes for transcription of 
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a protein such as galactosidase or luciferase, which is then measured directly or indirectly. 
In yeast cell assays, an estrogen receptor (typically hERα) must also be inserted into the 
cell along with the reporter-gene sequence, while the mammalian and fish cell lines 
contain endogenous receptors. These assays have been used the most frequently for 
assessing estrogenicity of environmental samples, particularly the YES (Yeast Estrogen 
Screen) assay. 
Cell proliferation assays use estrogen responsive cancer cell lines that proliferate in the 
presence of estrogenic compounds. The most commonly used assay is the E-Screen, which 
uses MCF-7 (human breast cancer) cells. Cells are exposed to estrogenic samples, 
incubated for 4-6 days, and the increase in number of cells is directly or indirectly 
measured (e.g., measuring protein or metabolised dyes) (70). The long incubation time, 
variation between cell lines, and poor reproducibility between laboratories may decrease 
the utility of the E-Screen assay, however it remains one of the most sensitive in vitro 
assays for assessing estrogenic activity in environmental samples (67).  
2.3 CHEMICAL ANALYSIS OF FREE ESTROGENS 
While bioassays provide information on the potential effects of effluents or other 
environmental samples, when used in isolation they provide no information on the 
causative compounds, which is essential for managing sources of estrogenic 
contamination. Chemical analyses typically target particular compounds or groups, 
although broad screen approaches have also been used. The targeted approach is most 
applicable when measuring trace levels of analytes in complex samples, as procedures are 
specifically adapted for the chemical properties of target analytes while interfering 
compounds in the samples are discarded or eliminated as far as possible. 
Specific analytical methods for quantifying free estrogens in environmental samples have 
been reviewed for a range of matrices including surface waters (77-79), municipal 
wastewaters (80), sludges, sediments and soils (81). The analyses of a broader range of 
estrogenic compounds and other endocrine disrupting compounds are reviewed in 
references (28,82,83) and those cited therein. 
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Because free estrogens are present at low concentrations in wastewaters (ng/L), large 
volume samples must be extracted and concentrated to allow their measurement. Solid 
phase extraction is a convenient way to do this and has been most widely used in this 
field, whereas liquid-liquid extraction is rarely used. Reverse-phase sorbents are typically 
used, such as C18 or carbograph, though more recently there has been a move towards 
newer phases such as divinylbenzenes (DVBs) and mixed-mode sorbents. After extraction 
of typically 0.5 L (sewage influents), 1 L (sewage effluents) or 2 L (waters), free estrogens 
retained on the cartridges can be eluted in a small volume of solvent, thus concentrating 
samples by a factor of 50-200. 
Subsequent cleanup of free estrogens depends on the sensitivity and selectivity of the 
quantitation method, but is generally required for sewage influents, effluents and 
agricultural wastes. The most commonly used clean-up strategies for free estrogens are 
based on adsorption/partition chromatography on SPE columns, using silica (84,85), 
florisil (58,63,86), C18 (57), aminopropyl (87) or a combination (88). GPC has been used to 
remove high molecular weight interferences before GC-MS analysis (65,89). Novel 
methods reported include strong anion exchange (65) and immunoaffinity adsorption 
chromatography (90). 
Most methods for quantitation of natural estrogens in waters and wastewaters use 
selective and sensitive techniques such as LC-MS(MS) or GC-MS(MS), though 
derivatisation to more volatile compounds is required for the latter. While LC-MS is more 
appropriate for semi-polar analytes such as estrogens without the need for derivatisation, 
detection limits have generally been too high for environmental samples, particularly for 
complex matrices such as sewage wastes, where ionisation suppression further increases 
detection limits. LC-MS-MS is becoming more common for analysis of environmental 
estrogens as these instruments become more widely available and they are able to achieve 
detection limits comparable to, or better than, GC-MS. Aspects of mass spectrometry have 
been previously reviewed for the environmental analysis of free estrogens (91) and for 
analysis of a broader range of EDCs (92). 
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2.4 CHEMICAL ANALYSIS OF CONJUGATED ESTROGENS 
Analysis of conjugated estrogens can be important as they are the primary form excreted 
in urine by mammals and there is potential for them to be hydrolysed in the environment 
to the more potent free estrogens. There are a large number of conjugated estrogens that 
may be excreted by mammals and some of these are listed in Table 2.1 along with their 
physico-chemical properties. These compounds demonstrate a wide range in aqueous 
solubility and pKa, factors which have relevance to their extraction and subsequent 
analysis. 
Table 2.1: Physico-chemical properties of conjugated estrogens a. 
Name Abbrev. CAS. No. Mol. 
wt. 
Water 
solubility 
(g/L) 
logP Est. 
pKa 
Estrone-3-glucuronide E1-3G 2479-90-5 446.5 549 1.375 2.80 
Estrone-3-sulfate E1-3S 481-97-0 350.4 7.4 3.508 -3.84 
17β-Estradiol-3-
glucuronide 
E2-3G 15270-30-1 448.5 410 1.818 2.80 
17β-Estradiol-17-
glucuronide 
E2-17G 1806-98-0 448.5 440 2.109 2.82 
17β-Estradiol-3-sulfate E2-3S 481-96-9 352.4 4.2 3.951 -3.82 
17β-Estradiol-17-sulfate E2-17S 3233-69-0 352.4 2.0 4.399 -3.50 
17β-Estradiol-3,17-
disulfate 
E2-3,17S 3233-70-3 432.4 6.9 4.219 -3.99 
17β-Estradiol-3-
glucuronide, 17-sulfate 
E2-3G,17S 84123-28-4 528.5 914 2.087 -3.49 
17β-Estradiol-3-sulfate, 17-
glucuronide 
E2-3S,17G 26923-03-5 528.5 999 1.929 -3.82 
17α-estradiol-3-sulfate 17α-E2-3S 22139-70-4 352.4 4.2 3.951 -3.82 
17α-estradiol-17-
glucuronide 
17α-E2-17G 33602-53-8 448.5 440 2.109 2.82 
Estriol-3-glucuronide E3-3G 2479-91-6 464.5 999 0.631 2.80 
Estriol-3-sulfate E3-3S 481-95-8 368.4 20 2.764 -3.82 
Notes: a Data sourced from SciFinder Scholar (American Chemical Society), calculated using Advanced 
Chemistry Development (ACD/Labs) Software V8.14 for Solaris. 
2.4.1 Sample Handling and Preservation 
Appropriate sample preservation is required to prevent the hydrolysis of conjugated 
estrogens to their free forms in the presence of bacteria, particularly in sewage influents. 
However, few studies have preserved samples and have relied on rapid extraction of the 
samples and storage at < 4 °C. Reddy et al. (93) compared sample preservation for 
conjugated estrogens and found that the addition of mercury chloride (50 mg/L) or 
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formaldehyde (0.4%) did not prevent hydrolysis of 17β-estradiol-3-glucuronide in sewage 
effluents and influents, even within the short period between sample collection, filtration 
and extraction, while acidification with sulfuric acid to pH 2 did prevent hydrolysis. 
Similarly, a Danish Environmental Protection Agency study (64) demonstrated the 
stability of conjugated estrogens spiked into STP effluents that were preserved by 
acidifying to pH 3 with sulfuric acid and storing at 4 °C. This study also demonstrated no 
appreciable loss of conjugated estrogens to glass sampling bottles, and no difference 
between untreated and silanised glassware (64). 
2.4.2 Sample Extraction 
All methods reviewed (Table 2.2) have utilised SPE, generally in cartridge form, to extract 
conjugated estrogens from aqueous samples after filtering to remove gross particulate 
material (usually through glass fibre filters, in particular GF/C). Internal standards are 
usually added at this stage and in some cases samples have been acidified prior to SPE 
procedures (58,60).  
Solid phases used include C18 silica-bonded phases that are frequently used for extracting 
free steroids, but divinylbenzene phases or graphitised carbon sorbents are now more 
commonly used (Table 2.2). Divinylbenzene sorbents (EDS-1, Oasis HLB) have 
hydrophilic properties in addition to the hydrophobic properties of C18 sorbents, which 
enhance the adsorption of the more polar conjugated estrogens, in addition to extracting 
free estrogns. Graphitised carbon sorbents (ENVI-Carb and Carbograph) are increasingly 
used as they also have good affinity for polar compounds within aqueous matrices. 
Matejicek et al. (66) demonstrated that Oasis WAX could also be used to extract 
conjugated and free steroid estrogens from a water:methanol extract of sediment, with 
recovery slightly better than Oasis HLB; however these cartridges have not yet been 
applied to the extraction of wastewater or surface water samples. 
Conjugated and free estrogens may be eluted in a single step (88,94-96) or can be 
selectively eluted from the SPE phases and recovered as separate fractions allowing for 
separate and optimised clean-up methods and/or instrumental analysis. The solvent used 
varies but for conjugated estrogens is typically methanol, or methanol mixtures, with  
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Table 2.2: Analytical methods for the analysis of conjugated estrogens in wastewaters and other aqueous environmental samples. 
Analytes Sample type & vol. SPE Elution solvent  Clean-up Analysis Detection limits Year Ref 
E1-3G, E1-3S, E2-3G, E2-
3S, E2-17G, E3-3G, E3-16G, 
E3-3S 
100 mL STP influent 
250 mL STP effluent 
2 L river water 
Carbograph 10 mL DCM:MeOH 
(80:20), with 5mM 
TMACl 
None LC-ESI(-)-
MS-MS 
0.005-0.63 ng/L river water 
0.04-6.0 ng/L STP effluent 
0.2-15.0 ng/L STP influent 
2002 (62) 
E1-3G, E1-3S, E2-3G, E2-
3S, E2-17G, E3-3G, E3-16G, 
E3-3S 
5mL urine 
50 mL septic tank 
100 mL STP influent 
250 mL STP effluent 
Carbograph 20 mL DCM:MeOH 
(60:40), with 10 mM 
sodium acetate 
None LC-ESI(-)-
MS-MS 
0.3-12 ng/L effluent 
0.8-30 ng/L influent 
2003 (16) 
E1-3G, E1-3S, E2-3G, E2-
3S, E2-17G, E2-3G,17S, E2-
3S,17G, E2-3,17diS, E3-3G, 
E3-3S 
1 L effluent, river 
water 
EDS-1 10 mL MeOH with 
5 mM TEA 
None LC-ESI(-)-
MS-MS 
0.1-3.1 ng/L 2003 (58) 
E1-3S, E1-3G, E2-S, E2-G, 
E2-S,G, E2-diS, E3-G, E3-Sb 
500 mL STP effluent Oasis HLB 6 mL MeOH (incl. free 
estrogens) 
Florisil and NH2-SPE LC-ESI(-)-
MS-MS 
0.1 – 1.3 ng/L 2004 (88) 
E1-3G, E1-3S, E2-3G, E2-
3S, E2-17G, E2-17S 
0.5 L STP influent 
1 L STP effluent 
Oasis HLB 8mL MeOH:MQ 
(75:25) with 2% 
NH4OH, 
Fractionation using 
WAX HPLC column 
with phosphate saline 
buffer 
LC-ESI(-)-
MS-MS 
0.04-0.28 ng/L MQ 
0.05-0.16 ng/L influent 
2005 (93) 
E1-3S, E1-3G, E3-16G, EE2-
3S, EE2-3G 
500 mL STP influent tC18 (Sep-Pak) 2mL ACN/MQ (70:30) 
(incl. free estrogens) 
None LC-ESI(-)-
MS 
0.8 – 4.5 ng/L DW; 1.9 – 7.1 
ng/L influent 
2005 (94) 
E1-3S and E2-3S 1 L STP effluent DVB-Phobic 
Speedisk 
(Baker) 
15 mL MTBE then 15 
mL MeOH (incl. free 
estrogens) 
GPC on Phenogel 
columns with 
THF:acetone (70:30) 
LC-ESI-MS 0.6-1.8 ng/L tap water a 
4-28 ng/L influent a 
2005 (96) 
E1-3S, E1-3G, E2-3S, E2-
3G, E3-3S, E3-3G 
2 L river, estuarine 
waters 
ENVI-CARB DCM:MeOH (80:20), 
with 5 mM TMACl 
None LC-ESI(-)-
MS-MS 
0.4-0.9 ng/L, matrices not 
stated, 12 ng/L for E3-3G 
2006 (63) 
E1-3G, E1-3S, E2-3G, E2-
3S, E2-17G, E2-17S, αE2-3S, 
E2-3G,17S, E2-3S,17G, E2-
3,17diS, E2-3,17diG, E3-3G, 
E3-3S 
100 mL agricultural 
effluents 
Carbopack 10 mL DCM:MeOH 
(80:20), with 5mM 
TMACl 
None LC-ESI(-)-
MS-MS 
Not reported 2007 (43) 
E1-3S 1 L sewage C18 10 mL MeOH then 
10 mL DCM (incl. free 
estrogens) 
GPC on PLgel columns 
with DCM:MeOH 
(90:10) then NH2-SPE  
LC-ESI(-)-
MS-MS 
0.1 ng/L, influent and 
effluent (E1-3S only) 
2007 (95) 
Notes: a Limit of quantitation reported only. b Positions of glucuronide and sulfate groups not specified. 
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the addition of an ion pair reagent such as tetramethyl-ammonium chloride (16,43,94), 
triethylamine (58,60) or ammonium hydroxide (93) to improve the recovery of the acidic 
conjugates. Free estrogens may be eluted before or after elution of conjugated estrogens, 
usually with MeOH (60) MeOH:DCM mixtures (16,43,62,63) or ethylacetate (58,65,93). To 
elute conjugated estrogens along with free estrogens from C18 sorbents, an 
acetonitrile:water mixture (70:30) (94) and MeOH followed by DCM (95) have been 
successfully used. MeOH has been used for elution from Oasis HLB sorbent (88) and 
MTBE followed by methanol for DVB sorbents (96). 
2.4.3 Purification of Extracts 
In many cases, conjugated estrogen analysis proceeded with no further purification of 
sample extracts (Table 2.2); however, to reduce matrix suppression in LC-MS-MS analysis, 
sample clean-up is generally required for complex samples such as sewage influents. 
Sample cleanup has been based on selective removal of high molecular weight 
interferences using GPC (95,96), or utilising the anionic nature of conjugated estrogens on 
anion exchange columns in either SPE (65,88,95) or HPLC format (93). 
2.4.4 LC-MS Analysis 
Separation of conjugated estrogens (usually along with free estrogens) has invariably been 
performed on C18 columns or modified C18 columns with methanol:water or 
acetonitrile:water mobile phases. There are contradictory reports for the most appropriate 
solvent, with some authors reporting better sensitivity with acetonitrile (93) while others 
reported improved sensitivity with methanol (66). Acetonitrile has been used for the most 
part, possibly due to better separation achieved with this solvent (66). 
Mobile phase modifiers are generally required for adequate retention of the most polar 
conjugates. These are usually basic modifiers, such as ammonium hydroxide (63,66,93), 
methylamine (43) or triethylamine (58,65), to prevent tailing of the acidic conjugates. 
Conversely Gentili et al. (62) developed a separation method using formic acid in the 
mobile phase at pH 2.88, which provided sharper peaks than at higher pHs (adjusted with 
Review of analytical methods 
  23 
ammonia). Other authors have reported adequate retention and separation without 
modifiers (94,96).  
Due to the anionic nature of conjugated estrogens, all studies reviewed (Table 2.2) have 
employed ESI interfaces in the negative mode to ionise the conjugates. Analysis has been 
by tandem mass spectrometry using triple quadrupole instruments, with only two 
exceptions. One study demonstrated a method using an ion trap mass spectrometer to 
measure conjugates in sediments (66), and a single quadrupole instrument was used by 
Gomes et al. (94) to analyse STP influents. 
Limits of detection (LODs) vary according to analyte and matrix, with detection limits for 
river water samples typically in the sub ng/L range (0.1-1.0 ng/L) when using tandem 
mass spectrometry. Lower detection limits were usually achieved for 17β-E2- and E1- 
sulfates, with higher limits for glucuronides, especially E3-glucuronides, generally due to 
poorer recovery of these more polar conjugates (e.g., ref (62)) and higher instrument 
detection limits (e.g., ref (63)).  
LODs are often 10-fold higher for sewage effluents, and 20-fold higher for influents, with 
most studies reporting detection limits in the low ng/L range (Table 2.2), depending on 
the compound. Reddy et al. (93) achieved the lowest detection limits reported for sewage 
influents at 0.05-0.16 ng/L, analysing only 17β-E2 and E1 sulfates or glucuronides. 
2.4.5 Hydrolysis Methods 
As stated, several of the reviewed papers which analysed conjugated estrogens in 
environmental samples first subjected samples to a hydrolysis step to cleave conjugated 
estrogens. The liberated free estrogens were then measured using GC-MS or LC-MS 
methods, and concentrations of conjugates calculated from the difference in concentration 
when compared to the results obtained for untreated samples. The hydrolysis step has 
been undertaken both on raw samples (43,59,61), so that subsequent extraction 
procedures follow those for free estrogens; and on extracted samples (57,60,64), requiring 
that sample storage, extraction and elution methods are optimised for conjugated 
estrogens. 
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Hydrolysis of conjugated estrogens is typically carried out using the β-glucuronidase 
enzyme, extracted from either the bacteria Escherichia coli or the terrestrial snail Helix 
pomatia, both of which are commercially available. The source of the enzyme used may be 
important as β-glucuronidase from H. pomatia also has some sulfatase activity and 
therefore will also cleave both glucuronide and sulfate conjugates, while the enzyme from 
E. coli reportedly has no sulfatase activity (16,97,98). This difference can be utilised to 
provide information on the forms of conjugates present in a sample if enzymes from both 
sources are used, as demonstrated by Hoffman et al. (99) in their analysis of conjugated 
estrogens in urine from pregnant cows. 
Solvolysis can also be used to cleave sulfate-conjugates and may be required for disulfates 
and sulfo-glucuronides, which are reportedly resistant to enzyme treatment (59,64). 
Labadie and Budzinski (60) used acidic solvolysis (TFA in THF:MeOH 9:1), after an 
enzyme hydrolysis step using β-glucuronidase from H. pomatia, to further cleave 
conjugated estrogens in STP effluents. 
Although the cleavage of conjugated estrogens is reported to proceed with high efficiency 
when standard solutions are tested, conflicting results have been reported for analysis of 
environmental samples. Hutchins et al. (43) reported loss of 17β-E2 after enzyme 
hydrolysis and suggested that the extended reaction time at 37 °C allowed degradation of 
free estrogens in the unpreserved samples. Finlay-Moore et al. (100) similarly reported 
losses of free steroid hormones after a methanolysis step prior to measurement of free 
estrogens using enzyme immunoassay (EIA). The reaction using anhydrous methanolic 
HCl was substantially faster (5 min, at 60 °C), suggesting the free steroids may also 
degrade through other (non-biologically mediated) mechanisms. 
2.4.6 Alternative Methods 
Immunochemical methods of analysis such as enzyme immunoassays (EIA) and 
radioimmunoassays (RIA) are available for E1-3S and have been used to measure steroid 
concentrations in cattle urine (101) and faeces (102), though they have not yet been 
applied to environmental samples. Similar assays for the free estrogens have been used to 
measure estrogens in sewage effluents (103) and agricultural effluents (39,46), but suffer 
from problems with cross-reactivity, low reproducibility and false positives (79). It is 
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likely that the increasing availability of LC-MS instruments with high sensitivity and 
selectivity for multiple compounds will result in less frequent use of immunochemical 
methods in the future. 
2.4.7 Limitations in Analytical Methods 
There is no consistency between the methods published for analysis of conjugated 
estrogens, with respect to sample preservation, extraction sorbents, clean-up methods and 
analysis. Most studies did not preserve samples, despite two studies published in 2005 
indicating the importance of appropriate sample preservation to avoid losses. LC methods 
differ between studies, with conflicting results for sensitivity in the presence of different 
solvents or modifiers. For the many studies that used triple quadrupole instruments to 
generate tandem mass spectra, sample clean-up was unnecessary, however, this may not 
be the case when analysing samples with more difficult matrices than sewage effluents or 
river water.  There is a need for analytical methods that are applicable to a range of 
matrices including agricultural wastes and use widely available equipment and 
instrumentation.  
2.5 SUMMARY 
Biological methods for analysis of steroid estrogens are well-established, with numerous 
sensitive assays available which integrate the activity of mixtures. Chemical methods for 
free estrogens are typically based on GC-MS or LC-MS after sample extraction and 
concentration using SPE. 
Analysis of conjugated estrogens is more difficult due to their higher polarity and acidity. 
As for free estrogens, sample extraction is typically based on SPE methods, however, 
common reversed phase sorbents like C18 appear to be less suitable. Conjugated 
estrogens have most frequently been analysed using LC-MS-MS; when using triple 
quadrupole instruments, sample clean-up is often unnecessary and low detection limits 
(< 1 ng/L) can be achieved. Detection limits for sewage influents and effluents are 
typically higher than for surface or ground water samples. Samples with complex 
matrices are more likely to require clean-up prior to LC-MS analysis.  
Review of analytical methods 
26   
 
 
  
CHAPTER THREE 
 
DEVELOPMENT OF AN ANALYTICAL 
PROCEDURE FOR DETERMINATION OF 
ESTROGENS AND CONJUGATED ESTROGENS 
IN DAIRY SHED EFFLUENT AND 
ENVIRONMENTAL WATER SAMPLES 
 
 
 
  
   27 
Chapter 3:  Development of an analytical 
procedure for determination of estrogens 
and conjugated estrogens in dairy shed 
effluent and environmental water samples 
3.1 INTRODUCTION 
The measurement of free and conjugated estrogens in DSE samples requires a sensitive 
and selective method. Chemical analysis of these compounds is challenging due to their 
low concentrations and is particularly demanding in wastewaters due to their high 
complexity. Consequently, methods based on mass spectrometry are the most applicable 
and have been used in many published studies (reviewed in Chapter 2). 
Triple quadrupole LC-MS-MS instruments have been the most frequently used for 
analysis of conjugated estrogens, due to their superior selectivity and sensitivity, however 
alternative instruments such as time-of-flight and ion trap are lower cost and being 
increasingly used for environmental applications (104). Time-of-flight MS (TOF-MS) 
instruments provide high mass resolution (typically >5000 FWHM), allowing the 
separation of analytes from isobaric interferences and measurement of accurate mass aids 
in unequivocal identification (105). Ion trap MS (IT-MS) instruments can perform tandem 
MS, making them highly selective, and can perform MSn experiments, aiding the 
identification of unknowns. 
LC-MS methods based on ESI can experience ionisation suppression due to matrix 
components, which results in loss of sensitivity (106). Sample preparation is therefore an 
important step in enriching trace analytes while reducing matrix interferences to improve 
method detection limits. This is extremely important for analyses of free and conjugated 
estrogens in treated and untreated animal wastes and effluents. These represent highly 
complex mixtures, containing extremely high concentrations of a multitude of organic 
compounds, with a wide range of chemical structures and functionality. 
Though sample clean-up is essential, each additional step in an analysis method can lead 
to reduced recovery. The overall recovery can be assessed by spiking blanks and samples, 
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and using the measured recovery to adjust the measured concentration of analytes in the 
samples. However this approach relies on the assumption that recovery will be constant 
for each sample. In addition, efficacy in derivatising analytes, variation in injection 
volumes, and matrix suppression or enhancement in the instrumental analyses each 
contribute to inaccuracies in the final concentration (107). These errors can be overcome 
by the use of surrogate internal standards (107,108). Isotopically labelled versions of the 
analytes make ideal surrogates, being as chemically similar to the analyte as possible,  
thus ensuring they act similarly through sample extraction, preparation and 
chromatography (107,108). Isotope dilution analysis has been widely used in trace 
environmental analysis, including that of emerging contaminants (104). 
This study aimed to develop a method to analyse both free and conjugated estrogens in 
DSE samples. The applicability of LC-TOF-MS and LC-IT-MS instruments for analysis of 
conjugated estrogens was assessed. A previously developed method to analyse free 
estrogen steroids based on derivatisation and GC-MS analysis (40) was adapted for 
analysis of DSE samples. Sample clean-up methods were trialled for their suitability for 
analysis of DSE samples, and isotope dilution was used for target analyte quantitation. 
Whilst many of the procedures used in this study were adapted from previously 
published steps, considerable changes were made to develop a method to allow for the 
analysis of both free and conjugated estrogens in DSE samples, a matrix in which they 
had not both been examined previously. The developed method was also assessed for its 
applicability to analysing free and conjugated estrogens in stream water samples. 
3.2 MATERIALS AND METHODS 
3.2.1 Materials 
17β-estradiol (E2), 17α-estradiol (17α-E2), estrone (E1), estriol (E3), ethynylestradiol (EE2) 
and 17β-estradiol-17-acetate (E2-17Ac) were purchased from Sigma-Aldrich (Auckland, 
New Zealand). The following conjugated estrogens were also purchased from Sigma-
Aldrich as sodium or potassium salts: estrone-3-glucuronide (E1-3G), estrone-3-sulfate 
(E1-3S), 17β-estradiol-17-glucuronide (E2-17G), 17β-estradiol-3-glucuronide (E2-3G), 17β-
estradiol-3-sulfate (E2-3S), estriol-3-sulfate (E3-3S), estriol-3-glucuronide (E3-3G), 17β-
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estradiol-3,17-disulfate (E2-3,17diS) and estradiol-3-sulfate-17-glucuronide (E2-3S,17G). 
17α-estradiol-3-sulfate sodium salt (17α-E2-3S) and 17β-estradiol-17-sulfate sodium salt 
(E2-17S) were purchased from Steraloids (Rhode Island, United States). 17β-estradiol-
2,4,16,16-d4 (E2-d4, min. 98% labelled), estrone-2,4,16,16-d4 (E1-d4, min. 98% labelled), 
ethinylestradiol-2,4,16,16-d4 (EE2-d4, min. 98% labelled), sodium 16β-estradiol-2,4,16,16-
d4-3-sulfate (E2-3S-d4, min. 98% labelled) and sodium estrone-2,4,16,16-d4-3-sulfate (E1-3S-
d4, min. 98% labelled) were purchased from C/D/N Isotopes (Quebec, Canada). Stock 
standards were prepared from the solids to concentrations of approximately 1 mg/mL in 
either acetone (free estrogens) or MeOH (conjugated estrogens). Working standards of the 
isotopically-labelled standards were prepared at 10 µg/mL in acetone (free estrogens) or 
MeOH (conjugated estrogens) for spiking samples. This ensured that the volume of 
solvent used in spiking did not affect sample extraction or recovery. 
ENVI-18 cartridges (1 g) were purchased from Supelco (Auckland, New Zealand), Oasis 
HLB cartridges (500 mg) were purchased from Waters (Auckland, New Zealand), florisil 
columns (1 g) and bulk aminopropyl packing were purchased from IST (Auckland, New 
Zealand). JT Baker aminopropyl, silica, florisil and diol SPE cartridges (each 500 mg) and 
cyclohexyl, cyano and C8 SPE cartridges (each 100 mg) were purchased from Biolab 
Group (Auckland, New Zealand). Phenyl SPE cartridges (100 mg) were purchased from 
Alltech (Auckland, New Zealand). Sephadex TM LH-20 was purchased from Pharmacia 
Biotech AB (Uppsala, Sweden). Solvents used were of HPLC or pesticide residue grade 
(Malinkrodt, Biolab Group NZ) or double distilled from analytical grade. Other reagents 
were analytical grade. Purified water (MQ) was obtained from in-house water purification 
systems (Millipore). 
3.2.2 SPE Procedures 
The SPE systems tested for the extraction and recovery of free estrogens are listed in Table 
3.1. Mixed standards in MeOH at concentrations of 1 and 10 µg/ml were used to add 25 
and 250 ng of each free and conjugated estrogens. Approximately 5 mL of water was 
added to the column reservoir of each cartridge and then a 250 µL aliquot of each mixed 
standard was added. Cartridges were eluted with the solvents listed (Table 3.1). 
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Table 3.1: SPE systems used for extraction and elution of free estrogens 
SPE cartridge Pre-conditioning Elution 
ENVI-18 (1 g) 10 mL acetone, 10 mL water 2 x 10 mL acetone 
Oasis HLB 
(500 mg) 
10 mL MeOH, 10 mL water 8 mL MeOH  
Oasis HLB 
(500 mg) 
10 mL MeOH, 10 mL water 8 mL ethyl acetate 
Oasis HLB 
(500 mg) 
10 mL MeOH, 10 mL water 30 mL DCM:diethylether:MeOH (40:10:1) 
To assess the extraction of conjugated estrogens, standards were loaded onto Oasis HLB 
columns. The cartridges were washed after loading using the procedure described by 
Reddy and Brownawell (109), with 30% MeOH:water containing 2% acetic acid (8 mL), 
followed by 60% MeOH:water containing 2% acetic acid (8 mL) and finally 30% 
MeOH:water containing 2% ammonium hydroxide (4 mL). The conjugated estrogens 
were then eluted with 75% MeOH:water containing 2% ammonium hydroxide (8 mL, 
(109)). The SPE columns were then dried under vacuum to remove residual water before 
elution of free estrogens using the DCM:diethylether:MeOH mixture. 
3.2.3 Sample Clean-Up Procedures for Free Estrogens 
Initially clean-up procedures for free estrogens used GPC followed by silica gel 
adsorption chromatography based on Sarmah et al. (40). Standards and sample extracts 
from SPE elution were dried under nitrogen and reconstituted in 0.5 mL of DCM for 
injection onto GPC. The GPC system consisted of a Shimadzu LC-10AT VP pump, SIL-
10AF auto-injector, SPD-10A UV-Vis detector and FRC-10A fraction collector. Biobeads 
SX-8 was packed into two 440 mm by 10 mm ID glass columns connected in series, with 
DCM as mobile phase, pumped at a flow rate of 1.4 mL/min. The fraction where free 
estrogens eluted (from 24-42.5 min) was collected for analysis. 
The analyte fraction from GPC was next dried down and reconstituted in 1 mL of 
hexane:acetone (65:35) for silica gel chromatography, based on the method reported by 
Ternes et al. (2002). One gram of silica gel (Merck Si 60, activated at 150 °C for 8 h, 
deactivated with 1.5% water) was made into a slurry with hexane:acetone and packed into 
a small glass column (ID 8 mm). The extract collected from GPC was quantitatively added 
to the column with 3 x 1 mL washes of hexane:acetone, and eluted with 5 mL 
hexane:acetone.  
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The second method for purification of the free estrogens combined elution from the Oasis 
SPE cartridges and clean-up in a single step. The dried Oasis HLB cartridge was 
connected in series to aminopropyl sorbent (500 mg) added to the top of a florisil 
cartridge (1 g), previously washed with acetone (10 mL). Free estrogens were eluted from 
the Oasis SPE and through the clean-up cartridges with 30 ml of DCM:diethyl 
ether:MeOH (40:10:1).  
An alternative GPC procedure followed this step, using the same set-up as described 
above, but with two Phenogel SEC columns (5 µm particle size, 7.8 mm I.D., 600 mm and 
300 mm, Phenomenex, Auckland, NZ) connected in series. Again, DCM was used as 
mobile phase, pumped at a flow rate of 0.5 mL/min. Standards (for recovery testing) and 
sample extracts from the SPE were dried under nitrogen and reconstituted in 0.25 mL of 
DCM for injection. The fraction from 42 to 62 min, containing the estrogens, was collected. 
This fraction was dried under nitrogen in preparation for derivatisation and GC-MS 
analysis. 
3.2.4 Sample Clean-Up Procedures for Conjugated Estrogens 
Several methods were tested for their suitability to clean-up samples for conjugated 
estrogen analysis, including GPC, HPLC fractionation and various SPE adsorbents (Table 
3.2). Mixed standards of conjugated estrogens were used to assess recovery through each 
method. Quantitation of analyte recovery was undertaken using LC-TOF-MS as described 
below. The final method selected for sample clean-up is described in more detail below. 
For the finalised clean-up procedure, the conjugated estrogen fraction eluted from the 
Oasis HLB was dried under nitrogen and resuspended in MeOH (250 µL) for clean up 
through two SPE phases. Pre-packed silica columns (500 mg) were preconditioned with 
5 mL of chloroform, then samples were transferred with three rinses of chloroform that 
were also transferred to the column reservoir. A further 1.55 mL of chloroform was added 
to the column reservoir give a maximum of 11% MeOH in chloroform. This mixed solvent 
solution was passed through the silica columns. The retained conjugate steroids were 
eluted from the silica columns with 20 mL of chloroform:MeOH (1:1) and dried under 
nitrogen. The conjugate steroids were reconstituted in MeOH in preparation for cleanup 
on aminopropyl columns (500 mg). The cartridges were conditioned with a sequence of 
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Table 3.2: Methods tested for clean-up of conjugated estrogens 
Method Column / stationary 
phase details 
Mobile Phase / 
Solvent 
Instrumentation 
GPC Phenogel SEC columns 
(7.8 mm x 200 mm and 
300 mm, 5 µm particle 
size, Phenomenex) 
THF / acetone (70:30) Shimadzu system 
incorporating LC-4A 
pump attached to 
Shimadzu SPD-2AS UV 
spectrophotometer and a 
Hewlett-Packard 3390A 
integrator 
GPC Phenogel SEC columns 
(as above) 
DCM / MeOH (50:50) As above 
GPC Sephadex TM LH-20 
packed in glass column 
9 mm x 450 mm)  
MeOH None required 
GPC/Partition Sephadex TM LH-20 
packed in glass column 
9 mm x 450 mm)  
Chloroform / MeOH 
(50:50) 
None required 
HPLC 
(reversed 
phase) 
Luna C18 (10.0 mm x 
250 mm, 5µm, 
Phenomenex) 
Water with 0.1% TFA, 
acetonitrile (variable 
concentrations) 
Dionex system 
incorporating P680 HPLC 
pump, ASI-100 
autosampler and TCC-
100 column oven 
attached to a UVD340U 
diode array detector, 
controlled by HP 
computer 
SPE  
(normal 
phase) 
Florisil, silica and diol 
(500 mg) 
DCM / MeOH 
mixtures and 
chloroform / MeOH 
mixtures 
None required 
SPE (reversed 
phase) 
Cyclohexyl, cyano, C8, 
phenyl (100 mg) 
MeOH / water 
mixtures 
None required 
SPE (anion 
exchange) 
Aminopropyl (500 mg) MeOH containing 5% 
ammonia 
None required 
 
MeOH, water and MeOH again. The MeOH extracts were loaded onto the aminopropyl 
columns, washed with 1 ml MeOH and eluted with 2 x 3mL MeOH containing 5% 
ammonia. Samples were dried under nitrogen and reconstituted in ammonium acetate 
buffer (0.01 mM) with 12% acetonitrile for LC-MS determination. 
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3.2.5 LC-MS Determination of Conjugated Estrogens 
LC-TOF-MS analysis 
Conjugated steroid estrogens were quantified using a Waters 2690 LC (Waters, USA) 
liquid chromatograph attached to a Micromass LCT TOF-MS operating in the negative ion 
mode. Separation was performed on an X-Bridge C18 column (150 mm x 1.0 mm I.D., 
3.5 µm particle size, Waters, USA) at 28 °C. The mobile phases were (A) MQ containing 
ammonium acetate buffer (0.01 mM), and (B) 60% acetonitrile with ammonium acetate 
buffer (0.01 mM); the flow rate was 50 µL/min. Initial conditions of 10%B were held for 
1 min, then increased linearly to 80% B at 24 min, held for 4 min then reset to the original 
conditions. 
The mass spectrometer was operated in negative mode electrospray ionization, with 
conditions optimized as follows: capillary voltage of -2600 V, sample cone voltage of -
38 V, extraction cone voltage 4V, source temperature of 100 °C, desolvation temperature 
200 °C, and MCP detector at 2600 V. Spectra were acquired over the 70-800 m/z range. 
The instrument was calibrated externally with sodium formate and the resolution was at 
least 4500 FWHM.  
Retention times and m/z ratios used for detection of the individual compounds are listed 
in Table 3.3. Data acquisition was carried out using MassLynx 4.0 software and the All 
File Accurate Mass Measure (AFAMM) software was used to calibrate the mass of 
analytes according to the reference mass of the isotopically labelled internal standards 
(E2-3S-d4 and E1-3S-d4). Linear nine-point calibration curves were made for each of the 
analytes (5-1000 ng/ml, r2>0.99). Analytes were quantified by isotopically labelled 
internal standardization against E2-3S-d4 and E1-3S -d4. 
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Table 3.3: Retention times and TOF-MS detection parameters for the conjugated estrogens 
Compound Rt (min) Selected Ion m/z 
E3-3G 3.47 [M-H]- 463.1968 
E2-3S,17G 4.19 [M-H]- 527.1507 
E3-3S 6.77 [M-H]- 367.1215 
E2-3,17-diS 9.94 [M-SO3H]- 350.1188 
E2-3G 12.02 [M-H]- 447.2019 
E2-17G 13.89 [M-H]- 447.2019 
E1-3G 16.74 [M-H]- 445.1862 
E2-3S 21.41 [M-H]- 351.1266 
E2-3S-d4 21.41 [M-H]- 355.1517 
17α-E2-3S 22.61 [M-H]- 351.1266 
E1-3S 23.68 [M-H]- 349.1110 
E1-3S-d4 23.68 [M-H]- 353.1361 
LC-IT-MS analysis 
Conjugated estrogens were analysed using an LTQ linear ion trap mass spectrometer 
fitted with an ESI interface (ThermoQuest, Finnigan, San Jose, CA) operating in negative 
ion mode, coupled to an Ettan Multi-Dimensional Liquid Chromatography system (GE 
Healthcare BioSciences). Separation was performed on an Extend C18 column (150 mm x 
1.0 mm I.D., 3.5 µm particle size, Agilent, USA) maintained at 30°C. The mobile phases 
used on the LC-IT-MS differed slightly to those used on the LC-TOF-MS due to the 
different columns used on each system. Mobile phases were (A) ammonium acetate buffer 
(0.01 mM) in 12% acetonitrile, and (B) ammonium acetate buffer (0.01 mM) in 89% 
acetonitrile; the flow rate was 50 µL/min. Initial conditions of 0%B were held for 10 min, 
increased linearly to 12% B at 12 min, held for 5 min, increased linearly to 30% B at 
25 min, held for 10 min, then increased linearly to 100% B at 40 min and held for 3 min to 
flush unwanted contaminants from the column before re-equilibrating to the original 
conditions. 
Mass spectral data were acquired in the negative mode by using a selective reaction 
monitoring (SRM) method that monitored the distinctive daughter ions formed by 
fragmenting the precursor ion [M-H]- for each of the conjugated estrogens (Table 3.4). The 
electrospray ionization voltage, capillary temperature, sheath gas pressure, sweep gas, 
and auxiliary gas were set at -10 V, 350 °C, 25 psi, 3 psi, and 3 psi respectively. Collision 
energy was 35 V. Ionisation parameters were previously optimised for each of the 
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compounds by directly injecting a constant concentration of a mixed standard, delivered 
by syringe pump. 
Table 3.4: Retention times and IT-MS detection parameters for the conjugated estrogens. 
Compound Rt (min) Precursor Ion Precursor Ion m/z Daughter Ions m/z 
E3-3G 6.67 [M-H]- 463.2 287.2, 445.2 
E2-3S,17G 8.23 [M-H]2- 263.2 254.2, 350.2, 379.2,405.2, 451.2 
E2-3,17-diS 12.34 [M-H]2- 215.2 175.2, 215.2, 333.2, 350.2 
E3-3S 14.23 [M-H]- 367.2 287.2 
E2-3G 16.55 [M-H]- 447.2 175.2, 271.2, 429.2 
E2-17G 16.76 [M-H]- 447.2 175.2, 271.2, 429.2 
E1-3G 20.61 [M-H]- 445.2 175.2, 269.2, 427.2 
E2-3S 30.01 [M-H]- 351.2 271.2 
E2-3S-d4 29.86 [M-H]- 355.2 275.2 
17α-E2-3S 33.23 [M-H]- 351.2 271.2 
E1-3S 35.30 [M-H]- 349.2 269.2 
E1-3S-d4 35.02 [M-H]- 353.2 273.2 
Data acquisition was carried out using XCalibur 2.0 software. Linear eight-point 
calibration curves were made for each of the analytes (5-1000 ng/ml, r2>0.99). Analytes 
were quantified by internal standardisation against isotopically labelled 17β-E2-d4-3-
sulfate and E1-d4-3-sulfate. 
3.2.6 GC-MS Determination of Free Estrogens 
Free steroid estrogens were derivatised to their respective trifluoroacetates using a minor 
modification of the procedure described by Lerch and Zinn (110). Samples were dried 
completely under nitrogen and redissolved in toluene (50 µl). Trifluoroacetic anhydride 
(TFAA, 10 µl) was added, and the reaction proceeded at room temperature for 5 min. Iso-
octane (200 µl) containing E2-17Ac (500 ng/ml) was added as a volumetric internal 
standard, and the mixture washed with aqueous potassium carbonate (1%, 2.5 ml) to 
remove acidic reaction by-products. The separated organic layer was transferred to GC 
vials and stored under refrigeration before analysis. 
Steroid estrogens were quantified by GC-MS using an Agilent 6890 gas chromatograph 
fitted with an Agilent split/splitless injector, PAL autosampler and an Agilent 5975 
quadrupole mass selective detector (MSD). Individual compounds were separated using a 
HP-5MS column (length 30 m, film thickness 0.25 µm, inner diameter 0.25 mm, Agilent) 
with an initial oven temperature of 90 °C for 1.5 min, then increasing at 20 °C per min to 
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130 °C, followed by 4 °C per min to 236 °C and 8 °C per min to 320 °C with a hold for 
5.5 min (total run time 46 min). Helium was used as carrier gas. The sample was injected 
(2 µL) into a split/splitless injector held at 270 °C. Transfer of volatile analytes onto the 
column was enhanced using pressure pulsed injection at 35 psi for 1.1 min. Following this 
pressure pulse, the column pressure was increased using a constant pressure ramp that 
optimised separation of the target analytes. Pressure was ramped throughout the analysis 
from an initial 17.50 psi for 1.5 min, increased at 1.5 psi/min to 20.5 psi, followed by an 
increase of 0.3 psi/min to 28.5 psi and finally 5.0 psi/min to 50.0 psi. The GC–MS interface 
and the quadrupole temperatures were set at 230 and 150 °C, respectively. Electron 
Impact Spectra (EIS) were obtained at 70 eV. The MSD was calibrated against PTFBA 
using the autotune function. The resulting electron multiplier voltage (EMV) was 
increased by 300 EMV for increased sensitivity. Retention times and m/z ratios used for 
detection of the individual compounds are listed in Table 3.5. Mass spectral data was 
acquired using the synchronous scan / single ion monitoring (SIM) mode. 
Table 3.5: Retention times and GC-MS detection parameters for the trifluoroacetylated estrogens 
Analyte Rt (min) Quantitation Ion Qualifier Ions 
E2-d4 27.621 468 311, 258 
17α-E2 27.020 309 351, 309 
17β-E2 27.676 464 351, 309 
E3 27.950 576 463, 349 
E1-d4 29.262 370 324, 311 
E1 29.328 366 322, 309 
EE2-d4 30.749 311 258, 396 
EE2 30.793 392 256, 309 
E2-17Ac (ISTD) a 35.407 314 315, 356 
Note: a Not a TFAA derivative. 
Data analysis was undertaken using the Chemstation software using data acquired in the 
SIM mode. Quantitation of estrogens in samples and spiked samples was by isotope 
dilution, based upon the relative response factors for the following pairings: 17α-E2/E2-
d4, E2/E2-d4, E3/E2-d4, E1/E1-d4, EE2/EE2-d4. Six-point calibration curves from 0-
250 ng/mL were prepared for quantitation at lower concentrations, and eleven-point 
calibration curves were prepared from 0-10,000 ng/mL for quantitation of spikes at 
2500 ng/L (see below). Although a linear regression fitted the data adequately, a 
quadratic curve provided higher r2 values (full range r2 > 0.99; lower range: r2 > 0.99 
except E3 at 0.96). 
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During initial method development, recovery of each target analyte was quantified 
against the relative response of E2-17Ac (as ISTD). This was also used to calculate 
absolute recovery of spiked samples. Eight-point calibration curves from 0-1000 ng/mL 
were used for method development and eleven-point calibration curves were made from 
0-2,500 ng/mL for quantitation of spikes at 2500 ng/L (see below). Quadratic curves were 
fitted to the data and weighted to the inverse of concentration, resulting in slightly poorer 
r2 values (r2 0.92 – 0.97, E3 0.88). 
3.2.7 Sample Preservation Experiments 
Fresh samples of DSE were collected and split into nine replicates in 2.5 L solvent-rinsed 
glass bottles. Three samples were immediately preserved with H2SO4 to pH < 2, following 
the method of Reddy et al. (93); three samples were preserved with formaldehyde at 1% 
v/v (16) and three samples were not preserved. All samples were stored at < 4 °C in the 
dark throughout the test period. Sub-samples were extracted immediately after collection, 
then at 24 hours, 48 hours, 96 hours and 168 hours (7 days) after collection. 
At each time period, ~500 mL of sample was removed from each bottle, centrifuged at 
3000 rpm at 4 °C for 10 min to remove bulk solids, then filtered through glass fibre filters 
(GF/C, pore size 1.2 µm Whatman) with the addition of filter aid. Samples were spiked 
with surrogate standards (250 ng each E2-d4, E1-d4, E1-3S-d4 and E2-3S-d4). Extraction, 
SPE elution, extract clean-up and analysis were as described above, with some 
modifications. 
During clean-up of the conjugated estrogen extract, aminopropyl columns were rinsed 
with acetonitrile (3 mL), acetonitrile with 10 mM ammonia (3 mL), and MeOH with 
10 mM ammonia (3 mL), before elution with two aliquots of MeOH containing 2% 
ammonia (3 mL). Eluted samples were dried under nitrogen and made up in the acetate 
buffer (0.01 mM ammonium acetate in water:acetonitrile, 88:12) for LC-MS analysis. 
For GC-MS analysis, six-point calibration curves from 0-250 ng/mL were used for 
quantitation of 17β-E2 and E1; eleven-point calibration curves from 0-2500 ng/mL were 
used for quantitation of 17α-E2 as this was present at higher concentrations. Although a 
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linear regression fitted the data adequately, a quadratic curve provided higher r2 values 
(r2 > 0.997). 
3.2.8 Matrix Spike Experiments 
Recovery of target analytes from various matrices was obtained by spiking samples of 
MQ water, stream water and DSE samples with mixed standards of unlabelled and 
isotopically-labelled analytes. 
MQ water 
This test was conducted in triplicate by spiking 25 ng and 250 ng of conjugated and free 
estrogens and labelled surrogate internal standards (250 ng each E2-d4, E1-d4, EE2-d4, E2-
3S-d4 and E1-3S-d4) into 1 L of MQ water. Samples were extracted through 500 mg Oasis 
HLB cartridges at 5-10 ml/min, previously conditioned with MeOH (2 x 5 mL) and MQ 
water (2 x 5 mL). Sample bottles were rinsed three times with 10 mL MQ water, which 
was also loaded onto the Oasis HLB cartridges. 
Cartridges were then washed using the procedure described by Reddy and Brownawell 
(109), with 30% MeOH/water containing 2% acetic acid (8 mL), followed by 60% 
MeOH/water containing 2% acetic acid (8 mL) and finally 30% MeOH/water containing 
2% ammonium hydroxide (4 mL). The fraction containing conjugates was eluted with 8ml 
of 2% ammonium hydroxide in MeOH:water (75:25). The Oasis SPE cartridges were dried 
under vacuum, connected to aminopropyl/florisil cartridges, and the fraction containing 
free estrogens eluted with a mixture of DCM (DCM):diethyl ether:MeOH (40:10:1) (30 ml) 
as previously described. The collected extract was dried under nitrogen and subjected to 
GPC clean-up (on Phenogel columns) before derivatisation and GC-MS analysis. 
The fraction containing conjugated estrogens was dried under nitrogen and resuspended 
in 0.25 ml of MeOH. This crude extract was further cleaned up using silica gel (500 mg) 
and aminopropyl (500 mg) SPE columns to remove polar interferences. The purified 
extract was dried under nitrogen and reconstituted in 250 µL of acetate buffer (0.01 mM 
ammonium acetate in water:acetonitrile, 88:12) for LC-IT-MS analysis. 
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Stream water 
A large volume (20 L) grab sample was collected from a local stream and immediately 
acidified to pH<2 with conc. H2SO4. On return to the laboratory, the sample was filtered 
through GF/C to retain particulate material. Due to low turbidity, the stream sample did 
not require centrifuging. The bulk sample was divided into 10 x 2 L replicates, then 
spiked with either 0 or 25 ng of conjugated and free estrogens, corresponding to samples 
containing 0 and 12.5 ng/L of analytes. Each sample was also spiked with 250 ng labelled 
surrogate internal standards. Sample treatment was as described for MQ water, with the 
exception that samples were not subjected to further clean-up using GPC (free fraction) or 
silica and aminopropyl (conjugate fraction) as the extracts were expected to be sufficiently 
clean for final analysis. 
Dairy Shed Effluent 
DSE was collected from a dairy farm on the Ruakura Research Station operated by 
AgResearch. Grab samples of DSE were collected from the collection sump and drains of 
the milking shed yard. Samples were immediately preserved by the addition of conc. 
H2SO4 (to pH ≤ 2). Sample processing began immediately on return to the laboratory and 
was completed within 36 hours. Samples were stored at <4 °C during this period where 
necessary. Due to the high suspended solids loading of DSE, samples were centrifuged at 
up to 1780 g for 10-20 min then the supernatant filtered through GF/C filters topped with 
Hi-flo supercel filter aid (BDH). The filtered samples were combined, then divided into 20 
x 500 mL aliquots for the spike recovery experiments. Five replicates were used for each 
spike concentration of 0 ng, 12.5 ng, 125 ng and 1250 ng, corresponding to 0 ng/L, 
25 ng/L, 250 ng/L and 2500 ng/L respectively, to cover the range of concentrations 
expected to be encountered in field samples. Each sample was also spiked with labelled 
surrogate internal standards, extracted and prepared as outlined above for MQ water. 
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3.3 RESULTS AND DISCUSSION 
3.3.1 Analysis of Free and Conjugated Estrogens by LC-MS 
The initial objective of method development was to develop an LC-MS method to analyse 
both free estrogens and conjugated estrogens, following extraction and clean-up. Initial 
attempts to analyse 17β-E2 using APCI (negative mode) and ESI on both LC-TOF-MS and 
LC-IT-MS indicated high instrument detection limits (IDLs) for pure standards (>10 ng 
injected), substantially higher than that reported by others (59,111,112). With such a 
relatively high IDL, the resulting method detection limits (MDLs) would not be within the 
required range for environmental samples owing to the effect of ion suppression 
associated with their complex matrices. Poor detection limits for estrogens by LC-MS have 
been previously reported by Hájková et al. (113). A decision was made to analyse the free 
estrogens by GC-MS after derivatisation, owing to the substantially lower detection limits 
that could be achieved. 
Conjugated estrogens cannot be derivatised and analysed by GC-MS but are amenable to 
LC-MS analysis. Therefore, LC-TOF-MS and LC-IT-MS systems were compared for their 
suitability for quantitative measurement of conjugated estrogens in DSE samples. 
Ammonium acetate buffer was selected as it is commonly used for analysis of weakly 
acidic analytes (114) and has also been used for analysis of conjugated estrogens in 
pharmaceutical formulations (115,116). The gradient conditions were optimised for 
separation of mixed standards and were specific to each column and LC system. 
Chromatograms of standard solutions analysed by each system are shown in Figures 3.1 
and 3.2. E2-3G and E2-17G were not completely resolved on either column. IDLs were 
determined from the lowest calibration standards injected that provided a signal to noise 
(S/N) ratio > 3 (Table 3.6). This indicated better sensitivity with the LC-IT-MS versus LC-
TOF-MS for the more polar conjugates, while a similar level of sensitivity was obtained 
for the estrogen sulfate conjugates with both LC-MS instruments. 
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Figure 3.1: Selected m/z chromatograms of 0.6 ng of each of the conjugated estrogens separated on X-bridge 
C18 column and analysed by LC-TOF-MS. E3-3G, E2-17G,3S and E2-3,17diS were not adequately retained 
on the column. 
 
Method development 
42   
 
Figure 3.2: SRM chromatograms of 1 ng of each of the conjugated estrogens separated on Extend-C18 
column and analysed by LC-IT-MS. 
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Table 3.6: Comparison of instrument detection limits (IDLs) obtained by LC-TOF-MS and LC-IT-MS for the 
conjugated estrogens 
  Instrument detection limit (ng/mL) 
Compound  LC-TOF-MS LC-IT-MS 
E3-3G  500 10 
E3-3S  40 5 
E2-3S,17G  500 5 
E2-3,17-diS  500 5 
E2-3G  40 10 
E2-17G  40 10 
E1-3G  40 25 
E2-3S  5-10 5 
17α-E2-3S  5-10 5 
E1-3S  5-10 5 
E2-3S-d4  5-10 5 
E1-3S-d4  5-10 5 
 
However, in the presence of the sample matrix from DSE samples, the resulting 
background contribution obtained by LC-TOF-MS was excessively high, resulting in 
decreased sensitivity. Improved signal to noise was obtained utilising the high resolution 
of TOF-MS by decreasing the mass window from 0.5 Da to 0.1 Da (Figure 3.3). Narrowing 
the mass window further reduced signal to noise as the overall ion count decreased. 
Despite the improvement using a mass window of 0.1 Da, the level of sensitivity achieved 
in the presence of sample matrix remained inadequate using LC-TOF-MS. By comparison, 
a low level of background noise was obtained by LC-IT-MS operating in SRM mode 
(Figure 3.4). 
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Figure 3.3: Increasing signal to noise (S/N) ratio calculated by peak-to-peak method for 17α-E2-3S peak with 
narrower mass window using LC-TOF-MS. 
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Figure 3.4: Comparison of LC-TOF-MS (a) and LC-IT-MS (b) traces for a DSE sample spiked with 
conjugated estrogens. 
3.3.2 Comparison of SPE Methods 
Initially Supelco ENVI-18 (1 g, Supelco) cartridges were tested for extraction of free 
steroid estrogens (Table 3.7). To extend the method to enable the simultaneous extraction 
of conjugated estrogens, a range of commercially available cartridges were evaluated, 
including ENVI-18 (1 g, Supelco), Oasis HLB (500 mg, Waters), Strata-X (500 mg, 
Phenomenex), Strata SDB-L (500 mg, Phenomenex), Strata C18-E (500 mg, Phenomenex), 
Isolute C18/Env+ (300 mg, Isolute), Isolute C18(EC) (500 mg, Isolute). The C18 sorbents 
provided poor recovery of conjugated estrogens (data not shown), while Oasis HLB 
cartridges showed promising recoveries of both conjugated and free estrogens compared 
to the other SPE types, and were selected for further evaluation. The use of Oasis HLB 
cartridges has been reported by several researchers for analysing both conjugated and free 
estrogens (58,87,109), owing to the advantages provided by their combination of lipophilic 
and hydrophilic properties. In addition, recovery of organic compounds is reportedly not 
affected by drying of the sorbent (117), a useful characteristic when extracting numerous 
samples simultaneously. 
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Table 3.7: Comparison of percentage recovery of free estrogens from MQ water spiked at 25 ng/L and 
250 ng/L, extracted through either ENVI-18 or Oasis HLB and eluted with various solvents a. 
Sorbent and 
solvent 
Spike 
conc. 
 
17α-E2 17β-E2 17β-E2-d4 E3 E1 EE2 
ENVI-18 25  115 ± 12 98 ± 12 116 ± 13 118 ± 27 117 ± 12 114 ± 12 
Acetone 250  119 ± 10 115 ± 6 121 ± 11 144 ± 3 127 ± 12 125 ± 13 
Oasis HLB         
MeOH 25  58 ± 35 59 ± 33 59 ± 33 101 ± 88 68 ± 13 74 ± 10 
 250  80 ± 24 77 ± 24 80 ± 25 105 ± 38 63 ± 27 53 ± 26 
Ethyl Acetate 25  141 ± 26 135 ± 26 151 ± 28 188 ± 27 147 ± 23 144 ± 24 
 250  120 ± 5 112 ± 5 121 ± 4 113 ± 7 194 ± 15 NM 
DCM mix 25  329 ± 13 374 ± 10 NM 118 ± 10 257 ± 8 311 ± 16 
 250  107 ± 3 89 ± 1 109 ± 4 49 ± 5 107 ± 1 109 ± 2 
Notes: a Mean ± standard deviation, n = 3 except for DCM mix, n = 5. NM = Not measured. 
Elution of free estrogens from Oasis HLB cartridges has been reported using ethyl acetate 
(6-8 ml) (58,109), MeOH (8 ml, (87)), or a mixture of DCM:diethyl ether:MeOH (40:10:1) 
(30 ml, M. Burkhardt, pers. comm). The recovery of free estrogens was assessed for each 
of these solvents (Table 3.7). Recovery regularly exceeded 100% due to signal 
enhancement when measured by GC-MS and quantified by external standards.  
Several solvents have been reported for elution of conjugated estrogens from Oasis HLB 
(58,87,93). Isobe et al. (58) and Labadie and Budzinski (87) used triethylamine as an ion 
pair reagent to elute the conjugated estrogens. However, as triethylamine has been shown 
to result in severe contamination of mass spectrometers (118), an alternative ion pair was 
sought to avoid this possibility. Ammonium hydroxide had been successfully used by 
Reddy et al. (93). The dairy wastes are a highly complex matrix containing significant 
quantities of polar acidic and basic compounds that are co-extracted with free and 
conjugated estrogens by the combined lipophilic and hydrophilic phases of the Oasis HLB 
cartridges. These interfering compounds were preferentially removed from the Oasis HLB 
cartridges, with the solvent elution scheme of Reddy et al. (93), followed by elution of the 
retained conjugated estrogens. 
Recovery was acceptable for the less polar conjugates, but was <80% for E2-17G, E2-
3,17diS and E3-3S (Table 3.8). Increasing the concentration of MeOH in the final wash step 
to 35% or 40% resulted in a slightly cleaner extract, but further reduced the recovery of the 
more polar conjugates (data not shown). E3 was also eluted along with the conjugated 
estrogens using this solvent (75% MeOH:25% MQ water with 2% ammonium hydroxide), 
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which reduces the application of this particular method when analysing STP influents and 
effluents where E3 is of interest. 
Table 3.8: Percentage recovery of conjugated estrogens from MQ water extracted through Oasis HLB a. 
 Percentage recovery (mean ± standard deviation) 
Conjugate Spike conc. of 25 ng/L Spike conc. of 250 ng/L 
E3-3G NM b NM 
E2-3S,17G NM NM 
E2-3,17-diS 76 ± 12 44 ± 5 
E3-3S 65 ± 6 40 ± 3 
E2-17G 84 ± 1 73 ± 2 
E1-3G 94 ± 6 84 ± 4 
E2-3S 90 ± 6 92 ± 5 
17α-E2-3S NM NM 
E1-3S 90 ± 7 91 ± 5 
Notes: a n = 3. b NM = Not measured. 
3.3.3 Clean-up of Free Estrogens 
Initially the protocol for free estrogen clean-up followed the scheme reported by Sarmah 
et al. (40) using a coarse GPC step on Biobeads SX-3 to remove high molecular weight 
interferences, followed by clean-up with silica gel chromatography. Initial tests indicated 
that though there was complete recovery through the GPC, recovery of E3 was poor with 
silica gel, and recovery of other analytes was variable when tested at a concentration 
equivalent to 25 ng/L in samples (Table 3.9). Clean-up on aminopropyl (NH2) cartridges 
as described by Labadie and Budzinski (60) was assessed as a substitute for silica gel and 
provided improved recovery of E3 (Table 3.9). 
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Table 3.9: Comparison of percentage recovery of free estrogens from various cleanup steps (results expressed 
as mean values ± standard deviation; n = 3). 
 Percentage recovery Clean-up 
method 
Spike 
conc.  17α-E2 E2-d4 17β-E2 E3 E1 EE2 
Silica a 25  76 ± 23 83 ± 33 72 ± 27 0 ± 0 76 ± 22 77 ± 24 
 250  102 ± 7 108 ± 2 98 ± 5 0 ± 0 109 ± 12 108 ± 12 
NH2 a 25  118 ± 11 132 ± 12 123 ± 15 66 ± 53 167 ± 5 154 ± 3 
 250  119 ± 36 122 ± 37 113 ± 34 135 ± 48 116 ± 48 61 ± 30 
NH2/Fl b 25  99 ± 14 NM c 81 ± 6 55 ± 7 107 ± 7 110 ± 4 
 250  183 ± 6 174 ± 7 152 ± 4 79 ± 3 118 ± 4 111 ± 4 
GPC (Phenogel) b 25  79 ± 11 72 ± 13 70 ± 9 35 ± 9 71 ± 18 141 ± 107 
 250  75 ± 7 85 ± 7 84 ± 8 60 ± 4 89 ± 10 77 ± 12 
GPC (Biobeads) a 25  106 ± 33 119 ± 34 114 ± 37 120 ± 59 110 ± 55 101 ± 45 
 250  103 ± 17 106 ± 11 102 ± 18 119 ± 15 112 ± 17 108 ± 17 
Notes: a Quantitated by external quantitation. b Quantitated against E2-17Ac. c Not measured, tested at 250 ng 
only. 
Florisil has also been used instead of (58,63,86) or in combination with aminopropyl 
sorbents to purify environmental extracts of estrogenic steroids (88). A method based on 
these sorbents has been used by the USGS (M. Burkhardt, pers. comm) and incorporates 
elution from the SPE extraction and cleanup in a single step (119). This reduces sample 
handling, the potential for cross-contamination, and reduces potential losses of more 
volatile components during nitrogen blow-down of the sample solutions. There was less 
variability in recovery rates with this method compared to that obtained by silica or off-
line aminopropyl columns (Table 3.9). Although the recovery exceeded 100% at a spike 
level equivalent to 250 ng/L in samples, re-quantitation against the surrogate standards 
indicated mean recoveries of 91 to 106%, with the exception of E3, at 12 and 8% for the 
spike levels of 25 and 250 ng/L respectively. 
After the NH2/Fl clean-up steps, substantial interference from the matrix of the DSE 
samples remained in the extracts (Figure 3.5a and 3.5c). An additional GPC step was 
included in the method to reduce this (Figure 3.5b and 3.5d). With the reduction in sample 
matrix following NH2/Fl cleanup, high resolution commercially packed Phenogel 
columns could be used, which provided better separation and used lower volumes of 
DCM compared to the Biobeads SX-8 laboratory packed columns. 
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Figure 3.5: TIC chromatograms of DSE sample by before (a) and after (b) GPC polish and SIM chromatograms before (c) and after (d) GPC polish. 
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There was no statistical difference (95% confidence level) between the purification steps at 
a low spike level for 17α-E2, 17β-E2, E3 or EE2. There was a significant difference in the 
amount of E1 recovered (p=0.013), with a statistical difference between NH2 and both 
Phenogel and silica purification. At the high spike level, there was a significant difference 
for 17α-E2, 17β-E2, 17β-E2-d4 and E3. This was due to higher recovery from NH2/Fl for 
17α-E2, 17β-E2, 17β-E2-d4 which was above that for all other cleanup methods. For E3, 
recovery from silica was significantly lower than with other tested methods. 
Recovery of E3 was also low from NH2/Fl and Phenogel column cleanups. In addition, 
much of the E3 was eluted with the conjugated estrogens, meaning a minimal amount of 
E3 was recovered from the full method. Many published studies for STP influents and 
effluent do not include E3, despite its likely occurrence in those samples, suggesting other 
researchers have also observed reduced recovery. This was not of concern for the study of 
dairy wastes, as E3 has not been identified as a metabolite in dairy cattle and was 
therefore not expected to be present in the samples. Because E3 and EE2 are not 
components expected to be present in DSE, they were not included in the final method 
validation. However, this may reduce the applicability of the method to analysis of other 
agricultural wastes where E3 is expected to be present.  
3.3.4 Clean-up of Conjugated Estrogens 
As matrix interferences greatly reduced detection of conjugated estrogens by LC-MS, 
several methods were tested for their suitability to clean-up sample extracts containing 
conjugated estrogens, including HPLC fractionation, GPC and various SPE adsorbents.  
HPLC fractionation using a semi-preparative C18 column gave good recovery; however, 
the wide variation in polarity between the estrogen conjugates meant that a long fraction 
needed to be collected, resulting in ineffective cleanup. Reverse phase (phenyl, cyclohexyl, 
cyano and C8) SPE cartridges were also trialled; however, conjugated estrogens were not 
adequately retained on C8 or cyano columns, and phenyl or cyclohexyl columns did not 
provide any clean-up. Ideally a clean-up procedure should use a different mode of 
adsorption to those used for the sample extraction and for separation during analysis, so 
alternative methods were sought. 
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Gel permeation chromatography of E2-3S and E1-3S using Phenogel SEC columns has 
recently been reported by Schlusener (96), using THF/acetone (70:30) as mobile phase, 
and this was also trialled for its application to DSE. Though glucuronide conjugates were 
eluted within the expected elution volume, sulfate conjugates were irreversibly bound to 
the column with this solvent mixture. Though this was not reported by Schlusener (96), 
adsorption effects have been previously reported with polystyrene/ divinylbenzene 
columns (120). These effects are thought to result from active sites associated with 
residual components of the monomer material used to the make the column packing, and 
can be extremely variable from column to column (121). The columns used by Schlusener 
et al. (96) differed from those used in this study in internal diameter (21.2 mm versus 
7.8 mm I.D.), length (300 mm versus 2 x 300 mm), particle size (5 µm versus 3 µm), 
column batch, and previously used solvents (not stated versus DCM). These differences 
could all contribute to subtle differences in the activity of binding sites for the acidic 
sulfate conjugates. A mixture of DCM:MeOH (1:1) was also trialled but conjugated 
estrogens eluted earlier than expected, co-eluting with other material in the sample 
matrix. This may be due to ionic exclusion, which has been reported for compounds with 
acidic functional groups (120). 
Gel permeation chromatography using Sephadex LH-20 has been extensively used for the 
preparative extraction and/or separation of conjugated estrogens from urine (122,123), 
bovine liver (124) and, more recently, used to remove impurities in the analysis of steroid 
estrogens from sediments (65). Its potential to remove matrix interferences from DSE 
samples was assessed in this study. Sephadex LH-20 was swelled in MeOH and packed 
into a glass column (9 mm ID x 450 mm). Standards or samples were diluted in MeOH, 
applied to the GPC column and eluted under gravity using MeOH as the mobile phase, 
and fractions collected according to time or elution volume. Recovery for standards 
spiked into the mobile phase was complete; however, when spiked samples were tested, 
changes in viscosity resulted in changes in the flow rate and the recovery of spiked 
samples was poor. In addition, some compounds in the matrix were irreversibly bound to 
the LH-20 material, potentially affecting its longer term performance. 
Sephadex LH-20 has also been used to separate conjugated estrogens with 
chloroform:MeOH containing low concentrations of salts (125,126). Under this solvent 
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system, partition is the major separation mechanism, rather than gel permeation (125). 
This solvent system was also trialled for purification of DSE samples; however, the 
problems observed with MeOH as solvent recurred, such as changes in viscosity and 
irreversible binding of matrix components to the Sephadex LH20 stationary phase. 
In comparison, partition chromatography on SPE cartridges offered several advantages: 
disposable sorbents eliminate potential issues with irreversible binding of matrix 
components; substantially smaller columns decrease solvent use and elution time; and 
many samples can be purified at once using a vacuum manifold system. Florisil, silica and 
diol cartridges were trialled, with mixtures of chloroform:MeOH based on the solvents 
used for LH-20 in partition mode (125), and also with DCM:MeOH mixtures.  
Initial trials indicated that silica could be suitable, as more polar interferences were 
retained on the columns. Silica SPE columns (500 mg) using a 1:1 mixture of chloroform: 
MeOH mixtures provided adequate recovery of the more polar glucuronides (Table 3.10). 
A higher proportion of MeOH was required using florisil, possibly due to the basic nature 
of florisil. An improvement on the silica clean-up can be achieved for sulfates with a 
mixture of 5:1 chloroform: MeOH. Under these conditions, recovery of E2-3S was 94 ± 6% 
at a spike concentration of 25 ng and 87 ± 3% at a concentration of 250 ng. Recovery of E1-
3S was 93 ± 5% and 93 ± 1% respectively. However, the recovery of glucuronides was 
unacceptably low and therefore this solvent mixture could not be used in their analysis.  
Table 3.10: Comparison of percentage recovery of conjugated estrogens from various cleanup steps * 
  Recovery on silica 
(1:1 CHCl3:MeOH) 
 Recovery on aminopropyl 
Compound  Spike 25 ng Spike 250 ng  Spike 25 ng Spike 250 ng 
E3-3G  41 43  NM NM 
E3-3S  102 123  NM NM 
E2-3S,17G  83 40  97 80 ± 13 
E2-3,17-diS  88 43  111 90 ± 5 
E2-3G  43 52  NM NM 
E2-17G  102 ± 17 96 ± 12  NM 86 ± 3 
E1-3G  100 ± 15 83 ± 10  92 85 ± 14 
E2-3S  115 ± 25 87 ± 16  NM 102 ± 2 
17α-E2-3S  114 145  NM 100 
E1-3S  80 ± 20 60 ± 13  6 76 ± 7 
E2-3S-d4  NM 96 ± 29  NM NM 
E1-3S-d4  73% 85 ± 23  NM NM 
Note: * Results expressed as mean values ± standard deviation where n = 3; single value reported where n=1. 
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Better cleanup was expected to be achieved when following this step with a sorbent 
orthogonal in selectivity to the reverse phase used in the LC-MS separation or the normal 
phase silica step. Aminopropyl cartridges were therefore assessed, using a mixture of 5% 
ammonia in MeOH, amended from Komori et al. (88) and Koh et al. (95), and provided 
acceptable recovery (Table 3.10). 
The final method included cleanup on both silica and aminopropyl cartridges. The use of 
both phases effected removal of different interferences, allowed for simultaneous cleanup 
of samples in batches of 12-20, and was substantially quicker than methods using GPC or 
preparative HPLC. Recovery of the polar conjugates was undesirably low, however 
sulfates were expected to be the most important conjugates in the dairy wastes, as these 
are found at highest concentrations in dairy cattle urine (99) and tend to be more 
recalcitrant in wastewaters (16). For these reasons, final method validation included E2 
and E1 sulfates only. 
3.3.5 Comparison of Sample Preservation Methods 
Sample preservation is required to prevent microbially-mediated degradation of 
conjugated estrogens into free estrogens and further degradation products. Methods were 
compared by measuring steroids in triplicate samples over the period up to 7 days after 
sample collection. E1-3S was the only conjugate that was detected in these DSE samples 
and was quantified by external calibration. Therefore some of the variation in E1-3S 
concentration may be due to differences in recovery between samples. However, the 
stability of E1-3S and other conjugated estrogens can be inferred from changes in free 
steroid estrogen concentrations.  
Higher concentrations of E1 and 17α-E2 were measured in unpreserved samples 
compared to the acid and formaldehyde preserved samples (Table 3.11). One explanation 
for this is hydrolysis of conjugates in the short period between sample collection and the 
end of extraction (approximately 8 hours), as previously reported by Reddy et al. (93). In 
the absence of preservative, 17β-E2 concentrations increased over the storage period, 
while 17α-E2 increased between 1 and 2 days after collection, then decreased slightly, and 
E1 was relatively stable. E1-3S was detected in unpreserved samples only during the first 
three days of storage. 
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Table 3.11: Percentage of initial estrogen concentration (day 0) determined in the effluent after storage for 1, 
2, 4 and 7 days. 
 Concentration measured (ng/L) Conc. relative to initial conc. (Day 0) 
 E1 17α-E2 17β-E2 E1-3S E1 17α-E2 17β-E2 E1-3S 
Unpreserved         
Day 0 49 ± 3 607 ± 2 6 ± 1 61 ± 24 100 ± 6 100 ± 0 100 ± 24 100 ± 51 
Day 1 42 ± 1 650 ± 10 25 ± 6 11 ± 0 87 ± 2 107 ± 2 456 ± 24 26 ± 60 
Day 2 44 ± 5 698 ± 55 30 ± 8 20 ± 5 89 ± 10 115 ± 8 548 ± 27 19 ± 0 
Day 4 42 ± 1 667 ± 25 45 ± 2 ND 86 ± 2 110 ± 4 806 ± 4 0 ± 0 
Day 7 50 ± 0 648 ± 33 55 ± 4 ND 103 ± 0 107 ± 5 991 ± 8 0 ± 0 
Formaldehyde         
Day 0 46 ± 1 429 ± 11 11 ± 1 63 ± 23 100 ± 3 100 ± 3 100 ± 6 100 ± 44 
Day 1 44 ± 2 503 ± 16 8 ± 0 22 ± 1 96 ± 5 117 ± 3 69 ± 5 75 ± 10 
Day 2 46 ± 0 536 ± 37 6 ± 0 35 ± 8 101 ± 0 125 ± 7 52 ± 7 24 ± 12 
Day 4 46 ± 3 537 ± 27 5 ± 1 25 ± 2 99 ± 7 125 ± 5 41 ± 12 35 ± 2 
Day 7 48 ± 2 534 ± 31 4 ± 1 ND 105 ± 5 125 ± 6 39 ± 25 0 ± 0 
Acid         
Day 0 38 ± 2 468 ± 17 18 ± 0 44 ± 27 100 ± 6 100 ± 4 100 ± 2 100 ± 80 
Day 1 34 ± 3 449 ± 16 19 ± 1 21 ± 0 90 ± 9 96 ± 4 102 ± 3 28 ± 0 
Day 2 36 ± 4 455 ± 17 20 ± 1 27 ± 6 93 ± 11 97 ± 4 107 ± 6 15 ± 22 
Day 4 35 ± 3 422 ± 10 19 ± 0 29 ± 1 86 ± 2 92 ± 1 101 ± 3 82 ± 10 
Day 7 35 ± 3 422 ± 10 19 ± 0 29 ± 1 90 ± 8 90 ± 2 102 ± 2 0 ± 0 
Prior studies of unpreserved samples of sewage influent and effluent have not reported 
increases in free estrogen concentrations over time. A possible explanation for this 
discrepancy could be higher concentrations of conjugated estrogens in the DSE samples. 
These contained freshly excreted urine and faeces, whereas human excreta can take some 
time to travel to sewage treatment plants. Faecal bacteria, including E. coli, are also 
expected to be present at high concentrations in unpreserved dairy and sewage effluents 
and they produce the β-glucuronidase enzyme which can hydrolyse conjugated 
estrogens, increasing free estrogen concentrations. 
In formaldehyde-preserved samples, 17β-E2 decreased slightly over the 7 day storage 
period and 17α-E2 concentrations demonstrated an initial increase then stabilised. E1 
concentrations were similar throughout the period and E1-3S was detected up to 5 days of 
storage. In acid-preserved samples, 17β-E2 and E1 were measured at constant 
concentrations throughout the 7 days of storage while 17α-E2 decreased slightly over the 
period. E1-3S was detected after up to 7 days of storage in the acid preserved samples; 
however, the concentrations were extremely variable over this time.  
The results suggest that acidification is the best preservation method, based on the stable 
concentrations of free estrogens in those samples compared to those measured in 
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unpreserved and formaldehyde preserved samples. However, given the decrease in 
concentrations of E1-3S measured on day 2 compared to day 1, it may be prudent to 
extract samples immediately, even if preserved by acidification.  
3.3.6 Method Detection Limits 
Method detection and quantitation limits were based on concentrations in actual samples 
corresponding to S/N ratio of 3 and 10 respectively. The detection limits (Table 3.12) for 
free estrogens for surface waters are comparable to those previously published based on 
GC-MS with large volume samples (127-129), and are a slight improvement on Lee et al. 
(130), Kolpin et al. (131) and methods using LC-MS-MS (e.g., (63)). Most importantly, the 
limit of detection for these compounds is within the range of environmental concern, with 
no effect concentrations suggested to be 1 ng/L (132). 
Table 3.12: Method detection and quantitation limits in stream water and DSE samples. 
  
Stream water 
2 L sample>250 µl  
DSE 
0.5 L sample>250 µl 
Compound  MDL MQL  MDL MQL 
E1  0.2 0.4  0.8 2.5 
17α-E2  0.1 0.4  0.8 2.5 
17β-E2  0.1 0.4  0.8 2.5 
E1-3S  3 9  15 45 
17α-E2-3S  12 26  15 45 
17β-E2-3S  3 9  15 45 
Detection limits for the free estrogens in DSE are higher, reflecting the effect of sample 
matrix on instrument performance. The detection limits are an improvement on early 
studies by Raman et al. (39), who reported a detection limit of 10 µg/L and on Hanselman 
et al. (125 ng/L for 17α-E2, 17β-E2 and E1, (47)), and Hutchins et al. (43) (4 ng/L, 20 ng/L 
and 12 ng/L for 17α-E2, 17β-E2 and E1 respectively). As the latter two studies used 
substantially lower sample volumes (40 mL and 25 mL respectively) compared to 500 mL 
in this study, it is likely that their detection limits could have improved with a higher 
concentration factor. The current method could also be adapted to use a lower sample 
volume if conjugated estrogens are not of interest. A further study (44) did not report the 
detection limits achieved using LC-MS-MS to analyse estrogens in swine wastewater 
lagoons, though the lowest concentration of 17β-E2 reported was 12 pM (3.3 ng/L), 
suggesting similar detection limits to the present study.  
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The detection limits obtained for the conjugated estrogens in surface waters are higher 
than those reported using triple quadrupole LC-MS-MS systems (16,58,62,63,93,94), 
despite the high concentration factor used for this study. The MQLs obtained for this 
study are above likely concentrations in most environmental waters, indicating that LC-
IT-MS instruments may not be appropriate for analysis of environmental samples. 
MDLs were not required to be as low when analysing effluent samples as much higher 
concentrations are expected in those samples. The MDLs for DSE samples were 
approximately 5-fold higher compared to cleaner stream water, due to sample matrix 
effects (ionisation suppression and higher background). This is consistent with the 
findings of previous studies; for example, detection limits for E2-3S and E1-3S were up to 
40-fold higher in sewage influent and 8-fold higher for sewage effluent compared to river 
waters (62). This indicates sample matrix can adversely affect detection limits even when 
using more sensitive triple quadrupole instruments. The only other published report on 
the analyses of conjugated estrogens in agricultural wastes reported a limit of detection of 
1 ng/L (43). However this LOD was based on the lowest quantitation standard and does 
not account for ionisation suppression and increased noise experienced when analysing 
samples, due to the presence of sample matrix. The corresponding MDL would most 
likely be considerably higher. 
3.3.7 Variation in Replicate Samples 
Replicate samples were analysed to provide an indication of the precision of the overall 
method. Samples were collected from the same location in separate sample bottles then 
extracted and analysed following the procedures developed. The results (Table 3.13) 
indicated good precision for the free estrogens, but variable concentrations of E1-3S. 
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Table 3.13: Concentration of estrogens in replicate samples of DSE (ng/L). 
 E1 17α-E2 17β-E2 E1-3S 
Replicate 1 41 472 18.6 34 
Replicate 2 37 482 18.2 74 
Replicate 3 37 449 17.9 24 
Average 38 467 18.2 44 
Standard Deviation 2 17 0.3 27 
CV 6% 4% 2% 61% 
3.3.8 Recovery in Different Matrices 
The performance of the entire method was assessed by spiking MQ water, stream water, 
and DSE samples with free and conjugated estrogens at a range of environmentally 
relevant concentrations. Recovery of free estrogens ranged from 65–144% at 
concentrations of 25 ng/L, with the exception of 17α-E2 in the DSE (Table 3.14), where 
interference in some of these particular samples resulted in apparently higher recovery 
(91-222%). Recovery was 91-129% at concentrations of 250-2500 ng/L. For the conjugated 
estrogen sulfates, recovery ranged from 71-176%, with the exceptions of E2-3,17diS and 
E2-17G,3S which were not recovered in the spiked samples, probably due to low recovery 
through SPE extraction and clean-up stages. 
Table 3.14: Mean recovery of estrogens in MQ, stream water and DSE samples (percentage recovery ± 
standard deviation, n=5). 
  MQ water  Stream water  DSE 
Compound  25 250  12.5  25 250 2500 
17α-E2  144 ± 47 103 ± 9  123 ± 2  172 ± 50 125 ± 16 129 ± 3 
17β-E2  99 ± 10 91 ± 14  92 ± 2  88 ± 2 90 ± 3 91 ± 2 
E1  104 ± 10 93 ± 8  92 ± 2  92 ± 4 91 ± 4 83 ± 1 
E2-3S  107 ± 8 92 ± 7  106 ± 8  158 98 ± 10 103 ± 2 
17α-E2-3S  124 ± 28 71 ± 48 98 ± 15 a  176 ± 32  236 100 ± 37 101 ± 21 
E1-3S  97 ± 9 75 ± 15  111 ± 8  228 121 ± 10 111 ± 9 
Notes: a Excluding outlier. 
During method development considerable signal enhancement was observed following 
the SPE steps, demonstrating external calibration was not a reliable method for 
quantitating the free steroid estrogens. Therefore, in order to assess the absolute recovery 
of free estrogens in the spiked samples, quantitation was based on the response relative to 
E2-17Ac, added to sample extracts as an internal standard. The resultant calculated 
recoveries (Table 3.15) suggest substantial loss of analytes at high concentrations 
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(2500 ng/L) in DSE, with recoveries averaging 31-43%. However the response of target 
analytes at 2500 ng/L was approximately 7.5-12-fold higher than that for samples spiked 
at 250 ng/L, which is close to the 10-fold increase in response expected from the linear 
calibration curves.  
Table 3.15: Absolute recovery of free estrogens spiked into MQ, stream water and DSE samples. 
  MQ water  Stream water  DSE 
Compound  25 250  12.5  25 250 2500 
17α-E2  143 ± 82 71 ± 22  166 ± 10  186 ± 24 73 ± 17 31 ± 6 
17β-E2  99 ± 41 67 ± 23  130 ± 11  67 ± 3 60 ± 13 31 ± 6 
E1  118 ± 41 73 ± 20  163 ± 9  111 ± 14 83 ± 7 43 ± 6 
It appears E2-17Ac is not a good choice of internal standard for the target analytes in these 
samples, as its response was enhanced in the presence of sample matrix, eluting at a 
similar time in the GC-MS chromatogram. Conversely, the response of the isotopically 
labelled surrogate internal standards and analytes was reduced in the presence of sample 
matrix, due to signal suppression in this earlier region of the chromatogram. Ratios of the 
deuterated standard response compared to E2-17Ac (ISTD) response are compared for the 
solvent standards, stream matrix and DSE (Table 3.16), and demonstrate the effect of 
residual sample matrix on signal response. 
Table 3.16: Comparison of ISTD response ratios between different matrices. 
 Solvent standards Stream samples DSE samples 
Response in matrix relative to solvent standard response  
ISTD E2-17Ac 1.0 1.3 1.4 
17β-E2-d4 1.0 0.54 0.42 
E1-d4 1.0 0.68 0.51 
Ratio of response within each matrix   
Ratio E2-d4 : E2-17Ac 1.0 0.41 0.31 
Ratio E1-d4 : E2-17Ac 1.1 0.58 0.43 
Preparation of calibration standards in matrix extracts can reduce this effect (107,133), but 
requires that the matrix of the sample is the same as the matrix used for the standards 
(106). This may be difficult to ensure when environmental samples are collected from 
different sources. On the basis of the recovery data, it is considered that the isotope 
dilution method is more accurate for quantification of estrogens in environmental 
samples compared to the internal standard method using E2-17Ac or other structural 
analogues of steroid estrogens. This is consistent with a previous study which 
demonstrated that the relative response of steroid estrogens was variable and when E2-
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17Ac was used as internal standard, their concentrations were more likely to be under- or 
over-estimated, when compared to concentrations calculated using the isotope dilution 
method (129).  
3.3.9 Comparison to Standard Addition Method 
The standard addition method can also be used for quantification in the presence of 
sample matrix. Concentrations of 17α-E2 and E1 in the non-spiked DSE samples were 
calculated based on the standard addition method from the samples spiked at 25, 250 and 
2500 ng/L. The response was first corrected against the response of E2-17Ac to allow for 
differences in final sample volume or injected volume. As the matrix was the same for all 
samples, this was considered acceptable. The concentration of 17α-E2 by standard 
addition was calculated to be 24 ng/L in the original sample, compared to 39 ng/L when 
calculated by isotope dilution. E1 was calculated at 3 ng/L and 7 ng/L for standard 
addition and isotope dilution methods respectively. For both analytes, the isotope dilution 
method gave a slightly higher concentration; however, given the complexity of the 
samples and the range in concentration observed in environmental samples, the 
difference in results obtained by isotope dilution and standard addition was considered 
acceptable for this study. The standard addition method requires the analysis of up to 
four injections for each sample, increasing the time (and cost) of analysis, and importantly 
for DSE samples and other complex waste matrices, increasing the negative impact on 
injector, column and detector performance resulting from accumulated sample matrix. 
3.4 CONCLUSIONS 
A sensitive and selective method was developed for analysis of the free estrogens 17β-E2, 
17α-E2 and E1 at ng/L levels in environmental and DSE samples. The developed method 
used SPE extraction with Oasis HLB cartridges, followed by elution and clean-up on 
aminopropyl and florisil sorbents. The extract was further purified through high 
resolution GPC, before derivatisation and analysis by GC-MS in SIM mode. Isotopically-
labelled standards were used for quantitation and the overall method detection limit was 
0.8 ng/L for free estrogens in DSE samples. The method developed was reliable and 
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robust for multiple matrices, and over a concentration range of several orders of 
magnitude. 
DSE samples required additional purification for the analysis of conjugated estrogens 
when compared to methods published for water samples. Substantial difficulties were 
experienced in determining a clean-up step that was suitable for all conjugated estrogens, 
due to the wide range in polarities and acidities of this group of compounds. LC-TOF-MS 
was shown to be unsuitable for DSE samples due to high background noise, despite the 
inclusion of rigorous purification steps prior to analysis. While LC-IT-MS could achieve 
acceptable method detection limits for the sulfate conjugates, detection limits for the 
glucuronide conjugates were not satisfactory. Neither LC-TOF-MS nor LC-IT-MS could 
achieve the lower detection limits that were required for environmental water samples. 
Despite these difficulties, a method was developed to measure sulfate conjugates in DSE 
samples. The developed method was based on SPE extraction and purification, and gave 
acceptable recovery for most conjugated estrogens. LC-IT-MS in SRM was used for 
analysis, and deuterated E2-3S was used for quantitation of conjugated estrogens, using 
istope dilution. The overall method provided detection limits of ~15 ng/L for sulfate 
conjugates in DSE samples. 
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Chapter 4:  Survey of steroid estrogens and 
estrogenic activity in New Zealand farm 
dairy effluents 
4.1 INTRODUCTION 
Estrogenic contamination of surface waters is of considerable concern world-wide, with 
accounts of feminisation of male fish, reproductive abnormalities and skewed sex ratios 
attributed to the presence of steroid estrogens and xeno-estrogens (7). Since initial studies 
demonstrated intersex fish downstream of sewage treatment plants (STPs) outfalls (2), a 
significant body of research has focussed on municipal effluents as sources of estrogenic 
chemicals, particularly natural estrogens including 17β-E2, E1, E3 and the synthetic 
steroid estrogen EE2 (9,16,85). In the past five years agricultural wastewaters have become 
widely recognised as potential sources of environmental estrogens (33-35,134). In fact, 
estimates of the loads of steroid estrogens excreted from humans and livestock in the 
United Kingdom (33), the United States (35) the Netherlands (34) and New Zealand (this 
study) suggest that, rather than humans, dairy cattle are the most significant contributor 
of steroid estrogens into the environment.  
Dairy farming is a major and growing industry in New Zealand, particularly in the 
Canterbury and Waikato Regions. There are 820 dairy farms in Canterbury, with a total of 
755,000 dairy cows (53). The Waikato Region has 5100 farms and a total of 1,669,000 dairy 
cows, over 30% of New Zealand’s total herd (53). On NZ dairy farms, the majority of 
animal excreta is deposited onto paddocks during grazing and is not subject to any 
treatment. However, 10-20% of excreta is deposited within the farm dairy shed or yard 
area during milking (50) where it is captured as farm DSE that also contains wash-down 
water and chemical products used to clean the milking plant (50). This effluent is then 
either applied to land, or treated and discharged into waterways. 
Recent studies of dairy manures and wastewaters confirm that steroid estrogen 
concentrations are high in these wastes, but there is limited data to properly assess the 
risk of dairy wastewaters to the receiving environment, especially aquatic environments. 
With the exception of the extensive study undertaken by Raman et al. (39), studies 
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published to date have focussed on characterising steroid content in a small number of 
dairy operations (typically one to three). Data varies between each study, with median 
concentrations of 17β-E2 ranging from 87 ng/L to 1700 ng/L (39,40,43,47). 
Furthermore, the majority of these studies have not considered the presence of conjugated 
estrogens. Steroid estrogens are excreted by mammals as conjugated metabolites, where 
they are attached to either a sulfate or glucuronide group (99). While these metabolites 
have lower estrogenic activity than the free forms, studies show that glucuronide forms 
can be readily deconjugated by bacteria found in sewage systems (15). As this process can 
take up to several days (16,97,98,135), the measurement of free estrogens alone may 
underestimate the total load of estrogens entering the environment from freshly excreted 
manures or wastewaters. A recent study, examining three replicate samples, provided 
preliminary data indicating their presence in dairy wastes with 17α-E2-3S present at 141-
182 ng/L, E1-3S at 85-91 ng/L and 17β-E2-3S at 39-44 ng/L, similar concentrations to 
those of free steroid estrogens in the samples (43).  
Because steroid estrogens and estrogen mimics have an additive effect in vivo (136,137), 
potential effects of complex effluents are best evaluated using bioassays. These integrate 
the estrogenic activity of all compounds present within a sample and thereby provide an 
estimate of the overall potential estrogenic effect. In vitro bioassays have been used in 
New Zealand (56) and internationally (reviewed in (28,68)) to assess potential estrogenic 
activities of sewage effluents, which can contain a mixture of steroid estrogens and 
estrogen mimics, such as alkylphenols. When used in combination with chemical analysis 
of target compounds, bioassays can indicate potential causation of observed estrogenic 
activity in environmental samples (68). This approach has been widely used in assessing 
estrogenicity of STP influents and effluents (e.g., (138-140)), rivers (141), and marine 
waters (142).  
This study has used chemical analysis and bioassay to investigate steroid estrogens in 
DSE, potentially a major source of estrogens to the New Zealand environment. 
Conjugated estrogens have been measured to provide an assessment of their significance 
in these wastes and of how much they contribute to the total load of estrogens released to 
the New Zealand environment from this agricultural waste source.  
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4.2 MATERIALS AND METHODS 
4.2.1 Sampling Locations 
DSE samples were collected from 18 privately owned farms operating with herd sizes of 
140 to 1000 cows. Because access on to private property was essential and information 
about the farms was required, farms were not selected at random throughout the two 
regions, but were located where farmers had existing relationships with scientists and 
regulators. Farms were located within three stream catchments, the Toenepi Stream 
(Waikato), Waikuku Stream and Pahau River (Canterbury), where dairy farming was a 
major land use.  
Samples were collected from the farms during the milking season, which begins around 
July to August and ends in April to May, with some variation by location. Samples were 
collected from farms in Toenepi and Waikuku catchments at the start and end of the 
2006/2007 milking season. The Pahau catchment, where farm sizes are generally larger, 
was only sampled at the end of the season. Three farms in the Toenepi catchment (T2, T4 
and T5) were sampled five times over two seasons to give some indication of variation in 
steroid levels and estrogenic activity with time. On these farms, sampling was undertaken 
in August 2006 and in May, August, November and December 2007. 
4.2.2 Sampling and Extraction 
In this study, samples were either collected directly from the milking shed collection 
sump or at the outlet from the final treatment pond depending on the effluent system. 
Grab samples were collected in solvent- and MQ water- rinsed amber glass bottles with 
Teflon-lined lids. Samples were immediately preserved by the addition of sulfuric acid (to 
pH ≤ 2) and transported to the laboratory on ice. Sample processing began immediately 
on return to the laboratory and was completed within 36 hours. Samples were stored at < 
4 °C during this period where necessary. In addition, subsamples were collected from the 
Waikuku catchment, and at the three farms repeatedly sampled, for analysis of total 
nitrogen, total Kjedahl nitrogen, total phosphorus and total organic carbon. These were 
analysed using standard methods at a commercial laboratory. 
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Samples were centrifuged at up to 1750 g for 20 mins at 4 °C, and then filtered through 
glass fibre filters (GF/C, pore size 1.2 µm Whatman) with the addition of filter aid. 
Samples were extracted in duplicate (500 mL each) for i) chemical analysis of steroid 
estrogens and conjugated estrogens, and ii) estrogenic activity using the E-screen assay. In 
the August 2006 survey, samples for chemical analysis were spiked with 250 ng 17β-E2-d4 
as a surrogate standard. In later surveys, samples for chemical analysis were spiked with 
a range of surrogate standards (250 ng each E1-d4, 17β-E2-d4, E1-3S-d4 and 17β-E2-3S-d4). 
All centrifuged and filtered samples were loaded onto 500 mg Oasis HLB cartridges 
(preconditioned with 10 mL of MeOH followed by 10 mL of MQ water) at a flow rate of 5-
10 mL/min. As samples collected in the Pahau catchment appeared to have a higher 
solids and organic content, 1 g cartridges were used to ensure that sorbents were not 
overloaded or blocked by fine particulates and colloidal components not removed by 
filtering. 
4.2.3 Chemical Analysis 
Samples for chemical analysis were eluted from the Oasis HLB cartridges in two fractions 
to separate conjugated estrogens and free estrogens, as described in detail in Chapter 3 
and summarized briefly here. Cartridges were washed with MeOH water mixtures, then 
conjugated estrogens were eluted with 75% MeOH/water containing 2% ammonium 
hydroxide (8 mL). Free estrogens were then eluted with 30 ml of DCM:DEE:MeOH 
(40:10:1) through aminopropyl and florisil sorbents, to provide preliminary clean-up 
before the extract was further purified by gel permeation chromatography (GPC). TFAA 
was added to the extract collected from GPC to derivatise estrogens prior to GC-MS 
analysis in SIM/Scan mode (as fully described in Chapter 3). 
In the first round of sampling, free estrogens were quantified against 17β-E2-17-acetate, 
added to the purified sample extracts as an internal standard, and their recovery corrected 
against the concentration of the surrogate 17β-E2-d4 measured in the samples. For the 
second sampling round, estrogens were quantified by isotope dilution, based upon the 
relative response factors for the following pairings: 17α-E2/E2-d4, E2/E2-d4, E3/E2-d4, 
E1/E1-d4. Only data collected in SIM mode was used for quantitation. 
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Samples collected in the second round (at the end of the milking season) were also 
analysed by LC-IT-MS to assess the presence of conjugated estrogens. The conjugated 
estrogen fractions from the Oasis columns were dried under nitrogen and reconstituted in 
MeOH (250 µL), then cleaned up through silica gel (10% deactivated, 1 g) and 
aminopropyl columns (500 mg, JT Baker) connected in series. The silica columns were 
eluted with 20 mL of chloroform:MeOH (1:1) onto the aminopropyl columns under a low 
vacuum. The aminopropyl columns were rinsed with acetonitrile (3 mL), acetonitrile with 
10 mM ammonia (3 mL), and MeOH with 10 mM ammonia (3 mL), then conjugated 
estrogens were eluted by applying 2 x 3 mL aliquots of MeOH containing 2% ammonia. 
Eluted extracts were dried under nitrogen and made up in acetate buffer (0.01 mM 
ammonium acetate in water:acetonitrile (88:12)), then analysed for conjugated estrogens 
using LC-IT-MS in negative ESI mode as described in Chapter 3. MS data was acquired by 
selected reaction monitoring (SRM) and conjugates were quantified by isotope dilution 
against 17β-E2-3S-d4. 
4.2.4 E-Screen Analysis 
Samples for E-screen assay were simply eluted from the Oasis HLB cartridges with 30 ml 
of DCM:DEE:MeOH (40:10:1), dried down to approximately 1 mL, and solvent exchanged 
into DMSO (500 µL). Samples were stored at <20 °C in the dark until analysed by the E-
screen assay.  
The E-Screen assay method followed that previously described by Soto et al. (32), Korner 
et al. (143) and Leusch et al. (144) with minor modifications. Estrogen receptor-positive 
human MCF-7 BOS breast cancer cells, obtained as a gift from A. Soto (Tuft University), 
were cultivated in an atmosphere with 5% CO2 at 37 °C in 25-cm2 flasks (Sarstedt) in 
growth media consisting of phenol-red-free Dulbecco's modification of Eagle's medium 
(DMEM), supplemented with 10% fetal bovine serum (FBS), 0.025 mM N-2-
hydroxyethylpiperazine-N′-2-ethanesulfonic acid (HEPES), 4 mM L-glutamine and 
0.1 mM non-essential amino acids. The steroid-free experimental medium consisted of 
phenol-red-free DMEM supplemented with 10% charcoal-stripped FBS, 0.025 mM HEPES, 
4 mM L-glutamine and 0.1 mM non-essential amino acids. The MCF-7 cells were 
reconstituted in steroid-free experimental medium, seeded at a concentration of 25,000 
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cells/mL in sterile 96-well flat-bottom tissue culture plates (Nunclon), and incubated 
overnight at 37 °C in 5% CO2/air. 
Serial dilutions of samples or 17β-E2 (standard) were prepared in DMSO and added to the 
96-well plate in triplicate. DMSO was used as the negative control. Outside wells were not 
used, due to the effects of evaporation (145). All plates were incubated for a further 5 days 
after cell exposure. Cell proliferation was assessed at the end of this period by analyzing 
formazan production after addition of 20 µL CellTiter 96 AQueous non-radioactive cell 
proliferation assay (Promega) to each assay well. After incubation (3 h), absorbance at 492 
nm was measured for each well using a plate reader (FLUOStar model 403, BMG Lab 
Tech).  
Absorbance in each set of wells was plotted against dilution and a curve was fitted by 
least squares regression based on the symmetric logistic model shown in Equation 4.1. 
Equation 4.1:    ( ) ]101[ loglog 50 slopexEC
MinMaxMiny ∗−+
−+=  
The slope was fixed at 1.0 for all standards and samples and the maximum response was 
constrained to that of the positive control (17β-E2) for that experiment, in order to fit 
realistic curves. In addition, where reductions in cell response were observed at high 
concentration due to cytotoxicity, the affected data were excluded from the regression 
analysis. The EC50 for each sample was determined from the modelled curve. If the 
calculated EC50 did not fall within the range of concentrations measured for that sample 
it was considered unreliable and that sample considered below the detection limit. 
Estrogen equivalent concentrations for each sample (EEQ) were calculated from EC50 
[17β-E2, ng/L] / EC50 [sample].  
The relative proliferative effect (RPE) was calculated for samples where a plateau of 
maximum estrogenic activity was reached. For consistency, maximal cell yield was set at 
EC95 and calculated from the modelled curve, and RPE calculated as the ratio of the 
maximum proliferation induced by a sample to that induced by the positive control, 17β-
E2. Samples were considered below detection limits if the maximum proliferation was less 
than 20% of the maximum proliferation of the standard curve.  
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Method quality control procedures included analysis of a standard curve for each 10 
samples; at least two independent assays were performed for each sample with the 
average value reported. The quantitation limit varied with the cytotoxicity of the samples 
in the assay; it was typically 5 ng/L, but ranged from 0.3-19 ng/L. 
4.2.5 Model Compounds and Calculation of Predicted Estrogens 
Steroid estrogens and their conjugates were tested using the E-Screen to determine the 
relative potency of compounds likely to be present in DSE samples. Free estrogens were 
prepared at a concentration of 10 µM in DMSO, while conjugated estrogens were 
prepared at a higher concentration of 1-2 mM due to their expected lower potency. All 
compounds were tested in the E-Screen following the procedure described above. The 
final concentrations in the microtitre plate wells were ~0.8-50,000 pM for the free 
estrogens and from 0.08-10,000 nM for the conjugated estrogens.  
To calculate EC50s, absorbance in each set of wells was plotted against concentration, the 
logistic curve was fitted and EC50 calculated as described above. The relative potency 
(RP) for tested compounds was calculated from the ratio EC50 [17β-E2, nM] to EC50 [test 
compound, nM]. The relative proliferative effect (RPE) was also calculated for pure 
compounds as described above. Full agonistic activity can be distinguished as RPE from 
80–100%, while values less than 80% represent partial agonist activity (138). 
Estrogen equivalents were predicted for the DSE samples from the measured 
concentration of each steroid (by GC-MS) multiplied by the relative potency (RP) of that 
steroid obtained by the E-Screen. The EEQs for each compound measured in a sample 
were summed to obtain the total predicted EEQ for that sample. This approach, based on 
the toxic equivalency factor (TEF) approach, has been shown to be appropriate for 
mixtures where each component acts through the same pathway and the dose-response 
curves are parallel for individual compounds (137).  
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4.2.6 Nutrient analysis 
Samples of effluent were analysed by a commercial laboratory for total organic carbon 
(TOC), total phosphorus (TP), total nitrogen (TN), total Kjeldahl nitrogen (TKN) and 
oxidised forms of nitrogen (NOxN: nitrate-N and nitrite-N) using standard methods (146). 
4.3 RESULTS AND DISCUSSION 
4.3.1 Response of Free and Conjugated Estrogens in the E-Screen 
All conjugated and free estrogens expected to be found in the DSE samples were analysed 
by bioassay to establish their potencies relative to 17β-E2. Although there are published 
potencies for many estrogenic compounds in E-Screen (29,31,32,138), there can be 
considerable variation due to inter-laboratory variation in the protocol and cell-lines used 
in the E-Screen (147). Potencies were therefore derived in this assay following the same 
procedures used to test environmental samples. 
The response of free estrogens in the E-Screen assay is shown in Figure 4.1 and 
demonstrates the characteristic S-shaped dose-response curve expected for this assay. 
Dose response curves were parallel, demonstrating that the TEF approach is suitable for 
combining the effect of mixtures of estrogenic compounds. Of the free estrogens, estriol 
(E3) was the most potent compared to 17β-estradiol (E2), followed by estrone (E1) and 
17α-estradiol (17α-E2, Figure 4.1). All the free estrogens tested demonstrated full 
proliferation, with RPE close to 100% of 17β-E2.  
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Figure 4.1: Estrogenic response of free steroid estrogens in the E-Screen assay. Results are expressed as the 
mean (± standard error) absorbance of the triplicate exposed wells with background absorbance subtracted. 
Absorbance is directly proportional to cell number. 
The response of conjugated estrogens in the E-Screen assay similarly displayed the 
characteristic S-shaped dose-response curve. Many conjugated estrogens also 
demonstrated full proliferation at the highest concentrations tested (Figure 4.2), although 
their potency was several orders of magnitude lower than the free steroids, evidenced by 
the higher concentrations required to cause a response in the assay. Estradiol-disulfate 
(E2-diS) and estradiol-17-glucuronide-3-sulfate (E2-3S,17G) did not reach an asymptopic 
range in cell proliferation at the concentrations tested, and the RPE is therefore a 
minimum. The dose response curves were parallel only for those compounds that 
demonstrated full proliferation, suggesting that the TEF approach may not be accurate for 
combining the effect of mixtures of these compounds. 
The potency of E1 and 17α-E2 was within the range of reported values for estrogenic 
potencies measured previously using the E-Screen (Table 4.1), and the potency of E3 was 
slightly lower. The RPE values for E1 and 17α-E2 were also very similar to literature 
values, whereas E3 was slightly higher (91% in this study compared with 82% (30)). 
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Figure 4.2: Estrogenic response of conjugated estrogens compared to 17β-E2. Results are expressed as the 
absorbance of the exposed wells with background absorbance subtracted. Absorbance is directly proportional 
to cell number. 
No comparative data was available for the estrogenicity of conjugated estrogens obtained 
by E-Screen, but data obtained using other assays was available (Table 4.2). 17β-E2-3S 
elicited estrogenic responses in two receptor-reporter gene yeast assays (148,149) with 
relative potencies 3-4 orders of magnitudes lower than 17β-E2, slightly lower than was 
measured in this study. 17β-E2-3G was estrogenic in one receptor-reporter gene yeast 
assay when tested at a concentration up to 10 µM (148), but not in the YES (149) or ER-
CALUX (150) assays, possibly due to the lower concentrations used in these assessments 
(maximums of 50 and 10 nM respectively). 17β-E2-3G,17S did not demonstrate estrogenic 
activity in a recombinant yeast assay (maximum concentration 10 µM, (148)), and less 
than 1% of E1-3S bound to rat ERα and ERβ at a maximum concentration of 100 µM (71). 
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Table 4.1: Potency of free estrogens relative to 17β-estradiol as measured in this study, and compared to 
literature values using the E-Screen assay. 
 17β-E2 17α-E2 E1 E3 
Relative Potency     
This study a 1 0.02 0.024 0.054 
Gutendorf & Westendorf (29) 1 NM b 0.01 0.071 
Soto et al. (32) 1 0.1 0.01 0.1 
Soto, unpubl., cited in Fang et al. (30)  0.0079 0.044 0.25 
Korner et al. (138) 1 NM 0.096 NM 
Leusch et al. (31) 1 NM 0.012 NM 
Relative Proliferative Effect     
This study a 100 91 94 91 
Soto, unpubl., cited in Fang et al. (30) 100 90 95 82 
Korner et al. (138) 100 NM 112 NM 
Leusch et al. (31) 100 NM 77 NM 
Note: a Values are average of at least two independent assays conducted in triplicate. b NM = Not measured. 
Table 4.2: Potency of conjugated estrogens relative to 17β-estradiol as measured in this study, and compared 
to literature values using a range of assays. 
  Relative Potency  RPE RIE 
 
 
E-Screen a 
This study 
ER-
CALUX 
b 
Yeast 
Assay c 
Yeast 
Assay 
d 
Receptor 
binding e  
E-Screen a 
This study 
Yeast 
Assay c 
17β-E2  1 1 1 1 1  100 100 
E1-3G  0.000029 - - - -  93 - 
E1-3S  0.000012 - - - <0.01  94 - 
17β-E2-3G  0.0013 NR f 0.0032 NR f -  95 90 
17β-E2-17G  0.00037 - - - -  101 - 
17β-E2-
3S,17G 
 
0.000017 - - - -  41 g - 
17β-E2-3S  0.0026 - 0.0001 0.001 -  93 20 
17β-E2-diS  0.000012 - - - -  33 g - 
17α-E2-3S  0.000036 - - - -  87 - 
E3-3G  0.00055 - - - -  98 - 
E3-3S  0.00055 - - - -  101 - 
Note: a Values are average of at least two independent assays conducted in triplicate. b (150) c (148). d (149) 
e (71). f No response in assay, potency not calculated. g Minimum RPE, asymptope not reached.  
Overall the results in this study confirm conjugated estrogens are weakly estrogenic when 
tested at µM concentrations, with potencies comparable to weak estrogen mimics such as 
phytoestrogens and nonylphenols (reviewed in (28) and (31)). Because the environmental 
concentrations of conjugated estrogens (ng/L) are expected to be much lower than 
industrial compounds (µg/L, (28)), they are considered to be inactive or have extremely 
low estrogenic potency (9,16,98,151). However, they remain a significant estrogenic risk as 
they can readily be deconjugated to their highly active free forms.  
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4.3.2 Steroid Estrogen Concentrations 
Steroid estrogens were detected in all samples of DSE, with 17α-E2 present at the highest 
concentration in all samples (Table 4.3), followed by E1 and then 17β-E2 (with one 
exception). Steroid concentrations in effluents from milking farms ranged from 110 to 
11,000 ng/L for 17α-E2 (median of 730 ng/L), 1 to 310 ng/L for 17β-E2 (median 24 ng/L), 
and 10 to 580 ng/L for E1 (median 100 ng/L). The concentration of free estrogens for 
samples collected in August was corrected by recovery of the surrogate standard 17β-E2-
d4. Differences in 17α-E2 and E1 recovery may mean that these were over- or under-
estimated; however, results obtained from later sampling provided similar 
concentrations.  
Steroid estrogen concentrations appeared to be higher in effluents from farms with 
treatment ponds for samples collected at the start of the season. It is hypothesised that 
hydrolysis of conjugated estrogens within the effluent system produced these higher 
concentrations. The retention time of a typical dairy farm pond system is 60-90 days (152), 
exceeding the half-lives for hydrolysis of 17β-E2-3S and E1-3S, which are estimated at 2.5 
days (16). By comparison, irrigated effluent is discharged almost immediately after 
collection (RT < 3 hours). Measurement of conjugated estrogens in samples at the end of 
season could neither support nor contest this hypothesis, as unfortunately three of the five 
treatment pond systems sampled had stopped milking prior to sampling (which meant 
that effluent from within those ponds was not representative of that obtained during 
milking). 
Conjugated estrogens were detected in most samples obtained in the end of season 
sampling. E1-3S was the most prevalent, with concentrations from 12 to 177 ng/L 
(median 21 ng/L) (Table 4.3). 17α-E2-3S was detected in only 4 of the 18 samples, at 
concentrations below the quantitation limit to 225 ng/L. 17β-E2-diS was also measured in 
four samples at 17-320 ng/L, although these results should be treated with caution due to 
the low recovery obtained in spiked samples. Similarly, quantitation of 17β-E2-3S was 
hampered by the presence of a large coeluting peak, and glucuronide conjugates were not 
quantified due to poor detection limits. 
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Table 4.3: Concentrations of estrogens and conjugated estrogens in dairy effluent samples (ng/L) a.  
     Start of milking season b  End of milking season c 
Farm 
No. 
Treat-
ment 
Dis-
charge d 
No. 
stock 
 E1 17α-E2 17β-E2 Total free 
estrogens 
 E1 17α-E2 17β-E2 E1-3S E2-diS 17α-
E2-3S 
Total free 
estrogens 
Toenepi                
T1 e 2-pond Water 160  200 880 55 1100  16 ND f 2 ND ND ND 18 
T2 None Land 250  35 160 9 190  190 1800 17 180 ND 130 2300 
T3 2-pond Land 144  240 500 45 780  450 1300 160 ND ND ND 1900 
T4 e APS g Water 350  580 760 310 1700  7 ND 1 ND ND ND 8 
T5 e 2-pond Water 152  270 570 78 920  14 ND 2 ND ND ND 16 
T6 Pond Land 264  370 1400 170 1900  260 1600 92 56 ND 29 2000 
Waikuku                
W1 None Land 420  26 230 44 300  NM h NM NM 43 ND ND  
W2 None Land 220  100 720 85 900  21 230 5 12 ND ND 260 
W3 None Land 380  45 130 24 170  26 290 3 29 ND ND 350 
W4 None Land 300  100 110 33 250  19 310 9 50 ND BQL i 390 
W5 None Land 260  120 380 62 560  20 210 3 58 ND ND 290 
W6 None Land 200  50 250 18 300  10 250 9 45 ND ND 320 
Pahau                
P1 None Land 1000  NM NM NM NM  210 1700 44 ND 320 ND 2200 
P2 None Land 823  NM NM NM NM  76 640 12 13 17 ND 760 
P3 None Land 490  NM NM NM NM  42 830 22 25 ND 230 1100 
P4 None Land 600  NM NM NM NM  49 1200 27 16 250 ND 1500 
P5 None Land 350  NM NM NM NM  40 750 8 ND ND ND 800 
P6 None Land 720  NM NM NM NM  480 11,000 64 110 60 ND 11,000 
Notes: a All data rounded to no more than two significant figures. b Quantitated against 1717β-E2-acetate as internal standard, recovery corrected. c Quantitated by 
isotope dilution. d Effluents discharged either to receiving waterways (“Water”), or spray-irrigated onto land (“Land”). e Samples collected after end of milking 
season on these farms. f ND = Not detected. g APS = Advanced Pond System. h Not measured as this sample destroyed during work-up. i BQL = Below 
quantitation limit, trace concentration detected. 
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The steroid estrogen concentrations in dairy effluent are expected to depend on the 
reproductive state of the cattle, as excretion varies to a great extent with reproductive 
state. Estrogen excretion increases significantly during pregnancy, particularly within the 
last month (99,153,154), followed by a marked decrease within two days post-partum 
(20,99). Faecal excretion is reportedly the major excretion route, as free steroids, while 
conjugated estrogens are primarily excreted in urine (20,153). Although there are many 
studies of reproductive steroids in cattle, most of these were undertaken in the 1960s and 
1970s using colourimetric and fluorometric methods that lack sensitivity and specificity 
(20) compared to modern methods of analysis. As such the data provided by these studies 
should be treated with caution. Recent studies have used radio- or enzyme- 
immunoassays to measure estrogens in faeces and urine.  
The concentration of 17α-E2 was reported at ~10 ng/g in faeces from non-pregnant cows, 
and more than 22 ng/g in faeces from pregnant cows (155). Estrone and 17β-E2 
concentrations were lower at 1.0 ng/g and 1.6 ng/g respectively in non-pregnant cows 
and 3.3 and 5.7 ng/g in pregnant cows (155). If it is assumed that DSE contains 
approximately 10% excreta (156), concentrations in effluent from cycling cattle could be 
estimated at 1000 ng/L for 17α-E2, 100 ng/L for E1, and 160 ng/L for 17β-E2. In effluent 
from pregnant cows, the concentrations would be higher at 2200 ng/L for 17α-E2, 
330 ng/L for E1, and 570 ng/L for 17β-E2. In cycling cattle, urinary excretion of E1-3S has 
been measured at 0.4-4 µg/L; however, levels increase in pregnant cattle, and range 
between 10 and 40 µg/L during mid-pregnancy (101). Again, assuming that DSE contains 
~10% excreta (156), E1-3S would be measured in the DSE at 40-400 ng/L in the early 
milking season and 1000-4000 ng/L at the end of the season. No recent data is available 
for other conjugated estrogens in urine, though E1-3S is reportedly the dominant 
conjugate in cattle urine (99). 
In this study, samples were collected at the start of the milking season (August), reflecting 
excretions from stock just a few days post-partum. Cattle return to estrus and are typically 
bred in November. Samples collected near to the end of the season (March to May) were 
derived from pregnant stock approximately 90-150 days pre-partum (157). The 
concentrations of steroid estrogens measured in the DSE were within the expected range, 
given the variation in excretion levels and effluent dilution. E1-3S concentrations were 
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typically lower than these estimated values, and the measurement of other conjugated 
estrogens at higher concentrations (Table 4.3) suggests that there may have been some 
loss of E1-3S, possibly during sample work-up, and that these concentrations may be an 
under-estimate. 
Despite differences in cattle estrogen excretion with reproductive state, total estrogen 
concentrations in the effluents collected near the end of the milking season were not 
consistently higher than at the start of the milking season, and there was no statistical 
difference in a t-test (two-tailed, p-value = 0.67). Repeated sampling at three farms 
demonstrated considerable variation over time but did not indicate a clear trend in the 
total or individual concentration of steroid estrogens over the sampling period (Figure 
4.3). Variation in the amount of excreta within these samples, due to differences in 
dilution from wash-down water or differences in the depth and timing of sampling, may 
mask any seasonal differences due to the reproductive cycle. Excreta (both faeces and 
urine) collected directly from the cattle may provide a clearer picture of seasonal 
differences, but was not examined in this study. Since milking stops at least 8 weeks prior 
to calving in August, DSE is not produced during the period when estrogen excretion 
reportedly peak (101,155). 
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Figure 4.3: Comparison of steroid estrogen concentrations for three sites within the Toenepi catchment 
sampled three to five times during milking season. 
The profile of individual steroids within urine and faeces also varies with reproductive 
stage. During pregnancy, 17α-E2 is the dominant estrogen excreted by cattle, 
predominantly in the form of a glucuronide conjugate in urine and a free steroid in faeces 
 T2                                                                    T4                                           T5 
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(20,99,153). The amount of E1 and 17β-E2 excreted is lower, though the ratio of E1 to 17β-
E2 differs in urine (where E1, predominantly excreted as E1-3S, dominates) to that in 
faeces (where the ratio appears to change during pregnancy (99)). However, during the 
estrus cycle, the relative concentrations of 17α-E2, 17β-E2 and E1 fluctuate (17). 17α-E2 
was the most abundant steroid in all but three samples collected from ponds on farms 
after the milking season had ended where E1 dominated. This may represent degradation 
of 17α-E2 and 17β-E2 to E1, which is more stable (158,159). E1 was the next most 
abundant steroid in the samples, where it was present at concentrations around 4-times 
higher than 17β-E2. This may reflect the relative concentrations excreted from stock, and 
the transformation of 17β-E2 to E1 following excretion.  
It has been suggested that larger herd sizes may increase the concentration of steroid 
estrogens in DSE (40). In this study, there was no relationship between the number of 
stock and the total concentration of steroids in all analysed samples (R2 = 0.15), or when 
samples collected from pond systems were excluded (R2=0.25). The volume of wash-down 
water used in the milking shed is estimated at 25 L per cow (152), suggesting that any 
increase in the amount of urine or faecal matter deposited with larger herds would be 
diluted by a larger volume of water. This would result in similar concentrations of steroid 
estrogens in effluents from all farms regardless of herd size, as observed in this study. 
It has been reported that as herd sizes increase, farms may use progressively lower 
volumes of wash-down water per cow (156), suggesting there may be some difference in 
steroid concentrations in effluent from the larger farms. One of the large farms visited in 
this study reported they minimised water use (P6). The sample from this farm contained 
the highest steroid concentrations, with 17α-E2 present at a concentration more than ten-
fold higher than the median across all analysed samples. As the majority of the effluents 
were obtained from farms with less than 350 cows (consistent with 66% of New Zealand 
farms (157)), further samples need to be collected from large farms and analysed to 
conclusively determine differences.  
4.3.3 Estrogenic Activity 
All effluent samples demonstrated an estrogenic response using the E-Screen assay, 
though most samples also demonstrated cytotoxic effects at high concentrations, 
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evidenced by a decrease in measured absorbance and by microscopic examination of the 
cell plates. Toxic effects were also noted in two-hybrid yeast and ERBA assays (data not 
presented). Despite the cytotoxicity, it was possible to calculate an accurate EC50 and 
therefore EEQ for each sample using the E-Screen. The EEQs obtained ranged from 1.4 to 
670 ng/L (Table 4.4). Calculation of RPE was possible for only four samples due to 
cytotoxicity at high concentrations, and each demonstrated full agonistic activity. 
Table 4.4: Estrogenic activity of DSE samples measured by bioassays (EEQ, ng/L) a. 
  Start of milking season  End of milking season 
Farm No. 
 
Measured Predicted b 
Ratio 
Meas:Pred 
 
Measured Predicted b 
Ratio 
Meas:Pred 
Toenepi Catchment       
T1  110 77 1.4  1.4 2.0 0.7 
T2  27 13 2.1  69 58 1.2 
T3  71 60 1.2  140 200 0.7 
T4  670 337 2.0  1.3 1.0 1.3 
T5  120 96 1.2  3.6 2.0 1.8 
T6  300 209 1.4  97 130 0.7 
Waikuku Catchment       
W1  NM c 49 NC d  32 NC e NC 
W2  59 101 0.6  18 9.8 1.8 
W3  20 28 0.7  18 9.7 1.9 
W4  NM 38 NC  18 16 1.1 
W5  NM 73 NC  26 7.9 3.3 
W6  30 24 1.2  11 15 0.7 
Pahau Catchment       
P1  NM NM NM  55 82 0.7 
P2  NM NM NM  32 27 1.2 
P3  NM NM NM  36 39 0.9 
P4  NM NM NM  65 52 1.3 
P5  NM NM NM  27 24 1.1 
P6  NM NM NM  570 290 2.0 
Notes: a All data rounded to two significant figures. b Predicted from potency of steroids in E-Screen (17β-
E2=1, 17α-E2=0.020, E1=0.024). c Not measured. d Not calculated. e Sample lost during work-up and 
chemical analysis not completed. 
EEQs predicted from chemical analysis and estrogenic potencies in the E-screen were 
similar to those measured by the E-Screen assay, with ratios typically within the range 0.6-
1.8 (Table 4.4). Comparisons within the same order of magnitude are considered to be 
within the precision of the assay and chemical analyses (138,160). Four samples had a 
ratio ≥ 2.0, which was outside the variation expected from the E-Screen assay; potential 
reasons for this are discussed later. 
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A comparison of the estrogenic activity predicted from the concentrations of the 
measured steroid estrogens in the DSE samples to that obtained by bioassay is shown in 
Figure 4.4. The steroid estrogens contributed 90 ± 38% of the EEQ measured in the E-
Screen (range 30-171%), indicating that most of the observed activity in the E-Screen was 
attributable to these compounds. This percentage is much higher than reported for STP 
influents and effluents, where steroids contribute up to 80% of measured activity in 
influents but regularly less than 50% in STP effluents (28,68). This is presumably because 
of a broader range of domestic and industrial chemicals that exhibit estrogenic activity  
entering these systems. Of the individual steroids, the largest mean contribution was from 
17β-E2 at 60 ± 35% (range 11–143%), followed by 17α-E2 at 25 ± 18% (range 0-60%), then 
E1 at 6 ± 5% (range 2-28%). The calculated contribution from conjugated estrogens to total 
estrogenic activity was negligible (0.000–0.035%), due to the significantly lower potency of 
these compounds. 
Despite the lower potency of 17α-E2 (~2% of 17β-E2), the concentrations in effluent 
samples are substantially higher than those of its isomer 17β-E2. This highlights the 
importance of measuring 17α-E2 in agricultural wastes, and contrasts with a previous 
suggestion that the contribution of 17α-E2 is negligible due to its low activity (33). Even at 
a potency of 1%, upon which that statement was based, the contribution of 17α-E2 
remains significant, at up to 30% (12 ± 9%) of the total EEQ. In contrast, estrone is 
commonly measured by authors assessing the estrogenicity of livestock wastes, but its 
contribution to the EEQ (6 ± 5%) was relatively minor for most samples analysed in this 
study. 
If conjugated estrogens are hydrolysed to free forms in the environment they could 
contribute additional estrogenic activity, particularly the 17β-E2-conjugates. For samples 
containing conjugated estrogens, the additional activity they could contribute, assuming 
complete hydrolysis of conjugates and no change to the parent steroid, would be 
relatively low for most samples, with a median of 1.5 ng/L. However, for those samples 
containing residues of 17β-E2–diS, the potential contribution would be significantly 
higher, up to 200 ng/L EEQ. The potential risk from conjugated estrogens depends on 
their likelihood to hydrolyse to free estrogens. It is therefore important to understand the 
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Figure 4.4: Comparison of EEQ predicted from potencies and concentrations of steroid estrogens with the 
EEQ measured by E-Screen for each sample (error bars represent standard error of duplicate measurements). 
Predicted EEQs based on the following potencies: 17β-E2 = 1, E1 = 0.024 and 17α-E2 = 0.02. 
fate of conjugated estrogens in receiving environments to develop realistic assessments of 
the sources and risks of estrogens in the environment. 
As mentioned, four of the analysed samples (T2 and T4 at the start of season and W5 and 
P6 at the end of season) demonstrated substantial differences between measured and 
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predicted EEQs, with ratios from 2.0 to 3.3. For sample T2 and W5, this may be due to the 
lower precision associated with the measurement of 17β-E2 at low concentrations (3 and 
9 ng/L in these samples). As this is the most potent estrogen, it can have a large influence 
on the predicted total EEQ. For the other two samples, the differences were outside the 
expected variation, and may be due to the presence of estrogenic compounds not 
quantified by chemical analysis. Bisphenol A and 4-nonylphenol, two weakly estrogenic 
compounds, were detected using GC-MS at ~20 ng/L in these samples (not recovery 
corrected). Due to their low potency (2.5-6.0 x 10-5 and 1.3-10 x 10-5 respectively in the E-
Screen assay (28)), their contribution to overall estrogenic activity of the sample would be 
negligible (<0.001 ng/L). The estrogenic potency of other nonylphenols present in the 
sample (identifiable only as part of the nonylphenol technical mix, at up to 60 ng/L) is 
about a tenth lower than the recognised xenoestrogen 4-nonylphenol (32), and therefore 
their contribution to measured activity is again negligible. 
Cleaning products used in milking sheds are predominantly based on inorganic acids 
such as sulfuric acid, or bases such as sodium hydroxide. Previously, products authorised 
for use in New Zealand included nonylphenol ethoxylate (NPE) surfactants (161). In 
addition, NPEs are found in several veterinary medicines, such as teat dips to reduce 
mastitis and bloat control remedies (161). The use of these products is under review (161), 
but it is likely they will continue to be used until effective alternatives are available.  
Phytoestrogens and mycoestrogens have been detected in manures (74,162) but were not 
measured in this study. Equol has previously been identified as a contributor to 
estrogenic activity in hog manure, at a concentration of 6.9-16.6 mg/L (74). The 
mycoestrogen zearalenone is slightly more potent than equol (0.01 cf. 0.005, (32)), and 
could contribute to estrogenic activity if present at the maximum concentration 
previously measured in cattle manure (up to 197 ng/g dry weight (163)). Zearalenone and 
its analogue zearalenol are produced by the fungus Fusarium, which is common in New 
Zealand grass. Zearalenone and zearalenol have also been measured in New Zealand 
maizes (164,165), and have have been shown to persist for 12 weeks in silage (163). It is 
highly probable these estrogen mimics, and/or their metabolites are present in DSE from 
grass-fed cattle. Their presence in DSE is likely to be site-specific, and be related to the 
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type and condition of pasture, and the use of additional stock feeds such as grain or 
silage.  
4.3.4 Comparison to Literature Data 
Free estrogens 
The free steroids measured in DSE in this study are comparable with previously 
published data for dairy wastes (Table 4.5), but 17β-E2 concentrations measured in this 
study (median 24 ng/L) were generally lower, especially when compared to E1 and 17α-
E2 concentrations (medians from 88-1700 ng/L, Table 4.5). 
Table 4.5: Median concentrations of free estrogens in dairy wastes (ng/L, median (range)). 
Sample description E1 17α-E2 17β-E2 
Total free 
estrogens N a Ref. 
DSE b 
100 
(10-580) 
730 
(110-6800) 
24 
(3-310) 
728 
(8-11,500) 27 
This 
study 
DSE after pond treatment 382 (NDc-3123) 
249 
(ND-1028) 
88 
(ND-331) 
719 
(ND-4416) 6 (40) 
Dairy lagoons 75 (57-80) 
212 
(177-283) 
167 
(110-168) 
436 
(362-531) 3 (43) 
Drain with dairy effluent 38 NM d 8.6 46.6 1 (45) 
Flushed dairy 
wastewater c 
672 NM 344 2  (46) 
Flushed dairy 
wastewater 
551 
(370-2356) 
2114 
(1750-3270) 
672 
(351-957) 
3462 
(2742-5103) 5 (47) 
Fresh dairy wastewater e ~300 ~2200 ~200 ~2700 6 (48) 
Dairy holding ponds 5500 (2500-5600) ~10,000 
e 1700 (800-1900) NC 
f 48 (39) 
Manure (solids) g 50 (28-72) 155 (120-190) 48 (46-50) NC f 3 (166) 
Notes: a Number of samples analysed. b Data for three samples collected after milking season not included. 
c ND = Not detected. d NM = Not measured. e Data estimated from graph. f Could not be calculated 
from data reported. g Data for solid samples (units ng/g). 
This was not due to degradation of 17β-E2 in the effluent systems, as untreated samples 
had particularly low levels of 17β-E2 compared to E1 and 17α-E2. A possible explanation 
for this observation is hydrolysis of 17β-E2 conjugates in inadequately preserved samples 
during storage and extraction. In this study and that of Raman et al. (39), all samples were 
preserved with acid to pH ≤ 2 and extraction was completed within 36 hours of collection. 
Preservation methods used by other researchers (formaldehyde, < 4 °C) do not prevent 
the hydrolysis of glucuronides in effluent samples (93).  
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Conjugated estrogens 
There is only one previous study reporting conjugated estrogens in agricultural wastes to 
compare the data to. Hutchins et al. (43) measured E1-3S, 17α-E2-3S and 17β-E2-3S in 
three dairy effluent samples at median concentrations of 87, 170 and 42 ng/L respectively, 
similar to concentrations found in this study (Table 4.3). 17β-E2-17S and glucuronides 
were not detected in the study of Hutchins et al., possibly due to low and variable 
recovery (43). For example, recovery of 17β-E2-17S was 23 ± 20% and 91% in blank spikes 
and a matrix spike (swine lagoon sample), and glucuronide recovery was 23-125% and 71-
150% in blank and matrix spikes (43). The variable recoveries demonstrated the 
difficulties involved in analysing these compounds in complex matrices. 
Hutchins et al. also examined conjugated estrogens by subjecting raw effluent samples to 
enzyme treatment, followed by extraction and analysis of free estrogens by GC-MS (43). 
The results were compared with those obtained for untreated samples and the difference 
used to calculate the contribution from conjugated estrogens in the samples. Their results 
suggested the presence of significant amounts of E1 and 17α-E2 conjugates, with increases 
of 420-570 ng/L of E1 and 52-270 ng/L of 17α-E2 (43). The observed increase in 17α-E2 
was similar to the concentrations of 17α-E2-3S measured by LC-MS-MS. In contrast, the 
increase in E1 was higher than the concentration of E1-3S measured by LC-MS-MS, 
though some of that increase results from the conversion of 17β-E2 and its conjugates. 
17β-E2 was lower in two out of three samples after enzyme treatment compared with 
samples not subjected to enzyme treatment. Hutchins et al. (43) hypothesised that free 
estrogens in the sample degraded to E1 during the enzyme treatment process, as samples 
were maintained at 37 °C for 16 hours. Rapid degradation of 17β-E2 to E1 has previously 
been demonstrated in unpreserved dairy manure samples stored at 30 °C (167). 
The present study indicates conjugated estrogens are present in DSE at significant 
concentrations when compared with the concentration of free estrogens. Specifically, the 
free and sulfate-conjugated forms of E1 were at similar concentrations in effluents 
analysed in this study, confirming the previous results of Hutchins et al. (43). Conversely, 
the free form of 17α-E2 was more prevalent than the sulfate-conjugate in analysed 
samples. This contrasts with the previous results for dairy wastes which suggested 
sulfate-conjugates comprised 40-45% of total identified 17α-E2 (43), but agrees with 
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studies of bovine excretion that suggest the glucuronide-conjugate is the principal 
conjugate of 17α-E2 rather than the sulfate form (99,153,154). Further improvements to the 
analytical methods used to analyse conjugated estrogens are required to provide 
additional information on the significance of conjugated forms of 17β-E2. 
Estrogenic Activity 
EEQs measured using the E-Screen assay in this study (Table 4.6) are comparable to those 
previously measured in DSE in New Zealand by ERBA assay (40), and in dairy manures 
in the Netherlands by ER-CALUX (166). The EEQs measured for an Australian DSE 
sample using the YES and ER-CALUX assays (45) were at the minimum end of the range 
measured in this study using E-Screen. To date, there are no comparative data for the 
estrogenic activity of dairy effluent or manure derived from the E-Screen assay, which 
was used most extensively in this study. 
Table 4.6: Comparative data (median (range)). 
Sample description 
EEQ 
(ng/L unless stated) Assay N Ref. 
Dairy shed effluents a 
46 
(18-670) E-Screen 24 This study 
Dairy shed effluents after pond 
treatment 
143 
(ND-521) ERBA 6 (40) 
Dairy shed effluent 14 ± 0 YES 1 (45) 
Dairy shed effluent 11 ± 6 ER-CALUX 1 (45) 
Dairy manure 190 (16-370) ER-CALUX 2 (166) 
Dairy manure (solids, ng/g) ~280 (22 – 2900) Yeast assay 7 (49) 
Notes: a Data for three samples collected after milking season not included. 
Lorenzen et al. (49) measured the estrogenic activity of solid dairy manure samples using 
the YES assay, and established a median of ~280 ng/g on a dry weight basis. Assuming 
0.9% solids in the dairy effluent (156), this would be equivalent to 2520 ng/L EEQ in a 
liquid sample, higher than the median and maximum EEQs determined in this study 
using the E-Screen, but similar to the maximum EEQ determined by the ERBA assay in 
this study (results not presented). 
Differences in estrogenic activity between the current study and those reported in 
literature may be due to differences in the in vitro assays used. The ERBA provides 
information on chemicals that can displace 17β-E2 and includes chemicals that can bind to 
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the ER without causing an estrogenic response. The E-Screen assay gives an indication of 
the potential estrogenicity on a cellular basis. Order of magnitude differences have been 
demonstrated when comparing receptor binding assays with the E-Screen (144) or 
receptor-reporter gene assays (72). Nelson et al. (168) reported a four-fold difference in the 
EEQ of wastewater samples measured using the ER-CALUX and receptor-reporter gene 
yeast assays. In the current study, the estrogenic activity of dairy effluent samples was 
considerably higher when measured with a two-hybrid yeast assay (Chapter 6) and by 
ERBA (data not shown) than with the E-Screen assay. 
4.4 CONCLUSIONS 
Steroid estrogens were detected in all DSE samples collected. 17α-E2 was measured at the 
highest concentrations, at a median of 730 ng/L. Conjugated estrogens were also present 
in some samples at significant concentrations; in particular E1-3S (13-180 ng/L) was 
present at similar concentrations to free E1 in those samples (10-480 ng/L). These values 
may be an under-estimate of the total free estrogens present in the samples, as free 
estrogens are known to sorb to particulates, which were not measured in this chapter.  
All effluent samples had measurable estrogenic activity in the E-Screen, with a median of 
46 ng/L by the E-Screen assay. Most of the observed estrogenic activity appears to be due 
to the presence of steroid estrogens. The majority of activity was attributable to 17β-E2 
and 17α-E2, despite the lower potency of 17α-E2. Although conjugated estrogens 
demonstrated weak estrogenic activity when measured in the E-Screen, they did not 
contribute to estrogenic activity, due to their low relative potencies. 
The presence of conjugated estrogens in the DSE is important as they can degrade to 
active steroids; however, they are rarely determined in agricultural wastes. Analytical 
methods need to be refined to reliably measure all forms of conjugated estrogens 
(including glucuronides) in complex waste matrices. The data from this study 
demonstrates that conjugated estrogens must be measured in future studies so that they 
can be included in risk assessments for these wastes. Because of the contribution of 
estrogens derived from conjugates, the total potential impact of steroid estrogens in 
regions of intensive dairy farming is significantly more than is immediately apparent 
from previous literature. 
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Chapter 5:  Assessing the Efficacy of Two-
Pond and Advanced Pond Treatment 
Systems to Remove Estrogens from Dairy 
Shed Effluent  
5.1 INTRODUCTION 
The presence of steroid estrogens in waterways can result in feminising effects on aquatic 
biota including skewed hormone ratios, the induction of the precursor yolk protein 
vitellogenin in male fish, and in extreme cases, intersex fish (7). In New Zealand, dairy 
farms are the major source of steroid estrogens to the environment, and potentially to 
aquatic ecosystems. While most of the animal wastes on New Zealand dairy farms are 
dispersed over the land during free-range grazing, wastes are also produced during dairy 
shed milking operations. The animal wastes (faeces and urine) excreted in the milking 
shed and yard are combined with cleaning products used in the cleaning and rinsing of 
milking equipment and storage tanks, and diluted with wash-down water from cleaning 
of the shed and yards (50). 
In many regions of New Zealand treated DSE was historically discharged to waterways 
after treatment, with two-pond systems (2PS) being widely used from the 1970s to reduce 
loads of total suspended solids (TSS) and biological oxygen demand (BOD) in discharged 
effluent. As this system is not effective at removing nutrients and pathogens (169), 
improvements have been sought, and the advanced pond system (APS) has recently been 
promoted. This reportedly removes dissolved nutrients (nitrogen and phosphorus) and 
faecal indicator bacteria considerably better than 2PS, and is more consistent at removing 
BOD and TSS (170,171). Neither of these systems was designed to remove micro-
contaminants such as steroid hormones from DSE, and their removal efficiency for these 
contaminants has not been characterised.  
Internationally, agricultural waste treatment systems have recently been examined for 
their ability to remove steroid estrogens, including systems for dairy wastewaters (48) and 
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swine manures (41,44). Lagoons, constructed wetlands and trickling filter systems have 
demonstrated the removal of steroid estrogens through loss mechanisms that include 
aerobic biodegradation, sorption and photolysis (41,44,48). However these systems are 
different to those used in New Zealand for the treatment of DSE and typically treat waste 
from much larger farms. For example, the dairy wastewater system described by Zheng et 
al. (48) includes three large lagoons, each approximately 100 m x 50 m and treats dairy 
manure and wastewater from a farm of 2000 cows. The majority of farms in New Zealand 
(63%) have between 100 and 350 cows, and only 2.3% milk over 1000 cows (157). Effluent 
ponds are accordingly much smaller, with design values of 19 x 35 m for the anaerobic 
and 22 x 53 m for the aerobic pond for a typical farm with 250 cows in the upper North 
Island. Despite being different to treatment systems used internationally, the New 
Zealand pond systems have potential to remove steroid estrogens as they incorporate 
aerobic degradation and photodegradation processes that are known to remove estrogens 
from wastewaters (159). 
Removal of steroid estrogens from sewage has been thoroughly investigated using 
laboratory batch reactors, pilot-scale plants and numerous sewage treatment plants 
(reviewed in refs (159,172)). The findings, which likely apply to dairy effluents, indicate 
that the most important removal processes are sorption to sludge and aerobic 
degradation. Under non-sterile aerobic conditions, 17β-E2 is converted to E1, which is 
somewhat more stable (159,172). It has been suggested that 17α-E2, the primary 
metabolite found in dairy effluent, also produces E1 during aerobic degradation (43,48). 
This suggestion was based on the prevalence of E1 measured in treated dairy effluents in 
the field; however, this has not been confirmed by laboratory tests. Degradation to E1 
would not decrease the potential for adverse effects, as E1 has similar estrogenic potency 
to 17α-E2, at least in in vitro assays (71,148,150).  
This chapter reports on an investigation into the removal of estrogens in DSE through 
two-pond and advanced pond systems. The objectives of this study were to identify and 
quantify steroid estrogens within each stage of the treatment systems and assess their 
contribution to measured estrogenic activity; investigate conversion of conjugates and free 
estrogens within the systems and a laboratory batch experiment; and to assess and 
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compare the overall removal of steroid estrogens and estrogenic activity by each 
treatment system. 
5.2 METHODS 
5.2.1 Study Sites 
The effluent systems investigated were both located in the same geographic area to 
minimise any differences in treatment efficiencies due to climatic effects. Both farms 
milked Fresian cattle, twice daily at approximately 6-7 am and 3-4 pm. Each milking shed 
and yard was hosed directly after milking and effluent was drained by gravity into the 
treatment system. Samples were collected during or directly after morning milking (7-
8 am). Sampling from each system was undertaken three times during the milking season 
to provide replication. The milking season begins in late July/August and ends around 
April, when cows dry off before calving in July/August. Samples were collected August, 
November and December 2007, being at the start and peak of the milking season. These 
months correspond to late winter, spring and early summer. 
Two-pond system 
Traditional two-pond DSE treatment systems are a low-cost, low-maintenance system 
consisting of an anaerobic pond (AP) followed by a facultative pond (FP) to treat effluent 
before discharge to receiving waters. Farm DSE is piped to the anaerobic pond where 
solids settle out of solution and organic matter is digested by anaerobic bacteria. Sludge is 
periodically removed (every 2-4 years) to maintain effective water depth and thus 
hydraulic retention time. The partially treated effluent drains by gravity into the 
facultative pond, which is usually shallower and has a larger surface area. The facultative 
pond provides further anaerobic treatment in the lower layer and aerobic treatment at the 
pond surface. The facultative pond typically discharges into a farm drain which flows into 
a natural stream. 
The system investigated consisted of two ponds approximately 20 m by 20 m, and 
received effluent from a farm milking 150 cows. Grab samples were collected from the 
Efficacy of treatment systems 
88   
drain carrying wastes from the dairy shed to the anaerobic pond (Raw); at the point of exit 
from the anaerobic pond or point of entry into the facultative pond (AP); and at the 
discharge point from the facultative pond (FP). 
Advanced Pond System 
The advanced pond system is designed to optimise natural wastewater treatment 
processes, thereby minimising maintenance and operating costs (170). The initial 
anaerobic pond (AP) provides the same functions as that in a two-pond system. Effluent 
from the AP is discharged into a high rate pond (HRP), a long shallow pond continually 
mixed by a paddle-wheel to prevent thermal stratification and to maintain aerobic 
conditions (170). This promotes algal growth, with a corresponding uptake of nutrients, 
and further degrades organic matter. This is followed by two algal settling ponds in series 
(ASP) which are deep to promote the algae to settle, thereby removing nutrients from the 
effluent. The final stage is the maturation pond (MP), which promotes further removal of 
micro-organisms through a combination of solar UV-radiation, sedimentation and 
protozoan grazing (171). 
The APS assessed within this study contained all of the described elements; the treated 
effluent was then discharged to a tile drain before release to a nearby farm drain and 
subsequent receiving water (Figure 5.1). A full description of this system and its treatment 
efficiency is provided by Craggs et al. (171). During the sampling period, approximately 
350 cows were milked twice daily in the dairy shed. Raw effluent samples were collected 
from the input to the pond, from within the drain at the dairy shed prior to entering the 
AP (November and December). In August there was no effluent in the drain at the dairy 
shed, due to the time of sampling, and the sample had to be collected from within the AP 
at the point of entry. Effluent samples were also collected from between each component 
of the pond system (AP, HRP, ASP, MP) and after the tile drain at the final discharge 
point to the receiving environment (TD).  
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Figure 5.1: Schematic diagram of the Advanced Pond System (adapted from Craggs et al. (171)). AP = 
Anaerobic pond, HRP = High rate pond, ASP = Algal settling ponds, MP = Maturation Pond and TD = 
Tile Drain.  
5.2.2 Sampling and Extraction 
Grab samples were collected during morning milking in solvent-rinsed amber glass 
bottles with Teflon-lined lids. Samples were immediately preserved by the addition of 
sulfuric acid (to pH ≤ 2) and stored at <4 °C until extraction (within 24 hours). 
Samples were extracted in duplicate for chemical analysis of free and conjugated 
estrogens and for biological analysis by E-Screen assay. Samples were also collected for 
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nutrient analysis in laboratory-supplied bottles containing preservative and were 
immediately delivered to a commercial laboratory for analysis. 
Samples for estrogen analysis were centrifuged at up to 1780 g for 20 mins at 4 °C, then 
approximately 2 L was filtered through glass fibre filters (GF/C, 47mm, pore size 1.2 µm) 
with the addition of filter aid. Samples were divided into two aliquots of 1 L each, and 
samples for chemical analysis were spiked with surrogate standards (250 ng each E2-d4, 
E1-d4, E2-3S-d4 and E1-3S-d4). Both aliquots were loaded at a flow rate of 5-10 mL/min 
onto separate preconditioned 1 g Oasis HLB cartridges (20 mL of MeOH followed by 
20 mL of MQ water). As part of quality control procedures, a method blank and two spike 
recovery samples were extracted with each batch of samples. Spike recovery samples (1 L 
MQ) were spiked with either 25 ng or 250 ng of the following free and conjugated 
estrogens: 17α-E2, 17β-E2, E1, 17β-E2-3G, 17β-E2-17G, 17β-E2-3,17S, 17β-E2-3S,17G, 17β-
E2-3S, 17α-E2-3S, E1-3G and E1-3S. 
The particulate fraction was extracted to assess the particulate associated concentration 
and the total concentration of free estrogens in each sample. The particulates recovered 
during centrifugation were stored at -20 °C prior to extraction. After defrosting at room 
temperature, approximately 6 g of wet solids was transferred to a centrifuge tube and 
spiked with 250 ng of E2-d4 and E1-d4 (25 µL of a 10 µg/mL solution). A mixture of 
isopropanol and MQ water (80:20, 10 mL, (173)) was added and the sample was extracted 
using sonication (10 min) followed by shaking on a reciprocal shaker at 235 rpm (30 min). 
The samples were centrifuged at 1000 g for 10 min to settle solids so that the supernatant 
could be removed. The extraction procedure was repeated with a 50:50 mixture of 
isopropanol and MQ water (173). The supernatants from each extraction were combined 
and diluted with 170 mL phosphate buffer (pH 7.0, 0.1M). The aqueous mixture was 
extracted through Oasis HLB cartridges (500 mg) conditioned as previously described. 
The extracted samples were eluted, purified and analysed for free estrogens as described 
below. Quality control procedures for the particulate analysis included blanks, solvent 
spikes, matrix spikes and duplicate extractions for each batch of samples. Spikes were 
prepared by addition of 250 ng of the free estrogens 17α-E2, 17β-E2, E1 to either solvent 
(isopropanol and MQ water) or solid samples (matrix spike). 
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5.2.3 Laboratory Biodegradation Experiment 
A laboratory batch degradation test was conducted to assess the degradation of 17α-E2 in 
DSE and its potential to produce E1. Fresh samples of DSE were collected in 4 L solvent-
rinsed glass bottles. These were combined into a single bulk sample, mixed and split into 
two samples of 5 L each in 10 L Schott bottles. One of the duplicate samples served as a 
control, while the other sample was spiked with 17α-E2 at a concentration of 25,000 ng/L. 
This concentration was selected to be in excess of the concentration of 17α-E2 or E1 that 
could potentially be found in the effluent sample. Both experimental bottles were stored 
in the dark at room temperature, and were frequently opened to the air and shaken to 
promote exchange of air and ensure that aerobic conditions were maintained within the 
effluent bottles. 
Subsamples were removed from the control and treatment bottles at the following times: 
immediately (0 hours), 1 hour, 3 hours, 24 hours, 48 hours, 120 hours (5 days) and 
192 hours (8 days). At each time period, 400-500 mL of sample was removed from each 
bottle, centrifuged at 1000 g at 4 °C for 10 mins to remove bulk solids, then filtered 
through glass fibre filters and filter aid as previously described. Samples were split into 
three replicates (100 mL each), spiked with surrogate standards (500 ng each 17β-E2-d4, 
E1-d4), and loaded onto 500 mg Oasis HLB cartridges (preconditioned with 10 mL of 
MeOH followed by 10 mL of MQ water) at a flow rate of 5-10 mL/min. Sample elution, 
clean-up and analysis of free estrogens is described below. 
5.2.4 Chemical Analysis 
The extracted samples for chemical analysis were eluted from the Oasis cartridges in two 
fractions to separate conjugated estrogens and free estrogens, as described in detail in 
Chapter 3 and summarized briefly here. The Oasis HLB cartridges were washed with a 
series of MeOH/MQ water mixtures to remove polar interferences (93) then conjugated 
estrogens were eluted with 75% MeOH/MQ water containing 2% ammonium hydroxide 
(8 mL, see Chapter 3 for details). The Oasis HLB cartridges were dried under vacuum to 
remove residual water and attached to the top of a Florisil cartridge (1 g cartridges, IST) 
onto which aminopropyl sorbent (500 mg, IST) was packed. Free estrogens were eluted 
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from the Oasis HLB cartridge and purified through the combined adsorbent column with 
30 ml of DCM:DEE: MeOH (40:10:1), which was collected for further purification.  
The free estrogen fraction was dried under nitrogen and further cleaned up using gel 
permeation chromatography (GPC) on Phenogel columns as detailed in Chapter 3. TFAA 
was added to the GPC extract to derivatise steroid estrogens prior to GC-MS analysis in 
SIM/Scan mode (see Chapter 3 for details). The steroid estrogens were quantified by 
isotope dilution against their deuterated surrogates, 17β-E2-d4 and E1-d4. 
The conjugated estrogen fraction eluted from the Oasis HLB cartridge was dried under 
nitrogen and reconstituted in MeOH for clean-up. Half of each extract was purified 
through silica gel (500 mg, JT Baker) and aminopropyl (500 mg, JT Baker) columns to 
remove matrix interferences (described further in Chapter 3). The purified extracts were 
reconstituted in ammonium acetate buffer for analysis of conjugated estrogens using LC-
IT-MS in negative ESI mode, as described in Chapter 3. MS data was acquired by selected 
reaction monitoring (SRM), and conjugates quantified by isotope dilution against 17β-E2-
3S-d4. 
5.2.5 Enzymolysis and solvolysis procedure to assess conjugated 
estrogens 
For samples collected from the 2PS and APS in December, the remaining half of the 
conjugated estrogen fraction of each sample was subjected to sequential enzymatic 
hydrolysis and solvolysis, to investigate whether conjugated estrogens not measurable by 
LC-MS were present in the samples. The sample extracts were dried under nitrogen blow-
down to remove MeOH and reconstituted in sodium acetate buffer (0.2 N acetate buffer 
with 10 mg/ml ascorbic acid, 5 mL). β-glucuronidase from Helix pomatia (Sigma HP-2) 
was used, as this preparation has glucuronidase activity (131,100 Fishman Units/mL) and 
some sulfatase activity (≤ 7500 units Sulfatase/mL). After adding 50 µL of the enzyme 
(corresponding to 1,311 FU/mL), extracts were incubated overnight at 37 °C. The reaction 
extracts were passed through Oasis HLB cartridges to retain any liberated free estrogens. 
The cartridges were washed with MeOH/water mixtures as described above for raw 
sample extracts, residual conjugate estrogens were then eluted, and free estrogens that 
had been liberated by the enzymatic hydrolysis reaction were eluted and purified using 
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aminopropyl and florisil adsorbents as described above. GPC, derivatisation and analysis 
of this fraction was undertaken as described above. 
The conjugated estrogen fraction recovered from the Oasis HLB cartridge was subjected 
to solvolysis to check for the presence of conjugated estrogens not readily cleaved by 
enzymatic hydrolysis such as sulfo-glucuronides and disulfates. A solvolysis procedure, 
modified from al Alousi et al. (174), was applied. The conjugate extract was completely 
dried under nitrogen and reconstituted in freshly distilled THF (5 mL). Acid was added 
(5 mL of 4M H2SO4) and extracts incubated at 53 °C for 2 hours. Extracts were diluted 
with 7 mL of potassium hydroxide (4M) and passed through Oasis HLB cartridges as 
above. Cartridges were washed as described above to remove polar interferences, and the 
free estrogen fraction was eluted with 30 ml of DCM: DEE: MeOH (40:10:1). These sample 
extracts contained little co-extracted material and did not require further purification. 
Samples were derivatised and analysed for free estrogens as described above. Free 
estrogens in the enzymolysis and solvolysis extracts were quantified against internal 
standards to account for differences in detector response due to signal enhancement or 
suppression. Because samples had been spiked with deuterated conjugates (17β-E2-3S-d4 
and E1-3S-d4) prior to extraction, and these may also be cleaved to their respective free 
forms, 17β-E2-d4, E1- d4 could not be used for quantitation and 17β-E2-17-acetate was used 
as an internal standard instead. 
The efficiency of the enzymolysis and solvolysis reactions was investigated by subjecting 
standards of conjugated estrogens to these reactions. For the enzymolysis reaction, mixed 
standards were prepared containing deuterated sulfates (17β-E2-3S-d4 and E1-3S-d4), 
glucuronides (17β-E2-3G, 17β-E2-17G, 17β-E2-3S,17G, E1-3G and E3-3G), sulfates (17β-E2-
3,17S, 17β-E2-3S,17G, 17β-E2-3S, 17α-E2-3S, E1-3S and E3-3G) and a mixture of all non-
deuterated forms. For the solvolysis reaction, the conjugates listed above were assessed in 
individual reactions. Enzymolysis and solvolysis reactions and Oasis extraction were 
undertaken as described above but samples were not subjected to clean-up prior to 
derivatisation and GC-MS analysis. 
Efficacy of treatment systems 
94   
5.2.6 E-Screen Analysis 
Samples for E-Screen assay were simply eluted from the Oasis HLB cartridges with 30 ml 
of DCM:DEE:MeOH (40:10:1), dried down to approximately 1 mL and transferred to 
brown glass vials. Solvent was evaporated under nitrogen, redissolved in DMSO (500 µL) 
and extracts stored at <20 °C in the dark until tested in the E-Screen assay. The E-Screen 
assay was conducted as described in Chapter 4. Method quality control procedures 
included analysis of a standard and a duplicate sample for each 10 samples; the assay was 
performed at least twice for each sample and the average value was reported.  
5.2.7 Fractionation of Samples for E-Screen Analysis 
Samples from November sampling were fractionated through florisil to investigate 
alternative causes of estrogenic activity. The sample extract eluted from the Oasis HLB 
cartridge was split into two, with one half subjected to further fractionation on florisil 
cartridges following a method previously reported (175). Extracts were dried under 
nitrogen then reconstituted in 1 mL hexane:DCM (3:1). Florisil cartridges (500 mg, Varian) 
were conditioned with 3 mL hexane. Samples were applied quantitatively using an 
additional 1.5 mL hexane:DCM then a further 2.5 mL hexane:DCM (3:1) was added to 
wash analytes through the cartridge. All eluent from these steps was collected (fraction 
NP). The second fraction (MP) was eluted with 2x 2.5 mL of acetone:DCM (1:9), and the 
third fraction (P) was eluted with 2x 2.5 mL of MeOH. Each fraction was completely dried 
under nitrogen and resuspended in 100 µl DMSO for analysis by E-Screen as described 
above. The unfractionated half of each sample was also analysed by E-Screen. 
5.2.8 Nutrient analysis 
Samples of effluent were analysed by a commercial laboratory for total organic carbon 
(TOC), total phosphorus (TP), total nitrogen (TN), total Kjeldahl nitrogen (TKN) and 
oxidised forms of nitrogen (nitrate-N and nitrite-N, NOxN) by standard methods (146). 
Total suspended solids (TSS) were measured using an in-house gravimetric method based 
on standard methods (146). 
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5.3 RESULTS AND DISCUSSION 
5.3.1 Two-pond System 
DSE Composition and Treatment System Performance 
Common indicators of effluent quality were measured at each stage of the two-pond 
system (2PS) investigated in this study. This demonstrated that, although there was 
substantial variation in the initial effluent quality on each monitoring occasion, there was 
efficient removal of TOC, phosphorus and nitrogen through the treatment system (Figure 
5.2). 
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Figure 5.2: TOC (a), TP (b), TKN (c) and NOxN (d) concentrations at each stage in each effluent treatment 
system for each time sampled. Note: Most measurements for NOxN were below detection limits and are not 
plotted on this chart. 
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A comparison of effluent quality from the 2PS with literature values indicates it was 
within the range expected for such a system (Table 5.1). Final concentrations of nitrogen 
and phosphorus were at the lower end of literature values. Pond effluent quality is 
typically poorest in spring and summer (176), and higher concentrations of TP, TKN and 
TOC were observed in November and December compared to August. Overall the data 
suggest this particular pond is working well to treat the DSE. This may be due to the 
ponds being approximately the correct size based on guidelines for dairy effluent ponds 
(177). 
Table 5.1: Performance and final effluent quality for nutrients in the 2PS. 
  Final effluent quality (mg/L)  % Reduction 
Parameter  This study Lit. a Lit. b Lit. c  This study 
TSS  200 d 198 105-307 220  84 d 
TOC  97 ± 40 98 e NM f 87  89 ± 10 
TP  12 ± 7 27 NM 20  73 ± 28 
TN  55 ± 31 NM 46-134 91  76 ± 23 
TKN  55 ± 31 >75 g 46-134 91  76 ± 23 
NOxN  0.016 (n=1) 0.065 0.066-0.36 0.44  NC h 
Notes: a Literature values, median for 11 ponds in Manawatu and Southland (169). b Range in median of 6 
ponds in Waikato (178). c Median for 12 ponds in Waikato (176). d n=1. e BOD data. f NM = Not 
measured. g Ammonia data, TKN not reported. h Not calculated due to large number of not detects. 
Steroid Estrogens in Effluent through the Two-Pond System  
E1, 17α-E2 and 17β-E2 were consistently measured in the untreated DSE (Raw, Figure 
5.3), after the anaerobic pond (AP), and in the final effluent (FP). In both the aqueous and 
particulate fractions 17α-E2 and E1 were the predominant steroids, with 17β-E2 as a 
minor component (0.3 – 35 ng/L in aqueous fraction and 2.6-39.7 ng/L in particulate 
fraction). There were insufficient solids retained in the final effluent samples (FP) to 
enable measurement of estrogens associated with particulate material at this sampling 
point. The samples measured indicated that a high proportion (56 ± 27%) of the total 
steroids was associated with the particulate fraction. The total concentration of steroids in 
the particulate fraction was highest in the untreated effluent, which had the highest 
corresponding concentration of solids. This highlights the importance of measuring the 
‘whole’ sample when assessing steroids in treatment systems, particularly for complex 
effluents like DSE with very high solids content. 
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Figure 5.3: Steroid estrogen concentrations in aqueous and particulate fractions at each location in the 2PS 
for the three times sampled ((a) August; (b) November; (c) December). 
The presence of steroids within the particulate fraction may be due to their excretion in 
faeces, immediate sorption of free steroids in urine to particulates, or from adsorption 
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during sample work-up. Acidification of the samples, necessary for preservation and 
sample treatment, is expected to increase adsorption of free steroids to the high organic 
matter content solid phase and to dissolved organic carbon. Schafer et al. (179) showed 
that adsorption of steroids to sludge at pH 2 was substantially higher than at pH 3 or 
more, and also that adsorption increased in the presence of higher concentrations of 
particulate matter. This resulted in increased adsorption of steroids to the particulate 
phase in raw effluents compared to treated effluents from the 2P system, which had much 
lower particulate content. 
Conjugated Estrogens in Effluent through the Two-Pond System 
Conjugated estrogens were investigated using LC-MS for all samples collected in August, 
November and December. An estradiol-glucuronide was detected in the input to the two-
pond system in August at an estimated concentration of 90 ng/L. This may have been 
either 17β-E2-3G or 17β-E2-17G, as these could not be differentiated by the LC-MS 
method. 17β-E2-3S,17G was measured once in the outlet at an estimated concentration of 
15 ng/L (December). As glucuronides detection limits were high and recovery sometimes 
low with this LC-MS method, the concentrations should be considered semi-quantitative 
only. No conjugates of either E1 or 17α-E2 were detected. 17β-E2-3S could not be 
quantified in these samples using LC-MS due to co-elution of an interfering compound. 
The presence of conjugated estrogens in samples collected in December was also assessed 
by enzymatic hydrolysis and solvolysis of samples, followed by GC-MS analysis of the 
liberated free estrogens. After enzymolysis, concentrations of 17α-E2 measured 0.2-
1.2 ng/L, while 17β-E2 measured 1.1-2.8 ng/L and E1 measured 3.6-12.1 ng/L. This 
suggests that glucuronide conjugates were present at only low concentrations in the 
samples, compared to the concentration of free steroids measured by GC-MS before 
enzymolysis (up to 228 ng/L, Figure 5.3). On the other hand, 30 ng/L of E1 was liberated 
by solvolysis of the sample collected after the anaerobic pond. This suggests that the 
parent conjugate was E1-3S, as E1-3G should have been cleaved during the enzymolysis 
step. 
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This comparison of the two methods to analyse conjugated estrogens shows confounding 
results. The LC-MS results for samples collected in December indicated the presence of 
17β-E2-3S,17G and no other conjugates, whereas the solvolysis results suggested the 
presence of E1-3S, which was not detected by LC-MS. The discrepancy in E1-3S 
measurement does not appear to be due to limitations in the LC-MS method, as the 
method detection limit of 15 ng/L for E1-3S should have been adequate to measure it if 
present in the sample at ~30 ng/L (as was suggested by the solvolysis results).  
Hutchins et al. (43) similarly found inconsistent results when using both LC-MS and 
enzyme hydrolysis to measure conjugated estrogens in agricultural effluents, including 
dairy effluent. Although E1 was liberated following enzyme treatment of three replicate 
samples from a poultry lagoon, neither E1-3S or E1-3G were detected using LC-MS-MS 
despite recoveries above 80% in matrix spikes and a limit of detection of 1 ng/L. In a 
dairy lagoon sample, 17β-E2-3S was detected by LC-MS but 17β-E2 did not increase after 
enzyme treatment (43). Finlay-Moore et al. (100) noted that methanolysis was unreliable 
for analysis of runoff samples from grasslands amended with broiler litter. In some 
samples free estrogen and testosterone concentrations increased by up to 150% but in 
others concentrations decreased by 63%.  
Matrix spike experiments performed by Hutchins et al. (43) indicated that the enzyme 
treatment of 17β-E2-conjugates (17β-E2-3G, 17β-E2-17G, 17β-E2-3S,17G and 17β-E2-3,17S) 
resulted in increased concentrations of free E1, indicating transformation either during the 
enzyme reaction or subsequent degradation of the released 17β-E2 to E1. The 
transformation of 17β-E2 to E1 did not occur in blank water spikes treated by enzyme 
hydrolysis, suggesting something in the sample matrix could mediate this reaction (43). 
The production of free steroids differing from the form present in the parent conjugate 
has been reported previously during enzyme hydrolysis (180,181), and was investigated 
for the enzymolysis and solvolysis reactions used in this study. There was no evidence of 
production of E1 from 17α-E2, 17β-E2 or E3 conjugates during either enzymolysis or 
solvolysis; however, recovery from enzymolysis was less than 50%, much lower than 
reported previously (43,57,59,61). The enzymolysis reaction had similar efficiency for 
sulfates as for glucuronides, possibly due to the sulfatase activity of the enzyme. Recovery 
from solvolysis was 60-87% for the sulfates but less than 5% for glucuronides. Around 
Efficacy of treatment systems 
100   
25% of 17β-E2-3S,17G was recovered, though >80% of that was transformed to E3 during 
the reaction. E3 was also produced from the cleavage of 17β-E2-3G, and 17α-E2 was 
produced from the cleavage of 17β-E2-3S. 
These results, along with those previously published (43,180,181) demonstrate that the 
presence of a free estrogen following cleavage reactions does not confirm the presence of 
that particular estrogen in conjugated form prior to cleavage. Confounding results are 
likely to be exacerbated in effluent samples where microbially-mediated degradation of 
the released free estrogen can occur during sample treatment. Rapid enzymolysis as 
described by Al Alousi and Anderson (174) (53 °C for 3-4 hours) may reduce the 
degradation of released steroids, but when trialled in this study the method was 
unsuccessful as the enzyme denatured at the higher temperature. 
Estrogenic activity in Effluent through the Two-Pond System 
The aqueous fraction of all samples elicited an estrogenic response in the E-Screen assay, 
with 17β-E2 equivalents (EEQ) of 4–66 ng/L (Figure 5.4a). Samples also demonstrated full 
agonism (RPE > 90%) in those samples that did not show cytotoxicity at high 
concentrations. In August and November, estrogenic activity was low in the raw effluent 
at 11 and 4 ng/L respectively, while in December, estrogenic activity was higher at 
32 ng/L. On all occasions, estrogenic activity was higher at the anaerobic pond outlet (AP) 
and lower at the facultative pond outlet (FP). Activity at the FP outlet ranged from 3 to 
14 ng/L. 
Predicted estrogen equivalents based on known potencies in the E-Screen for the 
identified and quantified steroid estrogens were within the error of the E-Screen assay for 
most samples (Figure 5.4b), though the estrogenic activity at the AP outlet in December 
was higher than predicted. The overall increase in estrogenic activity from the raw 
effluent to the anaerobic pond outlet was not specifically attributable to any particular 
steroid estrogen, as all hormones proportionally increased in concentration in the aqueous 
phase (Figure 5.3, discussed further below). 
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Figure 5.4: (a) EEQ measured by E-Screen (error bars represent standard errors) throughout the two-pond 
system. (b) EEQ predicted for each steroid hormone (E1, 17α-E2, 17β-E2) throughout the two-pond system. 
Raw effluent was collected from dairy shed drain, AP after anaerobic pond and FP after facultative pond. 
Estrogenic activity was also measured in the conjugated estrogen fraction (eluted from 
Oasis HLB cartridges) for the August samples. This indicated 2.6 ng/L EEQ was present 
in the conjugated estrogen fraction of the untreated effluent, compared to 14.7 ng/L in the 
free estrogen fraction. Similar proportions were measured in the conjugated estrogen 
fraction of raw effluent samples from a different treatment system (18 & 31%, data not 
shown). This is a relatively high proportion (15%), considering the potency of conjugated 
estrogens is two to four orders of magnitude lower than free estrogens. The conjugated 
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estrogen fraction could contain other acidic polar compounds such as conjugated 
phytoestrogens and mycoestrogens. Lower activity was measured in the conjugate 
fraction after the anaerobic and facultative ponds, at 0.8 and 0.6 ng/L EEQ respectively.  
Samples from November fractionated through florisil indicated 0.2 ng/L EEQ in the non-
polar fraction and 0.8 ng/L in the polar fraction of the raw effluent, compared to 3.1 ng/L 
in the moderately-polar fraction. The final effluent also measured some activity in the 
non-polar and polar fractions at 0.6 ng/L and 0.2 ng/L respectively, compared to 
3.8 ng/L in the moderately-polar fraction. The majority of the activity was associated 
within the moderately-polar fraction, which contains free steroid estrogens, nonylphenol, 
genistein and other similar polarity phytoestrogens (unpublished data, LH pers comm.). 
Anthropogenic compounds such as PCBs and PAHs are expected to be within the non-
polar fraction, while the polar fraction is expected to contain more polar compounds, 
including conjugated metabolites of steroid estrogens and phytoestrogens. 
Conversion and Removal of Estrogens in the Two-Pond System 
The estrogenic activity and aqueous concentrations of steroid estrogens increased from 
the raw effluent to the anaerobic pond outlet in both August and November (Figures 5.3 
and 5.4). This appears to be due to changes in distribution between dissolved and 
particulate phases of the steroid estrogens, conversion between conjugate and free forms, 
and transformation to E1. 
Desorption from the particulate phase may explain the initial increase in aqueous 17α-E2, 
as there was a concurrent decrease in particulate concentration. However, desorption 
does not explain the increase in 17β-E2 or E1, as similar concentrations were measured in 
the particulate fractions both before and after the anaerobic pond. The total (aqueous + 
particulate) concentrations of E1 and 17β-E2 actually increased after the anaerobic pond 
(Table 5.2). 
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Table 5.2: Reduction in total steroid estrogen concentrations through the 2PS (% reduction a). 
 August November December 
Anaerobic pond    
E1 -64% -3546% -55% 
17α-E2 25% 75% -10% 
17β-E2 -172% -196% 56% 
Sum 3% 39% -22% 
EEQ -349% -967% -47% 
Facultative pond    
E1 65% 99% 94% 
17α-E2 61% 96% 100% 
17β-E2 50% 100% 98% 
Sum 62% 98% 97% 
EEQ 62% 88% 94% 
Total removal    
E1 43% 67% 90% 
17α-E2 71% 99% 100% 
17β-E2 -37% 100% 99% 
Sum 63% 99% 96% 
EEQ -69% -29% 91% 
Note: a Reduction from aqueous and particulate fractions, does not include contribution from conjugated 
estrogens. b Negative value indicates increase in concentration. 
Cleavage of conjugated estrogens has been suggested as the cause of increases observed in 
the initial stages of sewage treatment plants (85,144,151). It is likely that the observed 
increase in the concentration of E1 and 17β-E2 in the anaerobic pond is due to cleavage of 
their conjugated forms. While considerable effort was made to quantify the concentration 
of conjugated estrogens in the raw and treated effluents to investigate this hypothesis, the 
results were not conclusive. One of the major metabolites, 17β-E2-3S, could not be 
quantified by LC-MS due to interference, and the recovery of glucuronides was poor. The 
enzymolysis and solvolysis reactions demonstrated poor efficiencies for many of the 
conjugates and in some cases resulted in conversion to free estrogens that differed from 
those in the parent compound. 
The conjugated estrogen 17β-E2-G was detected in the influent to the 2PS. This could 
account for the increase in both steroid concentrations and estrogenic activity on that date, 
if it was cleaved to 17β-E2 and subsequently partially degraded to E1 within the anaerobic 
pond. Although cleavage of conjugated estrogens is reported to be incomplete under 
anaerobic conditions (135,182), it may be that there is sufficient β-glucuronidase enzyme 
released by E. coli within the anaerobic pond to cleave at least a portion of the conjugated 
estrogens present. 
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Although the anaerobic pond did not decrease concentrations of estrogens, or descrease 
estrogenic activity, it is likely to indirectly aid in degradation of steroids. This pond 
removes a large proportion of the organic matter in dairy effluents (177) and higher 
organic loadings can lead to reduced degradation rates for 17β-E2 (183). 
A considerable reduction in total estrogens was observed at the outlet from the facultative 
pond (Table 5.2), consistent with studies on estrogen degradation noting higher removal 
under aerobic than anaerobic conditions (184-186). The hydraulic retention time of more 
than 30 days in this pond is sufficient to degrade E1 to substantially lower concentrations. 
Aerobic degradation of E1 and 17β-E2 has been determined to be <3 to 14 days in the 
presence of activated sludge (98,186), and approximately 10 days in aquifer and river 
sediments (187). There are no similar studies for the degradation of 17α-E2, the major 
steroid detected in these effluents. 
Removal efficiency in the facultative pond was higher in November and December than 
August, possibly due to warmer temperatures in these months or the presence of adapted 
microbial populations. Higher temperatures have been shown to increase aerobic 
degradation of estrogens in dairy wastes (167), municipal wastes (188) and soils (189). 
Adapted microbial populations may also increase the rate of aerobic biodegradation of 
steroid estrogens, as demonstrated by differences in 17β-estradiol and estrone 
degradation rates when using sludges from municipal wastewaters compared to 
industrial wastewaters (188), aquifer materials or river sediments (187,190). Sampling in 
August was undertaken near the start of the milking season, when the degrading 
microbial population required may not have been acclimated, compared to in November 
and December, when it had experienced considerable exposure to estrogens. 
5.3.2 Advanced Pond System 
DSE Composition and Treatment System Performance 
The analysis of nutrients indicated a substantial difference in total nutrient concentrations 
in raw effluent samples obtained in August compared to those from November and 
December (Figure 5.5). This was due to a change in the sample collection point: in August 
this was adjacent to the inlet pipe of the anaerobic pond, while in November and 
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December the sample was collected from the farm dairy drain. These samples also 
differed in that they contained considerably higher amounts of solids compared to the 
pond inlet samples (data not shown). 
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Figure 5.5: TOC (a), TP (b), TKN (c) and NOxN (d) concentrations at each stage in each effluent treatment 
system for each time sampled. Note several measurements for NOxN were below detection and are not 
plotted on this chart. 
At the other sampling locations within the APS, nutrient concentrations at different times 
were less varied and the system provided efficient removal of solids and associated 
nutrients (phosphorus and nitrogen). Increases in TP and TKN in the HRP compared to 
the preceding anaerobic pond may result from the higher solids in the HRP effluent (data 
not shown). The increase in solids is due to both the growth of suspended algae and 
resuspension of bottom sediments in this shallow pond, which is designed for vertical 
mixing to facilitate algae growth.  
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The APS appears to be under-performing when compared to its first two years of 
operation (Table 5.3). This may be partly due to seasonal variation, poor pond operation 
or maintenance, or an overall decline in performance since pond commissioning. Seasonal 
variation in chemical and biological constituents of two-pond effluents has been reported 
with highest values reported for spring and summer (176). This was observed for TP and 
TKN in this treatment system, both being highest in the final effluents during November 
and December; in contrast TOC was higher in August. 
Table 5.3: Performance and final effluent quality for nutrients in the APS. 
  Final effluent quality (mg/L)  % Reduction 
Parameter  This study Literature a  This study 
TSS  650 b 87  98 b 
TOC  369 ± 35 43 (BOD)  73 ± 37 
TP  38 ± 9 19  59 ± 36 
TN  157 ± 25 NM  69 ± 21 
TKN  157 ± 25 61  69 ± 21 
NOxN  0.34 ± 0.41 NM  -21 ± 166 
Notes: a Data from (171) b n=1  
The paddle-wheel used in the high rate pond to maintain vertical mixing was not 
operating during November and December, which likely contributed to poor performance 
of the pond as the HRP is a critical component of the nutrient removal process (170,171). 
Appropriate pond maintenance is also important, as excess sludge build-up results in 
poor effluent quality (152). 
Steroid Estrogens in Effluent through the Advanced Pond System 
As with the two-pond system, E1, 17α-E2 and 17β-E2 were consistently found in the 
untreated DSE, and at most stages of the APS treatment system (Figure 5.6). Free steroid 
concentrations in the raw effluent were substantially higher in August compared to 
November and December. This is likely to be due to the change in sample collection point 
from near the inlet of the anaerobic pond to the dairy shed drain. The sample collected 
from the pond inlet would reflect not only the effluent discharged into the pond on the 
morning of sampling, but also effluent from previous days. The difference in steroid 
concentrations is likely due to hydrolysis of conjugated estrogens from previously 
discharged effluents. 
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Figure 5.6: Steroid estrogen concentrations in aqueous and particulate fractions at each location in the APS 
for the three times sampled ((a) August; (b) November; (c) December). Raw effluent was collected from dairy 
shed drain, AP after anaerobic pond, HRP after High Rate Pond, ASP after Algal Settling Pond, MP after 
maturation pond and TD after tile drain. 
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Concentrations and proportions of each steroid were lower in the particulate fraction in 
August compared to November and December. Higher proportions of 17β-E2 were found 
in the particulate fraction (53%) compared to E1 (37%) and 17α-E2 (40%), consistent with 
laboratory sorption studies which indicate typically higher sorption to solids (sludge and 
soils) for 17β-E2 than E1 (172,191,192). Nonetheless, Hutchins et al. (43) found no 
difference in the phase distribution of steroids in samples from a dairy lagoon, with 50-
52% of each steroid (E1, 17α-E2 or 17β-E2) associated to particulate matter.  
Conjugated Estrogens in Effluent through the Advanced Pond System 
E1-3S was detected in 2 out of 3 samples from the input to the APS at 138 and 239 ng/L in 
December and November respectively and 17β-E2-17-G,3S was measured once in the 
outlet at 26 ng/L (November). No conjugates of 17α-E2 were detected at any location nor 
were any conjugates detected in the sample collected from the anaerobic pond input in 
August. 
The presence of conjugated estrogens in samples collected in December was also assessed 
by enzymatic hydrolysis and solvolysis of samples. The amounts of free estrogens 
released by enzymolysis were minor (Table 5.4) compared to the concentrations of free 
estrogens measured in the samples, but they were detected in all samples. In contrast, no 
further steroids were released by solvolysis. The enzyme hydrolysis step did not 
distinguish between glucuronide and sulfate forms, as the enzyme used had sulfatase 
activity as well as glucuronidase activity. This was demonstrated by hydrolysis of 17α-E2-
3S when tested as a pure standard, though this was not complete. It is likely that the 
conjugates in these effluent samples were sulfate forms, as E. coli is expected to be in the 
effluent at high levels (this releases a form of β-glucuronidase, which can cleave 
glucuronides but has little or no sulfatase activity (16,97,98)). 
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Table 5.4: Concentration of free estrogen conjugates measured by enzymatic hydrolysis of samples from the 
APS in December (ng/L). 
Sample Location E1 17α-E2 17β-E2 
Raw ND a 1.3 1.0 
AP 1.9 0.3 0.2 
HRP 6.8 ND 1.7 
ASP 2.1 ND 0.2 
MP 0.9 ND ND 
TD 4.9 ND 1.7 
Notes: a Not detected. 
Estrogenic activity in Effluent through the Advanced Pond System 
All analysed samples elicited an estrogenic response in the E-Screen assay, with 17β-E2 
equivalents from 4.1 – 382 ng/L (Figure 5.7a). As with the two-pond samples, APS 
samples that did not show cytotoxicity at higher concentrations demonstrated full 
agonism (RPE > 90%) in the assay. At most locations, the estrogenic activity of the DSE 
was higher in August compared to November and December.  
The estrogenic activity at the APS inlet was 382 ng/L in August, substantially higher than 
in November and December (both at 32 ng/L, Figure 5.7a). In August, estrogenic activity 
decreased through the APS, showing an 80% reduction after the aerobic pond (HRP). 
Though a slight increase at the ASP and MP was observed, this was within the range of 
error for the assay. In November and December, estrogenic activity increased from the 
input to the anaerobic pond outlet, similarly to the trend observed in the two pond 
system. Again the largest decrease in estrogenic activity in the APS was observed after 
aerobic treatment, in this case the HRP, with a 92% decrease in estrogenic activity in 
November (84 to 7 ng/L) and a 94% decrease in December (249 to 14 ng/L). The 4-fold 
increase observed at the ASP in November was consistent with the increase in steroid 
concentrations (Figure 5.6); however, activity decreased immediately after this stage to a 
level comparable to that measured at the HRP. The final outlet consistently measured the 
lowest concentrations, at 43, 4.1 and 3.2 ng/L respectively. 
Predicted estrogen equivalents based on known potencies in the E-Screen for the 
identified steroid estrogens demonstrated a close agreement to the EEq measured in the 
assay for many of the samples, particularly those from the August sampling (Figure 5.7). 
Efficacy of treatment systems 
110   
This indicates steroid estrogens are likely to be the dominant source of observed 
estrogenic activity in the raw and treated effluent samples. 
Raw AP HRP ASP MP TD Raw AP HRP ASP MP TD Raw AP HRP ASP MP TD
0
100
200
300
400 August November December
M
ea
su
re
d 
EE
Q
 (n
g/
L)
Raw AP HRP ASP MP TD Raw AP HRP ASP MP TD Raw AP HRP ASP MP TD
0
100
200
300
400 EEQ from 17α -E2
EEQ from E1
EEQ from 17β-E2
August November December
Pr
ed
ic
te
d 
EE
Q
 (n
g/
L)
(a)
(b)
 
Figure 5.7: (a) EEQ measured by E-Screen throughout the advanced pond system (error bars represent 
standard error of 2 or 3 measurements). (b) EEQ predicted for each steroid hormone (E1, 17α-E2, 17β-E2) 
throughout the advanced pond system. Raw effluent was collected from dairy shed drain, AP after anaerobic 
pond, HRP after High Rate Pond, ASP after Algal Settling Pond, MP after maturation pond and TD after 
tile drain. December samples not analysed by E-Screen. 
The compounds responsible for the observed estrogenic activity appear to change as 
effluent progressed through the system in August (Figure 5.7b). For samples collected 
from the raw effluent and anaerobic pond (AP), the majority of estrogenic activity was 
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due to 17β-E2, while following the HRP, activity was primarily due to E1 and 17α-E2. This 
pattern was not repeated in samples obtained in November or December. 
Estrogenic activity was also measured for the conjugated estrogen fraction (as eluted from 
Oasis HLB cartridges) in samples obtained in August, and demonstrated a decrease from 
the raw effluent (13.2 ng/L) through to the final effluent (3.7 ng/L). The activity in this 
fraction was minor compared to the free estrogen fraction (2-8% of total) and similar to 
that obtained in samples from the 2PS (1-3%), excluding the raw effluent (15%). 
Samples from November fractionated through florisil also indicated that the majority of 
the activity was retained within the moderately-polar fraction, which contains the free 
steroid estrogens. Minor estrogenic activity was measured in some samples within the 
non-polar fraction at 0.6-0.7 ng/L and the polar fraction at 0.3-0.7 ng/L, though activity 
was higher in the polar fraction of the AP sample at 2.4 ng/L. 
Conversion and Removal of Estrogens in the Advanced Pond System 
Overall, the APS provided variable treatment for the period monitored, with only 65% of 
total estrogens removed in August compared to >90% in November and December (Table 
5.5). Most of the increased removal in November and December occurred between the 
ASP and the tile drain. Total estrogen concentrations reduced 96% between the ASP and 
tile drain in November and 86% in December, compared with only 45% in August. There 
are many possible reasons for this difference in treatment performance, including the 
differences in initial concentrations, changes in pond operation, and climatic factors. 
These are discussed below. 
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Table 5.5: Reduction in total steroid estrogen concentrations through the APS (% reduction a). 
 August November December 
Anaerobic Pond    
E1 14% -749% b -257% 
17α-E2 12% -504% -58% 
17β-E2 41% -329% 31% 
Sum 15% -566% -115% 
EEQ 22% -163% -667% 
High Rate Pond    
E1 -26% -17% 76% 
17α-E2 43% 36% 80% 
17β-E2 94% 68% 74% 
Sum 29% 14% 77% 
EEQ 80% 92% 94% 
Algae Settling Pond    
E1 -4% 67% 35% 
17α-E2 -4% 37% 79% 
17β-E2 -173% 51% 95% 
Sum -4% 57% 51% 
EEQ -13% -335% 12% 
Maturation Pond    
E1 1% 78% 98% 
17α-E2 12% 72% 25% 
17β-E2 41% 74% -87% 
Sum 8% 75% 88% 
EEQ -21% 63% 65% 
Tile Drain    
E1 31% 84% 4% 
17α-E2 50% 85% 9% 
17β-E2 43% 54% -205% 
Sum 41% 83% -17% 
EEQ 46% 62% 26% 
Total Removal    
E1 23% 89% 99% 
17α-E2 77% 90% 96% 
17β-E2 97% 92% 95% 
Sum 65% 90% 97% 
EEQ 89% 87% 90% 
Note: a Reduction from aqueous and particulate fractions, does not include contribution from conjugated 
estrogens. b Negative value indicates increase in concentration. 
The largest reduction in total estrogens in August was observed after the aerobic pond 
treatment stage of APS (HRP, Table 5.5), consistent with results obtained for the 2PS. 17α-
E2 decreased by 43% while 17β-E2 decreased by 94%. Conversely, E1 concentrations 
increased by 26%, mainly due to an increase in concentration in the particulate phase. E1 
degradation was lower compared with the facultative pond of the 2P system, which may 
be due to the difference in hydraulic retention time between the HRP (8 days) and the 2PS 
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(>30 days). The timeframe for complete degradation of estrone can be up to 10 or 14 days 
(186,187), longer than the retention time of the HRP. E1 remained at a steady 
concentration throughout the system in August (Figure 5.6), while a slight increase in 17β-
E2 was observed after the ASP. Anaerobic production of 17β-E2 from E1 has been 
observed in laboratory tests using cultures from lake water and sediment under 
methanogenic, nitrate-, sulfate-, and iron-reducing conditions (193), and may account for 
the apparent rise of 17β-E2 observed in this pond. 
In November and December, the free estrogen concentrations and the estrogenic activity 
increased after the anaerobic pond at the APS, consistent with the results obtained for the 
two-pond system. Unlike the two-pond system, the observed increase does not appear to 
result from changes in the phase distribution, as the total (aqueous + particulate) 
concentration of estrogens also increased after the anaerobic pond. 
The increase could neither be fully explained from the measurement of conjugated 
estrogens. E1-3S, the most common conjugate in cattle excreta (99), was detected in the 
raw effluent, but the concentrations (238 and 138 ng/L) were substantially lower than the 
observed increase in E1 concentration (920 and 899 ng/L). 17β-E2-conjugates were not 
fully quantified and may be the source of the increased concentration of free steroids 
measured after the anaerobic pond. In addition, conjugated estrogens were not measured 
in the particulate fraction as they are generally considered to be water soluble; however, it 
is possible that the low pH conditions applied prior to sample extraction increased their 
sorption to the solid phase, lowering the aqueous concentrations.  
The HRP was not as effective at removing steroids in November, with a total removal of 
only 14%, compared to 29% in August. As noted above, the paddle-wheel was not 
working during this period and is required to maintain algae populations and consistent 
treatment (171). Despite this, 77% of total estrogens were removed in the HRP in 
December, possibly due to warmer temperatures increasing aerobic degradation, and/ or 
the presence of adapted microbial populations, as discussed above. 
 Total steroid concentrations reduced by 51-57% after the ASP in November and 
December. TSS measurements in December indicated a 75% reduction in suspended 
solids in this pond, which is designed to remove solids and algae through gravity. The 
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results suggest that adsorption to, and settling of, solids is a significant removal 
mechanism for steroids. 
The maturation pond further reduced steroid concentrations, with 75% and 88% 
reductions in November and December. The shallow depth and long residence time (15 
days) maximises solar-UV radiation in order to reduce bacteria numbers, and the 
radiation can also be expected to reduce steroid estrogen concentrations. Estimates for the 
photolytic half-life of 17β-E2 vary from 41 hours (194) to 10 days in clear, colourless 
waters (195). As photodegradation follows pseudo-first-order kinetics (196), degradation 
increases with longer UV exposure and may explain the increased removal in the MP in 
November and December compared to August. The observed reduction may not be solely 
from photodegradation, as there is also potential for continued biodegradation in this 
aerobic pond. The tile drain further reduced the concentration of total estrogens in August 
and November, but not in December, when concentrations were already lower.  
5.3.3 Biodegradation of 17α-Estradiol in Laboratory Test 
Only 20% of the 17α-E2 spiked at 25,000 ng/L was recovered from the sample 
immediately after spiking, suggesting either immediate degradation or rapid sorption to 
solids in the incubation vessel and/or during centrifuging. Immediate sorption of 17α-E2 
is supported by a study showing that 87-97% of E1 and 17β-E2 was sorbed onto activated 
sludge within 30 mins when it was added to water samples at 1 g/L (172), a concentration 
comparable to the mass of solids in the DSE. The practice of acidifying samples prior to 
centrifuging and filtering will likely further enhance the sorption of estrogenic steroids to 
organic particulates. 
In the spiked sample, 17α-E2 concentrations decreased over time from an initial mean 
concentration of 5,420 ng/L to a final mean concentration of 4,100 ng/L after 216 hours 
(Figure 5.8). It has previously been suggested that 17α-E2 degrades to E1 (43,48); however, 
in this test, the reduction in 17α-E2 was not associated with a clear or quantitative increase 
in either E1 or 17β-E2. E1 and 17β-E2 increased by 110 ng/L and 220 ng/L respectively, 
much less than the concurrent decrease in 17α-E2 of 1320 ng/L.  
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Figure 5.8: Concentration of steroids over time in spiked and control DSE samples (points are mean of three 
replicates, error bars represent ± 1 standard deviation).  
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Quantitative degradation of 17β-E2 to E1 has been observed in sewage effluents, river 
sediments and aquifer materials (98,186,187), followed by slower degradation of E1. It is 
possible that 17α-E2 did quantitatively degrade to E1 which then subsequently sorbed to 
solids in the DSE or further degraded. Sorption is likely, as these DSE samples had high 
solids content; the organic carbon content of effluent sludges is also high (0.75-1.7% wet 
weight (197)), increasing the sorptive capacity for steroid estrogens (198). This would 
need to be confirmed by analysis of the particulate fraction of the samples. Concentrations 
of both E1 and 17β-E2 were slightly higher in the spiked samples than the control, 
suggesting possible formation of these from 17α-E2. This may occur through initial 
oxidation of 17α-E2 to E1, followed by formation of 17β-E2 in anaerobic conditions (193). 
If this can occur, it could increase the potential risk to aquatic environments due to the 
higher estrogenic potency of 17β-E2, although the extent of this transformation is likely to 
be relatively low (193). 
In the control sample, 17α-E2 concentrations approximately doubled between 0 and 48 
hours after sample collection, then decreased slightly. 17β-E2 also increased substantially 
between 0 and 48 hours, reaching a peak concentration of 130 ng/L, then decreased 
slightly during the period to 216 hours. By contrast, E1 increased only slowly between 0 
and 48 hours, but then increased to a peak concentration of 110 ng/L at 120 hours, 
probably due to degradation of 17β-E2 and possibly 17α-E2, before decreasing again. 
The observed increases in 17α-E2 and 17β-E2 within 48 hours in the control samples are 
likely to be due to hydrolysis of 17α-E2 and 17β-E2 glucuronides. This has been shown to 
occur within about 20 hours for 17β-E2 in domestic wastewater and activated sludge 
solutions (16,98) and is mediated by β-glucuronidase enzymes released by faecal bacteria, 
including E. coli (16). As E. coli are expected to be present in DSE at high levels (based on 
faecal coliform measurements of 3 x 105 – 16 x 105 (199)), enzyme-mediated hydrolysis 
processes are expected to be rapid in the DSE. Glucuronide forms of E1 are expected to be 
at lower concentrations, as the sulfate form dominates in cattle urine (20,99). 
Overall the results indicated slow degradation of the estrogens, contrasting with results 
reported previously for activated sludge, soils, river sediments and aquifer sediments 
(184-187,190,192), where estrogens completely degraded within 3-14 days. This is unlikely 
to be due to a lack of bacteria, but may be due to the high organic loading of the effluent 
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or lower oxygen levels maintained in this test system. As mentioned, in experiments with 
activated sludge, E1 degradation rates were substantially slower with high organic 
loadings in the influent. 
5.3.4 Comparison of Treatment Systems and Potential Improvements for 
Estrogen Removal 
At each sampling occasion, the final effluent from each treatment system contained 
measurable steroids and demonstrated estrogenic activity above levels known to cause 
adverse effects in fish (132). There was little difference in the overall removal of total free 
estrogens between the two systems (Table 5.6). Furthermore, removal through both 
systems was poorer in August than in November or December, indicating neither system 
was more robust than the other. 
Table 5.6: Reduction in steroid estrogen concentrations in the systems studied. 
  Final concentrations in effluent (ng/L a)  Reduction throughout system (%) a 
  Particulate Aqueous Total b EEQ c  Particulate Aqueous Total b EEQ c 
 Two-pond system 
August 0 295 295 25  100% -15% e 63% -69% 
November 0 20 20 5.5  100% -24% 99% -29% 
December 0 17 17 3.3  100% 91% 96% 91% 
 Advanced Pond system 
August 78 1290 1370 43  87% 62% 65% 89% 
November 24 18 42 4.1  94% 60% 90% 87% 
December 29 16 45 3.2  97% 97% 97% 90% 
Note: a Sum of free estrogens, does not include conjugated estrogens. b Total of aqueous and particulate 
fractions. cAqueous fraction only. d ND = Not detected. e Negative value indicates increase in 
concentration. 
A comparison of the nutrient removal data for each treatment system indicates the two-
pond system was producing a higher quality final effluent than the APS (Tables 5.1 & 5.3). 
No relationship was seen between the concentration of nutrients in the effluent and 
individual steroids, total estrogens, or estrogenic activity in individual samples. This 
indicates that effluent composition cannot be used to predict final steroid concentrations. 
On the other hand, the total removal rate of steroid estrogens and estrogenic activity was 
similar to that of TSS and TOC for both systems, suggesting that a system designed for 
improvement of these parameters may have secondary beneficial effects in reducing 
steroid estrogens levels and estrogenic activity. 
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The laboratory degradation experiment demonstrated the persistence of the estrogens in 
the DSE, with significant concentrations remaining after 8 days. Degradation was much 
slower than had been previously reported for activated sludge, where 17β-E2 and E1 were 
completely removed after 3 days. This occurred even when the sludge was spiked at 
1 µg/L, within the same order of magnitude of 17α-E2 in the unspiked DSE samples used 
in the experiment reported here. 
These results suggest that the retention time of an aerobic pond must be considerably 
longer than 8 days to provide effective removal of estrogens. The higher removal rates in 
the facultative pond of the 2PS compared to those for the high rate pond of the APS most 
likely reflects the longer retention time of the former. Despite this, the subsequent ponds 
of the APS provided effective treatment, ensuring that the overall removal rate was 
similar for the two systems studied. 
An improved system for removal of steroid estrogens could be to incorporate an aerobic 
pond with a long retention time into APS. The potential overall reduction that may be 
achieved with that kind of configuration could be estimated from the final effluent quality 
of the 2PS and the further removal currently achieved in the latter ponds of the APS (45-
96% removal from the ASP to the tile drain outlet). Based on a total estrogen 
concentration of 20 ng/L in November and subsequent reduction of 96%, a final estrogen 
concentration of 0.8 ng/L could be achieved. Alternatively, based on the December results 
of 17 ng/L after the facultative pond and a subsequent reduction of 86%, a final 
concentration of 2.4 ng/L could be achieved. These would represent a great improvement 
on the current concentrations in the final treated effluent and would be similar to the 
concentrations typically measured in effluent from sewage treatment plants. An 
alternative option could be to improve the efficiency of the aerobic ponds of each system 
by ensuring that they are fully oxygenated, for example, using a mechnical aerator. 
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5.4 CONCLUSIONS 
Estrogenic activity and steroid estrogens were found at variable levels in the raw DSE 
samples, with a large proportion of the steroid estrogens adsorbed to particulates in the 
samples. In both effluent treatment systems, free estrogen concentrations typically 
increased between the raw effluents and effluent exiting the anaerobic ponds. This is most 
likely due to hydrolysis of conjugated estrogens and possibly due to desorption of free 
estrogens from the solid phase. Conjugated estrogens were detected in some samples, 
particularly in raw effluent. Results obtained using enzymolysis and solvolysis suggested 
the presence of further conjugated estrogens that were not identified using LC-MS. 
Most of the estrogen removal occurred within the aerobic pond of each treatment system. 
The inclusion of an aerobic pond therefore appears to be the most important consideration 
in designing effluent treatment systems to remove steroids. Although it has been 
suggested that aerobic degradation of 17α-E2 may increase the concentration of E1, this 
could not be concluded from the results from either pond system or from the laboratory 
degradation test. 
Estrogen concentrations also increased in the first days of the laboratory degradation in 
the unspiked samples, again suggesting the cleavage of conjugated estrogens to free 
forms. The degradation study also indicated that steroid estrogens remained at high 
concentrations after 8 days, contrasting with results for activated sludge and other 
matrices. 
As neither pond system completely removed estrogens from the dairy effluent, the 
effluents released to the environment from these treatment systems remain a source of 
estrogens to the environment and a potential risk to aquatic life living downstream of 
these discharges. 
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Chapter 6:  Evaluation of Three In Vitro 
Bioassays to Estimate the Estrogenic 
Activity of Dairy Shed Effluents  
6.1 INTRODUCTION 
Steroid estrogens and estrogenic compounds can affect exposed biota by disrupting 
normal hormonal processes. Biological approaches have been developed to assess the 
potential effect of estrogenic compounds on fish, amphibians and mammals (200). To 
reduce time and ethical costs of animal testing, a range of in vitro assays has been 
developed, based on well-characterised mechanisms of action for initial screening of 
compounds for estrogenic activity (12,200). 
These in vitro assays developed to evaluate potential estrogenic activity of pure 
compounds have also been extensively applied to assessing environmental samples. 
Because bioassays measure the total estrogenic activity of samples without requiring any 
information regarding chemicals present (68), the results indicate the potential exposure 
of aquatic biota to mixtures of estrogens and estrogenic compounds. In vitro assays have 
been used to assess estrogenic activity in river waters (e.g., (166,201)), sediments (202), 
sewage treatment plant influents and effluents (reviewed in (68)) and more recently, 
agricultural wastes (41,44,49). 
The E-Screen assay has been widely used for analysis of estrogenic activity of 
environmental samples. As it is a cell proliferation assay, it represents a higher level of 
biological complexity than other in vitro assays, and takes account of non-ER mediated 
effects (70). Furthermore, as the E-Screen has been extensively used to screen compounds 
for estrogenic activity, potency data is available for a wide range of compounds (32). 
However, progesterone and other pregnanes can cause cell proliferation in some MCF-7 
strains (203,204). As dairy cattle excrete progesterone naturally, and from implants or 
injections used to bring the cows into synchronised estrus, samples of DSE are likely to 
contain elevated concentrations of progesterone. This may result in false positives when 
measuring estrogenic activity with the E-Screen assay.  
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Receptor-reporter gene assays measure estrogenic effects mediated through the estrogen 
receptor (67) and have been widely used internationally to assess activity of 
environmental samples (45,64,205,206). A yeast-based receptor-reporter gene assay has 
recently been developed in two strains: one incorporating the human ERα (hER) and the 
other the ERα from the Japanese medaka (Oryzias latipes, medER). The use of these two 
strains in combination can be used to suggest causes of estrogenicity, as the medER has 
higher affinity for xenoestrogens than the hER (207). A larger estrogenic response in the 
medER can suggest the presence of xenoestrogens in samples, while a similar response in 
each assay suggests the activity is more likely due to steroid estrogens. 
In vitro assays have only recently been applied to assessing estrogenic activity in 
agricultural wastes and a small number of samples have been assessed compared to 
sewage effluents and surface water samples. To date, few of the studies including 
agricultural samples have supported the bioassay results with chemical analyses of 
known estrogenic compounds (44,45,166). While in vitro assays can be sensitive and rapid, 
there is potential for them to be affected by other compounds present in the samples that 
may cause cytotoxicity or anti-estrogenic activity. A comparison of assay and chemical 
results can help to elucidate non-estrogenic effects. 
The aim of the investigation described in this chapter was to confirm the estrogenic 
activity of DSE samples observed using the E-Screen by testing samples in receptor-
reporter gene yeast assays. Potential contributors to observed activity were assessed by 
comparing assay responses and from predictions of 17β-estradiol equivalents (EEQ) based 
on known chemical constituents and relative potencies. 
6.2 METHODS 
6.2.1 Sample Preparation 
Grab samples of DSE were collected in MQ water-rinsed amber glass bottles with Teflon-
lined lids and immediately preserved by the addition of sulfuric acid (to pH ≤ 2). Samples 
were transported on ice and extracted within 24 hours of collection. Samples were first 
centrifuged at up to 1780 g for 20 min at 4 °C, then filtered through glass fibre filters 
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(GF/C) with the assistance of a layer of filter aid. Centrifuged and filtered samples were 
loaded onto Oasis HLB cartridges (preconditioned with 10mL of methanol followed by 
10 mL of MQ water) at a flow rate of 5-10 mL/min. For 500 mL samples, 500 mg Oasis 
HLB cartridges were used while 1 g cartridges were used for 1 L samples. Oasis HLB 
cartridges were dried under vacuum to remove residual water then eluted with 30 ml of 
DCM: DEE: MeOH (40:10:1). 
6.2.2 E-Screen 
The E-Screen assay was conducted as described in Chapter 4. At least two independent 
assays were performed for each sample with the average value reported. 
6.2.3 Two-hybrid Yeast Assay 
The two-hybrid yeast assay followed the procedure described in detail in Shiraishi et al. 
(208). This assay system used yeast cells (Saccharomyces cervisiae Y190) incorporating an 
estrogen receptor (either the human ERα or Japanese medaka (Oryzias latipes) ERα), the 
coactivator TIF2, and the β-galactosidase reporter gene. Yeast cells were grown overnight 
at 30 °C in a modified synthetic dextrose medium. The yeast was diluted in growth media 
to achieve an absorbance of 0.175-0.185 at 595 nm using a spectrophotometer, after a 1 in 
10 dilution. Serial dilutions of sample extracts (in DMSO) were prepared in the wells in 
60 µL of growth medium with a constant volume of DMSO in each (2%). The yeast 
mixture was added to the 96-well plates (60 µL per well) and then plates were incubated 
for 4 hours at 30 °C. 
A mixed solution for inducing chemiluminescence and for enzymatic digestion was 
added at the ratio of 5:3 (v/v) Zymolase 20T and GalactLux substrate buffer (Aurora Gal-
XE kit; ICN Biomedicals, California, USA), then plates were incubated at 37 °C for 1 h. A 
light-emission accelerator reagent was added immediately before measurement, The 
chemiluminescence produced by released β-galactosidase was measured with a 96-well 
plate luminometer (FLUOstar OPTIMA, BMG Lab Tech). Estrogenic activity was recorded 
as the ECx10, which was defined as the concentration of test solution producing a 
chemiluminescent signal 10 times that of the blank control. EEQ concentrations were 
calculated by the formula: 
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EEQ = ECx10 [17β-E2] / ECx10 [sample] 
6.2.4 Calculation of EEQs based on Chemical Analysis 
Free estrogens in the DSE samples were analysed by GC-MS as described in Chapter 3, 
then EEQs were calculated for each sample following a toxicity equivalents approach. 
This has been demonstrated to be appropriate for mixtures where each component acts 
through the same pathway and the dose-response curves are parallel for individual 
compounds (137). The concentration of each steroid measured by GC-MS was multiplied 
by its relative potency (RP) obtained by E-Screen and two-hybrid yeast assays. The EEQs 
for each compound measured in a sample were summed to obtain the total predicted EEQ 
for that sample. 
∑ ×= }{ iii RPCmixtureforEEQpredictedTotal  
6.2.5 Statistical Analyses 
Regression analyses used to examine differences between assays and between measured 
and predicted values were undertaken with the statistical software package JMP v6 (SAS 
Institute Incorporated). 
6.3 RESULTS AND DISCUSSION 
6.3.1 Performance of Assays 
DSE samples indicated a concentration-dependent response in all assays although 
cytotoxic effects were evident at high concentrations with a reduction in response. As 
described in the methods, these data points were removed from the linear regression for 
the E-Screen assay. Because cytotoxicity occurred only at higher concentrations and the 
EEQs for the two-hybrid yeast assays were calculated from the EC10, cytotoxicity did not 
affect the calculation of EEQs in those assays. 
The limit of quantitation (LOQ) for the E-Screen assay was typically 5 ng/L, but ranged 
from 0.3-19 ng/L, depending on the cytotoxicity of samples in the assay. The LOQ for the 
Evaluation of bioassays 
  125 
hER assay was slightly lower and ranged from 0.9 to 5.3 ng/L. The LOQ for the medER 
was slightly higher, ranging from 6.6 ng/L to 10 ng/L. 
The variation of the E-Screen assay was assessed by repeated analyses of three samples 
over six to seven assays. Coefficients of variation were determined as 33%, 29% and 17% 
(n=6, 7 and 7 respectively). Variation within each assay run was lower, with an average 
difference in duplicate measurements of 12%. This variation should be considered when 
comparing between assays and with EEQ predicted from chemical analysis. 
6.3.2 Comparison of EEQs of DSE Samples in Each Assay 
There were 28 DSE samples analysed by both E-Screen and the two-hybrid yeast assays. 
All samples elicited an estrogenic response in the E-Screen assay, while one sample was 
below the limit of quantitation in the hER assay and another in the medER assay. This 
confirmed that the DSE samples were estrogenic and that the estrogenicity was mediated 
through the estrogen receptor. 
The three assays gave very different EEQs, with a median of 28 ng/L with the E-Screen 
assay, 69 ng/L with the hER assay and 343 ng/L with the medER assay (Figure 6.1). 
Although different results are not surprising, due to differences in receptors, assay 
mechanisms and transport of compounds through the cell membrane, the order of 
magnitude difference between the E-Screen and medER assays was larger than expected.  
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Figure 6.1: Summary of estrogenic activity for 28 effluent samples in the three assays. Note: The box 
indicates the interquartile range (IQR), the bar the median value, whiskers = 1.5 * IQR and dots indicate 
outlier values. 
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Previous studies of STP influents and effluents have shown similar EEQs when 
comparing assays: the ER-CALUX and YES assays (72); four receptor-reporter gene assays 
in MCF-7 or HeLa cells (209); and the YES assay, a zona radiata protein production assay 
based on trout hepatocytes and a receptor-reporter gene assay in rainbow trout gonad 
cells (160). Order of magnitude differences have only been demonstrated previously when 
comparing receptor binding assays (RBA) with receptor-reporter assays (72) or the E-
Screen (144). This can be expected as the RBA measures both ER agonists and antagonists 
and does not require compounds to cross the cell membrane (72). 
The assays used in this study were compared by regression analysis of the EEQs obtained 
from each assay. The E-Screen assay was weakly correlated to the medER assay results 
(Figure 6.2, R2=0.58, p-value < 0.001) but not well correlated to hER data (R2=0.28, p-value 
= 0.0043). The hER and medER data were weakly correlated, with R2 = 0.54 (p-value < 
0.001). 
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Figure 6.2: Correlation of EEQ measured in the three assays. Solid line is regression line and dotted lines are 
95% prediction intervals for new data points. 
The regression analysis indicates that although EEQ values were much higher with both 
yeast assays compared to the E-Screen, the samples followed a broadly similar pattern. A 
potential reason for the higher EEQs in the yeast assay is the presence of cytotoxic 
compounds in the E-Screen, which would suppress cell proliferation and result in lower 
calculated EEQs. Further research is required to assess the presence of cytotoxic chemicals 
that may affect the E-Screen results. An alternative explanation is related to the mixtures 
of compounds contained in the DSE samples. Differences in estrogenic potencies of the 
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compounds in each assay can result in higher or lower overall EEQ for a sample. This is 
explored further in the next section. 
6.3.3 Comparison of Bioassay and Predicted Estrogenic Activity 
The estrogenic potency of chemicals differs between in vitro assays (132,210,211) resulting 
in different results for the relative estrogenic potential of samples containing mixtures 
(29). A comparison of the relative potencies of chemicals in the E-Screen assay and the 
yeast assays indicates that the steroid estrogens have much higher potency in the yeast 
assays. Both strains of the yeast assay exhibit higher relative potencies for E1 (0.50-0.63, 
Table 6.1) and 17α-E2 (0.1 – 0.051) compared to potencies from the E-Screen (E1 0.024; 
17α-E2 0.02). For the weakly estrogenic compounds, higher potencies were measured in 
the medER assay than the E-Screen or hER. The largest differences were observed for 
genistein (19-fold higher in medER than E-Screen) and the anthropogenic compounds, 
NP, OP and BPA (38, 19, 14-fold respectively). The few exceptions to this are 17α-E2 and 
E1 (which both had highest potency in the hER assay) and E3 (which was highest in the E-
Screen). 
Table 6.1: Comparison of steroid estrogens and estrogen mimics in the E-Screen and Yeast Assay. 
Compound RPP Escreen RPP hER a RPP medER a 
17β-E2 1 1 1 
17α-E2 0.020 b 0.11 0.052 
E1 0.024 b 0.73 0.67 
E3 0.054 b 0.0043 0.0019 
Genistein 0.00015 c 0.00038 0.0028 
4-NP 0.000045 c 0.0000051 0.0017 
4-OP 0.00012 c 0.00075 0.0022 
Bisphenol A 0.000027 c 0.000017 0.00037 
Note: a L. Hamilton, pers. comm. b This study, Chapter 4. c Mean of data from (29-32,138). 
The difference in potencies may explain why EEQs were higher when measured by the 
yeast assays, as E1 and 17α-E2 are found at higher concentrations in DSE than 17β-E2. 
Higher values in the medER compared to the hER assay can suggest the presence of 
xenoestrogens in samples, while a similar response in each assay suggests the activity is 
more likely to be due to steroid estrogens. 
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Calculated EEQs for individual samples were based on GC-MS analysis of steroid 
estrogens and their estrogenic potencies as measured in the E-screen and two-hybrid 
yeast assays (Table 6.1). This was not possible for two of the DSE samples (where either 
the assay or GC-MS results were below quantitation limits), but was possible for the 
remaining 26 samples. 
The predicted EEQs for the effluent samples were compared to the measured EEQs in 
each assay. The median ratios of measured to calculated EEQ were 1.2 for E-Screen and 
hER assays and 5.1 for medER. Generally values within the same order of magnitude are 
considered to be within the precision of assay and chemical analyses (138,160), which 
suggests a reasonable agreement overall for the E-Screen and hER assays. The EEQs 
measured with the medER assay were systematically higher than those calculated from 
steroid concentrations. This contrasts with many previous studies comparing chemical 
and biological analyses (138,139,160,212,213), where measured EEQ was lower than 
predicted EEQ. 
The predicted EEQs for the effluent samples are compared to the measured EEQs for each 
assay in Figure 6.3. A positive correlation was observed between the measured and 
calculated EEQ for each assay but there was considerable variation for the individual 
values (log-transformed fits for E-Screen, R2 = 0.66; hER, R2 = 0.72; medER, R2 = 0.65; p-
values < 0.001 for all fits). The regression line for the medER assay indicates a substantial 
difference between the measured and predicted values (Figure 6.3), while the values for 
the hER are similar overall (regression line is close to 1:1 line). For the E-Screen, there was 
overall a reasonable relationship between measured and predicted EEQs, though values 
were under-predicted at high EEQs and over-predicted at low EEQs (Figure 6.3). The 
results suggest that lower EEQs in the E-Screen compared to the hER assay were due to 
lower potencies of the steroid estrogens in the E-Screen assay than in the hER assay. 
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Figure 6.3: Comparison of EEQ measured in assay to that predicted from chemical analyses and relative 
potencies for each steroid in the assay. Shaded area represents 95% confidence interval around the regression 
line. Dotted line represents 1:1 regression between predicted and measured EEQ. 
There are several potential reasons for the difference between predicted and measured 
estrogenic activity in the medER assay. The first is the method used to calculate predicted 
concentrations. The toxicity equivalence approach used only produces reliable estimates 
when dose-response curves for individual chemicals are parallel in the assay. When this is 
not the case, a different model, such as the concentration addition model, may be more 
appropriate (137,214). 
A second explanation is the presence of unmeasured estrogenic compounds in the 
samples, as chemical analysis is targeted at specific compounds, in this case steroid 
estrogens. The medER assay is substantially more responsive (RP > 100-fold higher) to 
anthropogenic compounds such as nonyl- and octylphenols and bisphenol A, and to 
phytoestrogens such as genistein, when compared to the hER assay (Table 6.1). The higher 
EEQs measured in the medER assay, coupled with the discrepancy between predicted 
and measured concentrations, suggests that anthropogenic compounds or phytoestrogens 
may be present in the samples. 
Bisphenol A, 4-nonylphenol and other nonylphenols were detected in some samples; 
however, their contribution to overall estrogenic activity of the sample would be low 
(<0.5 ng/L), even in the medER assay where they are more potent. Although 
phytoestrogens were not measured in this study, equol has previously been identified as a 
contributor to estrogenic activity in a hog manure sample (74) and the mycoestrogen 
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zearalenone has been measured in cattle manures (162,163). If these or similar compounds 
are present in the DSE at concentrations high enough to cause a response, this may 
account for the systematic difference between predicted and measured activities for the 
medER. 
The relative contribution of each of the measured steroid estrogens was assessed for each 
effluent sample and the mean is shown in Figure 6.4. This indicates that for the E-Screen, 
the calculated EEQ is dominated by 17α-E2 and 17β-E2, whereas for both yeast assays, E1 
and 17α-E2 dominate and 17β-E2 is minor (<20%). The difference between assays is due to 
the higher relative potency of E1 and 17α-E2 in the yeast assays compared to the E-Screen. 
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Figure 6.4: Relative contribution of individual steroid estrogens to total calculated EEQ (median % of 26 
DSE samples). 
Despite the lower relative potency of 17α-E2 (0.020), the concentrations in effluent 
samples are substantially higher than those of 17β-E2. The mean contribution was 40% of 
total EEQ in the E-Screen (range 0–71%), 35% in the hER (9-69%) and 25% in the medER 
(6-57%). The contribution of E1 was much higher in the hER (mean 53%, range 15-7%) and 
medER assays (56%, 18-86%) than the E-Screen (12%, 1.6-39%). This indicates that both 
17α-E2 and E1 are environmentally important when assessing the overall estrogenic 
potential of dairy wastes. 
The results presented in Figure 6.1 demonstrate that differences in relative potency of 
estrogenic compounds in in vitro assays lead to substantial differences in the measured 
EEQ from 17β−E2 
EEQ from 17α−E2 
EEQ from E1 
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estrogenic activity of samples containing mixtures. The relative potency of estrogens in in 
vitro assays can also be substantially different to those measured in vivo (210,211,215), 
where chemical uptake, induction of binding compounds such as sex hormone binding 
globulins, metabolism and inactivation can increase or decrease the potential estrogenic 
effect (67). The relative potency of E1 in vivo is 0.2-0.3 (132), closer to the potency in the 
yeast assays (0.67-0.73) than the E-Screen (0.024). This suggests that the E-Screen assay 
may under-estimate, and the hER and medER assays may over-estimate, the potential 
effect of the dairy effluents in vivo. There is no published information on the in vivo 
potency of 17α-E2 and therefore it is not known whether its potential effects would be 
better predicted by either the E-Screen or the hER and medER assays.  
At this stage it is not known whether the presence of 17α-E2 in the DSE would be of 
significance in terms of adverse effects in exposed biota. Comparisons of the estrogenicity 
of individual estrogenic compounds in vitro and in vivo indicate that in vitro tests may 
underestimate potential effects, as the higher level of biological organisation is associated 
with higher complexity (210,211,215). Predictions of in vivo effects using information from 
in vitro assays must therefore be done with caution. 
6.4 CONCLUSIONS 
Bioassays are an important tool in assessing potential sources of estrogenic activity at least 
at a qualitative level when working with samples from complex matrices such as DSE. 
Analysis of DSE samples using the two-hybrid yeast assays confirmed the estrogenicity as 
measured by E-Screen assay, and indicated estrogenic activity in the samples was 
mediated through the estrogen receptor. 
The E-Screen assay was more sensitive than the two-hybrid yeast assays indicating the 
advantage of this assay in analysing samples with low estrogenic activity. When samples 
contain cytotoxic compounds, the two-hybrid yeast assays offer an advantage over the E-
Screen. Firstly, yeast-based assays tend to be less sensitive to cytotoxic compounds than 
the mammalian cells. Secondly, the quantitation method used for the two-hybrid yeast 
assay is not affected by cytotoxicity at higher doses, while the E-Screen can be.  
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The estrogen equivalents determined by E-Screen were much lower for than those 
measured by hER or medER assays. For hER this could be mostly explained by the higher 
relative potency of E1 and 17α-E2 in that assay compared to E-Screen. Measured values 
and those calculated from chemical analysis were in general agreement for E-Screen and 
hER, but not for medER. Much higher EEQs measured in the medER assay may be due to 
the presence of additional estrogenic compounds in the samples, potentially 
phytoestrogens or mycoestrogens. The E-Screen assay may underestimate the potential 
effect of the DSE in aquatic environments. Proper risk characterisation of the presence of 
estrogenic compounds in the environment should include an in vivo component to assess 
effects at higher levels of biological organisation.  
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Chapter 7:  Investigation of Steroid 
Estrogens and Estrogenic Activity in 
Aquatic Receiving Environments of Dairy 
Catchments 
7.1 INTRODUCTION 
Estrogenic contamination of waterways is of considerable concern, with numerous studies 
indicating adverse effects on aquatic life, particularly freshwater fish (216). Field studies 
demonstrate that the effects are widespread, ranging from increased vitellogenin in male 
fish in the US (215), Germany (201) and Japan (217) to intersex development in fish in UK 
rivers (2,6). The effects are most clearly demonstrated downstream of sewage treatment 
plant effluents, where natural and synthetic estrogens have been established as causative 
compounds (9,10), producing effects at concentrations as low as 10-100 ng/L (reviewed in 
(132)). 
Recent research, including this thesis, has demonstrated the high concentrations of steroid 
hormones and estrogenic activity in agricultural wastes (e.g., (39,40,43,44)). Further, 
steroids have been measured in streams and ponds receiving discharges of treated 
agricultural effluents (127,218), in runoff from fields after application of animal wastes 
(100,219-221), in streams draining fields with stock grazing (128,222) and where stock 
have access to streams (128). Groundwater contamination has also been reported adjacent 
to dairy wastewater ponds (127) and in agricultural areas (223). Steroids from agricultural 
sources have also been linked to demasculinisation of male and defeminisation of female 
fathead minnow (224) and vitellogenin induction in painted turtles (225). 
In New Zealand, it is widely recognised that agricultural land use (226,227) and dairy 
farming in particular (228) has an adverse effect on stream water and groundwater 
quality. Despite this, endocrine disrupters, and steroids in particular, have not yet been 
investigated in agricultural waterways. Dairy farming practices in New Zealand could 
lead to estrogenic contamination of stream waters through several routes: stock having 
direct access to waterways, particularly minor headwater streams; DSE is discharged 
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directly to waterways after minimal treatment in many regions; and inappropriate land 
application of effluent can result in contaminants leaching into groundwater or being 
transported to surface waters (228-230).  
This chapter presents the results of investigations into steroid estrogens in streams within 
dairy catchments. Firstly, samples were collected to measure estrogen concentrations and 
activity from streams and groundwater in three catchments where DSE had been 
sampled. One of the reasons for including these catchments in the DSE study was the 
willingness of farmers to allow sampling of their effluent and provide general information 
about their farm, owing to a good prior relationship between the farmers and scientists 
and regulators. Because of the efforts by farmers in these catchments to reduce the impact 
of their farm effluents on waterways, and their high level of environmental awareness, it 
was recognised that results from these stream catchments may not reflect conditions 
predominating throughout each region. 
Secondly, the potential for groundwater contamination was further investigated in an 
intensive dairying catchment located above a shallow unconfined aquifer. This catchment 
uses border-dyke irrigation, a method involving the regular flooding of paddocks during 
dry periods. Because water is applied unevenly with this method, there is potential for 
significant macropore or bypass flow where cracks and other macropores exist in the soil 
profile (231). This bypass flow decreases filtration and the retention time in soil and 
vadose zones. Previous studies in this catchment indicated groundwater was 
contaminated with pathogens and bacteria originating from dairy farming (231). There is 
also potential for steroid estrogens from dairy effluents to be transported to the aquifer, 
thereby resulting in groundwater contamination. 
Thirdly, a wider survey was undertaken in the Waikato Region to investigate the extent of 
estrogen contamination from treated effluents discharged to waterways. Sampling sites 
were selected from information supplied by Environment Waikato regarding streams 
thought to be heavily impacted by dairy farming (R. Wightman, pers. comm.) and from 
maps of dairying in the region. Sites were region-wide and included streams receiving 
water discharges of treated effluent, and those with few or no water discharges but 
having numerous discharges to land in the catchment. Three rivers draining 
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predominantly dairy catchments were also investigated to determine whether estrogenic 
steroids in dairy effluents had an effect on water quality on a regional scale. 
7.2 METHODS 
7.2.1 Sampling Sites 
Catchment Survey 
Samples were collected twice (in August 2006 and May 2007) from several locations in the 
Toenepi Stream including two tributuaries (Figure 7.1). Samples were collected once each 
from the Waikuku Stream and Pahau River (March and April 2007, Figures 7.2 and 7.3). 
Groundwater samples were also collected in the Pahau River catchment in March 2008 
(Figure 7.3), and an additional sample was collected from the Pahau River at this time.  
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Figure 7.1: Sampling locations in the Toenepi catchment.  
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Figure 7.2: Sampling locations in the Waikuku catchment.  
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Figure 7.3: Sampling locations in the Pahau catchment.  
Waikakahi Border-Dyke Irrigation Catchment 
Sampling was conducted during late summer, when irrigation is at its peak. Because the 
irrigation water is sourced from a nearby river, stream flows are high in summer due to 
the additional input from irrigation. Samples were collected from five groundwater wells, 
where groundwater depths were 1.2-7.3 m below ground level. Samples were also 
collected from three locations along the length of the Waikakahi Stream (Figure 7.4). 
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Figure 7.4: Sampling locations in the Waikakahi catchment.  
Waikato Regional Survey 
Samples were collected from 12 streams distributed throughout the Waikato Region to 
provide further information on the effect of effluent discharges. Sampling was conducted 
during summer baseflow conditions to ensure that the influence of effluent discharges 
dominated through reduced potential for runoff from diffuse sources of estrogens (i.e. 
from urine and faeces deposited during grazing). In addition, at this time there was lower 
dilution of effluent directly discharged into waterways for most streams. Streams were 
located throughout the region (Figure 7.5). Specific details on each stream are provided in 
Appendix B. 
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Figure 7.5: Sampling locations around the Waikato Region.  
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7.2.2 Sample Collection and Extraction 
Grab samples were collected from below the water surface in the middle of the stream 
where possible, or within a flowing section. Groundwater samples were collected after 
purging the wells for at least three well volumes and once conductivity and pH 
measurements had stabilised. 
Water samples were collected in solvent- and Milli-Q water (MQ)- rinsed 4 L amber glass 
bottles with Teflon-lined lids. Samples were immediately preserved by the addition of 
sulfuric acid (to pH ≤ 2) and transported on ice to the laboratory. Sample processing 
began immediately on return to the laboratory and extraction was completed within 36 
hours. Samples were stored at < 4 °C during this period where necessary. 
Samples were filtered through glass fibre filters (GF/C, pore size 1.2 µm Whatman). 
Filtered samples were extracted in duplicate (2 L each) for i) chemical analysis of steroid 
estrogens, and ii) estrogenic activity using the E-screen assay. Samples for chemical 
analysis were spiked with surrogate standards (100 ng each E1-d4, 17β-E2-d4, E1-3S-d4 and 
17β-E2-3S-d4). In the spring 2006 sampling, samples were spiked only with 17β-E2-d4 
(250 ng). All samples were loaded onto 500 mg Oasis HLB cartridges (preconditioned 
with 10 mL of methanol followed by 10 mL of MQ water) at a flow rate of 5-10 mL/min.  
7.2.3 Chemical Analysis 
Samples for chemical analysis were eluted from Oasis HLB cartridges in two fractions to 
separate conjugated estrogens and free estrogens as described in detail in Chapter 3 and 
summarized briefly here. Cartridges were washed with methanol water mixtures then 
free estrogens were eluted with 30 ml of DCM: DEE: MeOH (40:10:1). TFAA was added to 
the extract to derivatise estrogens to their trifluoroacetate derivatives for GC-MS analysis 
in SIM/Scan mode (as fully described in Chapter 3). 
Data collected in SIM mode was used for quantitation of the steroid estrogens E1, 17α-E2 
and 17β-E2. These were quantified by isotope dilution, based upon the relative response 
factors for the following pairings: 17α-E2/17β-E2-d4, 17β-E2/17β-E2-d4, E3/E2-d4, E1/E1-
d4. 
Aquatic receiving environments 
142   
For the initial samples collected in the Toenepi catchment (spring 2006), estrogens were 
not quantified by isotope dilution as described above. Estrogens were quantified against 
E2-17Ac which was added to the purified sample extracts as an internal standard. 
Estrogens were recovery corrected against the concentration of the surrogate standard 
17β-E2-d4 that was added to raw samples and subsequently measured.  
7.2.4 E-Screen Analysis 
Samples for analysis by E-screen assay were eluted from the Oasis HLB cartridges with 
30 ml of DCM: DEE: MeOH (40:10:1), dried down to approximately 1 mL and solvent 
exchanged into DMSO (250 µL for samples collected 2006-2007, 50 µL for 2008). Samples 
were stored at <20°C in the dark until analysed by E-screen assay. 
The E-Screen assay was performed as described in Chapter 4. EEQs were calculated from 
EC50 [17β-E2, ng/L] / EC50 [sample]. The quantitation limit ranged from 0.012-0.20 ng/L 
depending on sample volume, concentration factors and cytotoxicity in the assay. 
Samples were considered below detection where the maximum proliferation was less 
than 20% of the maximum proliferation of the standard curve and where the calculated 
EC50 was not within the range of actual measurements. Method quality control 
procedures for the E-Screen assay included analysing a standard and a duplicate sample 
for each 10 samples; and performing two independent assays for each sample (with the 
average value reported). 
7.2.5 Quality Assurance and Quality Control 
Quality assurance and quality control procedures included analysing a 2 L MQ blank and 
MQ spike (12.5 ng/L) for each sampling event. No steroids were detected in the blank 
samples. Recovery of the MQ spikes ranged from 77-105% for the Waikato sampling. 
Spike recovery was lower for samples collected in Waikakahi and Pahau catchments at 55-
73%. 
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7.2.6 Statistical Methods 
Regression analysis was used to investigate relationships between estrogenic activity and 
catchment characteristics. Dairy land use, number of DSE discharges to water and land 
and the number of stock in each catchment were provided by Environment Waikato (D. 
Borman, pers. comm.). These data were normalized to the catchment area of each stream. 
Best subsets linear regression analysis was undertaken using the statistical software 
package Minitab v15.1.0.  
7.3 RESULTS AND DISCUSSION 
7.3.1 Catchment Sampling 
Samples from the Toenepi, Waikuku and Pahau Streams indicated low to very low 
concentrations of steroid estrogens and estrogenic activity (Table 7.1). E1 was the only 
steroid estrogen detected in the water samples, and was identified in 13 out of 18 stream 
and groundwater samples at concentrations up to 3.3 ng/L. Despite detection limits of 
~0.1 ng/L for 17α-E2 and 17β-E2 (based on a signal:noise ratio of 3:1), these compounds 
were not detected in any stream or groundwater samples.  
Eleven of 18 samples tested elicited an estrogenic response as measured by the E-Screen 
assay. All samples collected from the Toenepi catchment in spring 2006 had measurable 
activity, consistent with the detection of E1 in these samples. All samples from the 
Waikuku Stream and the Pahau River demonstrated estrogenic activity by E-Screen assay 
in Autumn 2007 sampling, while only one sample from the Toenepi Stream or its 
tributaries was above the quantitation limit.  
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Table 7.1: Estrogenic activity and steroid estrogen concentrations in stream and groundwater samples from 
the Toenepi, Waikuku and Pahau catchments. 
 Spring 2006  Autumn 2007  Summer 2008 
 
Stream / Well 
EEQ 
(ng/L) 
E1 
(ng/L) 
 EEQ 
(ng/L) 
E1 
(ng/L) 
 EEQ 
(ng/L) 
E1 
(ng/L) 
Toenepi         
Mid Toenepi Stream 0.88 1.7  0.25 ND a  NM NM 
Lower Toenepi Stream 0.28 1.4  ND ND  NM NM 
Tributary 1 0.38 3.3  ND ND  NM NM 
Tributary 2  0.31 0.38  ND 0.9  NM NM 
Waikuku         
Upper Waikuku Stream NM NM b  0.08 ND  NM NM 
Mid Waikuku Stream NM NM  0.10 ND  NM NM 
Lower Waikuku Stream NM NM  0.07 0.37  NM NM 
Pahau         
Upper Pahau River NM NM  0.32 1.4  NM NM 
Mid Pahau River NM NM  0.20 0.40  ND ND 
Unprotected g/w well NM NM  0.04 ND  NM NM 
Groundwater well 1 NM NM  NM NM  ND ND 
Groundwater well 2 NM NM  NM NM  ND ND 
Groundwater well 3 NM NM  NM NM  ND ND 
Notes: a ND = Not detected, less than detection limit of 0.1-0.2 ng/L for E1 and 0.01-0.04 ng/L for EEQ. b NM 
= Not measured. 
There was some estrogenic activity (0.04 ng/L) in a shallow groundwater sample 
collected from an unprotected well adjacent to a dairy shed. This activity was not 
confirmed in further sampling of groundwater from three wells in the catchment. All 
steroids were below detection limits and no estrogenic activity was measured by the E-
Screen assay at a quantitation limit of 0.02 ng/L. The initial groundwater sample is not 
expected to reflect groundwater concentrations throughout the catchment as the well was 
located adjacent to a dairy shed, was not covered and was not purged prior to sampling. 
Later samples were from protected wells, purged for three well volumes prior to 
sampling, according to standard groundwater sampling protocols. 
Overall there were several unexpected findings in these results. Firstly, the highest 
concentration measured from the Pahau River was in a sample from a site upstream of all 
the dairy farms. The upper catchment is predominantly used for grazing by dry stock 
(beef) and sheep, which can also be sources of estrogen (128). An alternative source may 
be leachate from septic tanks (232) or waterfowl activity. The results suggest that rural 
streams with other land use in the catchment may also be at risk of contamination with 
estrogens. 
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Secondly, the highest E1 concentration measured (3.3 ng/L) was from a sample collected 
from a tributary of the Toenepi Stream that had no consented water discharges of treated 
dairy effluent. Further, higher concentrations (0.38-3.3 ng/L) were measured in samples 
collected under high flows (391 L/s, spring 2006) in the Toenepi Stream than under low 
flows (ND-0.9 ng/L, flow of 13 L/s, autumn 2007). 
The singular detection of E1 in all samples is likely due to the persistence of E1 relative to 
17β-E2, and possibly 17α-E2. Similarly only E1 was detected in waterways in the 
Netherlands and the U.S. (128,166). The higher concentrations during high stream flows 
suggest that overland runoff and sub-surface flows transport steroid estrogens to the 
river. This is supported by the detection of estrone in the tributary with no direct 
discharges of dairy effluent into the waterway. Steroid estrogens may be sourced from 
land applications of effluent, from estrogens bound to soil from prior effluent applications 
or from diffusely deposited manure.  
During wet weather increased discharge volumes from treatment ponds may increase the 
concentrations of estrogenic steroids in the Toenepi main-stem. Although effluent 
treatment ponds should exclude rainwater from the surrounding farmland or dairy shed 
(152), not all systems are rigorously designed. During wet periods, increased flow into the 
ponds results in increased discharge volumes and decreased treatment efficiency due to 
reduced retention time.  
7.3.2 Border-Dyke Irrigation Catchment 
Samples collected from the Waikakahi Stream and five groundwater wells in the 
catchment demonstrated the presence of steroid estrogens and estrogenic activity in the 
waterways (Table 7.2). All samples elicited an estrogenic response in the E-Screen assay, 
with EEQs of 0.05-0.34 ng/L (Table 7.2). All three steroids were detected in stream 
samples, contrasting with the results obtained for the stream samples from the other three 
catchments. E1 concentrations were highest, measuring 0.61-1.2 ng/L, followed by 17α-E2 
(0.21-0.68 ng/L) and 17β-E2 (0.12-0.16 ng/L). 
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Table 7.2: Estrogenic activity and steroid estrogen concentrations in streams sampled from the Waikakahi 
catchment. 
   Steroid estrogen concentrations (ng/L) 
Stream / Well  
EEQ 
(ng/L)  E1 17α-E2 17β-E2 Total estrogens 
Groundwater well 1  0.07  ND a ND ND ND 
Groundwater well 2  0.08  ND ND ND ND 
Groundwater well 3  0.07  ND ND ND ND 
Groundwater well 4  0.15  ND ND ND ND 
Groundwater well 5  0.05  ND 0.21 ND 0.21 
Waikakahi Stream 1  0.10  0.61 0.22 0.12 0.95 
Waikakahi Stream 2  0.34  1.2 0.26 0.12 1.5 
Waikakahi Stream 3  0.15  0.72 0.68 0.16 1.6 
Notes: a ND = Not detected, less than detection limit of 0.1-0.2 ng/L for E1 and 0.1 for 17α-E2 and 17β-E2. 
Interestingly, 17α-E2 was detected in one groundwater sample. This well was 
downgradient of most dairy farms but significantly, the neighbouring (and immediately 
upgradient) farm has swine manure spread on it. Application of piggery manure has been 
shown to result in leaching of E1 and 17β-E2 into tile drains (233). Although swine do not 
excrete 17α-E2, it has been detected in lagoons treating swine wastes (39,43) and it may be 
produced from 17β-E2 and E1 under anaerobic conditions (193), suggesting that the 17α-
E2 may have originated from the piggery wastes. 
The remaining groundwater well and stream samples were collected upgradient and 
upstream of this manure spreading operation, indicating that it was not the sole source of 
steroid estrogens and estrogenic activity in the catchment. Colloidal facilitated transport is 
thought to enhance leaching of steroids through soil, resulting in environmental 
concentrations above those predicted by soil sorption experiments (234). As dairy 
effluents contain high concentrations of dissolved and colloidal organic carbon, this is 
likely to enhance leaching of estrogens into groundwater and stream water through sub-
surface flows. 
7.3.3 Waikato Regional Survey 
Eleven of the 12 streams demonstrated estrogenic activity by E-Screen assay at 0.02 to 1.44 
ng/L (Table 7.3). Steroid estrogens were detected at trace concentrations in five samples. 
E1 and 17α-E2 were the most frequently detected (each in 3 samples), with 17β-E2 also 
detected in one sample. Estrone concentrations were somewhat higher than 17α-E2 and 
17β-E2, ranging from 0.34 to 4.2 ng/L, while 17α-E2 measured 0.12 to 0.31 ng/L and 17β-
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E2 0.58 ng/L. The presence of 17β-E2 in water samples suggests that the steroid estrogens 
may have been recently excreted, as 17β-E2 is less persistent than E1 in the aquatic 
environment (195).  
Table 7.3: Estrogenic activity and steroid estrogen concentrations in streams sampled from Waikato. 
   Steroid estrogen concentration (ng/L) 
Stream  
EEQ 
(ng/L)  E1 17α-E2 17β-E2 Total estrogens 
Mangakawaru Stream  0.35  ND a ND ND ND 
Mangaorongo Stream  0.15  ND ND ND ND 
Mangapiko Stream  0.40  ND ND ND ND 
Matatoki Stream  0.18  ND 0.12 ND 0.12 
Mellsops Drain  0.16  ND ND ND ND 
Owairaka Stream  0.19  ND 0.15 ND 0.15 
Owairaka tributary  0.29  ND ND ND ND 
Piako River  0.28  0.65 ND ND 0.65 
Pokaiwhenua  ND  0.34 ND ND 0.34 
Puniu River  0.05  ND ND ND ND 
Toenepi Stream  NM b  0.48 ND ND 0.48 
Waihou River  0.02  ND ND ND ND 
Waihuka Stream  1.44  4.2 0.31 0.58 5.1 
Notes: a ND = Not detected, less than detection limit of 0.1-0.2 ng/L for E1, 0.1 for 17α-E2 and 17β-E2 and 
0.01 ng/L for EEQ. b NM = Not measured. 
Highest estrogenic activity and steroid concentrations were measured in the Waihuka 
Stream. This is a small stream (less than 1 m wide) receiving a single discharge of treated 
DSE. The second highest concentration of total estrogens was measured in the Piako 
River. In addition to receiving dairy effluent discharges throughout its catchment, the 
Piako River also receives discharge from the Morrinsville township sewage treatment 
plant, servicing a population of ~6000 people. 
7.3.4 Comparison to Literature Values 
This is the first study detecting estrogenic activity within waterways in New Zealand 
using an in vitro assay and chemical analysis. A previous study on the Waikato River did 
not find evidence of estrogenic activity, though that study was somewhat limited by the 
small number (3) of river samples analysed and by methodological issues (235). The 
Waikato River is a very large river by New Zealand standards, with a median flow in 
Hamilton of 321 m3/s (236), at least ten-fold greater than the waterways examined in the 
current study (median flows of a few L/s to 32 m3/s). The greater flow therefore provides 
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much greater dilution of any estrogens entering it from STP effluents and DSE discharges 
when compared to the small streams and rivers examined in this study. 
Estrogenic activities measured in the streams from the dairy catchments were similar to 
values reported in international literature for streams impacted by agricultural activities, 
and particularly dairy farming. In this study, 24 of 29 stream samples demonstrated 
estrogenic activity in the E-Screen assay. The mean EEQ was 0.32 ng/L, with a maximum 
of 1.4 ng/L. This is comparable with values up to ~1 ng/L (E-Screen assay) in a drain 
receiving effluent from a beef cattle feedlot (218), up to 2.41 and 1.75 ng/L (YES and ER-
CALUX assays respectively) measured in streams in dairy catchments in Australia (45), 
and up to 1.1 ng/L (YES assay) in Denmark in drains from fields where cattle and pig 
manure was applied (64). Estrogenic activity (YES assay) was measurable in 25 of 130 
samples collected from streams and lakes in animal husbandry catchments (cattle and 
pigs) in Denmark, with values typically between 1 and 2 ng/L but up to 8.8 ng/L (64). 
The EEQ measured in drains from cattle breeding areas in the Netherlands were lower, 
with a maximum of 0.2 ng/L (ER-CALUX) (166). Conversely, higher average EEQs 
(average 1.4 ng/L, YES assay) were estimated in streams draining mainly dairy farms in 
the United Kingdom, using passive samplers (222) deployed for an average of 39 days. 
These samplers integrate concentrations over the deployment period and would 
incorporate any transient peaks in concentration due to storm runoff, or cattle excreting 
directly into the streams, potentially leading to overall higher values compared to grab 
samples. Estrogenic activities measured in the current study and internationally in 
streams in dairy catchments, are similar to those measured in streams and rivers receiving 
STP discharges (68), though maximum values are often higher downstream of STPs (5-
20 ng/L, (68,237)).  
In this study, E1 was measured above the quantitation limit in 15 of 30 samples, while 
17α-E2 was measurable in 6 and 17β-E2 in 4 samples. Concentrations were typically less 
than 1 ng/L, lower than expected based on the measured EEQs. However, the data is 
within the range reported for rural streams in dairy catchments in North America 
(127,128,218), the Netherlands (166) and Denmark (64,233). Williams et al. (45) reported 
substantially higher concentrations of E1 and 17β-E2 in streams draining stock grazing 
and dairy land use in Australia, including a stream receiving wash-down water from a 
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dairy shed, drains collecting irrigation runoff from dairy operations, and streams where 
dairy cattle had access. Using ELISA, they measured E1 concentrations from 1.57 to 
18.71 ng/L and 17β-E2 from 0.81 to 3.37 ng/L. E1 and 17β-E2 concentrations were higher 
in these dairy-impacted streams than in streams in areas where sheep and beef cattle 
grazed. Results obtained by ELISA need to be treated with caution as the presence of 
natural organic matter in samples can interfere with measurements, resulting in false 
positives (79,103) and, as stated by the authors, these results need to be confirmed with a 
more selective analytical measurement (45). Despite this, they do highlight the greater 
potential for estrogen contamination in dairy catchments compared to other agricultural 
uses. 
In the current study, estrogenic activity was low in groundwater and steroid estrogens 
were detected in only one sample, indicating that the steroids in dairy effluents are either 
strongly retained by soil and/or degraded before they reach groundwater. This contrasts 
with concentrations of 6-20 ng/L of 17β-E2 measured in karst aquifer springs in Arkansas 
under baseflow conditions and up to 66 ng/L following recharge (223). These springs also 
contained E. coli measured at 102 to 104 cfu/100 mL, indicating contamination from animal 
effluents and/or wastes. Although E. coli was not measured in this study, previous 
measurements of groundwater from these wells indicated values typically <101 to 
103 MPN/100 mL (231), suggesting that, although vulnerable, this groundwater is at less 
risk to contamination from animal wastes applied to soil than the afore-mentioned karst 
aquifers. 
7.3.5 Sources and Routes of Estrogen Contamination 
A linear regression analysis was undertaken to examine predictors of estrogenic activity 
in the streams from the Waikato Region. The Piako River was excluded from this analysis, 
due to the input of treated sewage upstream of the sampling location. The regression 
analysis indicated that the normalised number of DSE discharges to water could predict 
64% of the variability in EEQ. The inclusion of the number of cattle within the catchment 
improved the fit of the model, accounting for a further 11% of the variability. Discharges 
of DSE to land, and the area of land in dairy land use, were not important in predicting 
EEQ, (each contributing < 1% variability). 
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Stock numbers were used to examine the potential influence of other stock on estrogenic 
activity in the Waikato Streams. The number of dairy cattle in the catchments of Waikato 
streams explained 29.5% of the variation using a best subsets regression. Pig numbers 
added an additional 16%, while sheep numbers added only 7%. Deer and beef cattle 
numbers did not appear to influence the estrogenic activity of the streams, adding only a 
further 1.7%. This analysis suggests that dairy cattle are the likely and predominant 
source of estrogens measured in the Waikato catchments. 
There are several potential routes for estrogens sourced from dairy cattle to enter 
waterways, including direct discharges of effluent, stock access to streams and overland 
runoff. The relationship between estrogenic activity measured in streams and discharges 
of DSE to water, seen in the results of the Waikato Region survey, indicates the potential 
importance of this route under baseflow conditions. On the other hand, steroid estrogens 
and estrogenic activity were also detected in streams with no effluent water discharges, 
indicating that diffuse runoff is an additional route of estrogen contamination. As 
demonstrated in the Toenepi catchment, this route is likely to be important under wet 
weather conditions. Similarly, Kolodziej et al. (128) measured highest concentrations of 
estrone following a storm event when sampling waterways within dairy farm catchments. 
The ability of stock to access the streams for watering or grazing was not quantified in this 
study, though it is expected that stock would have access to most, if not all streams 
surveyed, thereby permitting direct excretion into the water. Streams were not always 
fenced in the sampling locations and cattle were observed on the stream bank 
immediately downstream of the sampling location at one site. Even in the ‘best practice 
catchments’ stock had access to the streams: the Toenepi Stream was unfenced along 54% 
of its reach and the Waikakahi Stream was unfenced along 22% (238).  
Recent studies indicate that leaching of steroids applied to land is likely to be greater than 
predicted from standardised soil sorption experiments, due to macropore transport and 
colloidal facilitated transport (233,234). Furthermore, degradation may be lower than 
experimentally predicted due to several reasons. Firstly, biological degradation of 
estrogens is reduced at cooler soil temperatures (189,233). Secondly, transport through the 
soil profile reduces exposure to microbial populations which are primarily located in the 
rhizosphere near the soil surface (239). Thirdly, at greater depths soils may be anaerobic 
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and estrogens are less readily degraded under anaerobic conditions (182). This would 
result in greater persistence of estrogens and increased potential for further transport into 
groundwater (233). These processes may have resulted in the estrogenic activity observed 
in the Waikakahi Stream, as this stream is largely fed by groundwater and sub-surface 
flows from summer irrigation. 
7.3.6 Potential for Effects on Wildilife 
The results indicate widespread estrogenic contamination in these waterways in dairying 
catchments, with estrogenic activity and/or steroid estrogens measured in 83% of 
streams, albeit at low levels. Freshwater fish are considered to be the most at-risk of 
adverse effects from steroid estrogens, and the effect of low concentrations of steroids has 
been investigated in many laboratory studies (132). Young et al. (132) used these studies 
to derive proposed Predicted No Effect Concentrations (PNECs) for 17β-E2 and E1, at 
1 ng/L and 3-5 ng/L respectively. 
The PNEC for 17β-E2 was not exceeded in any of the samples measured in this study, 
with a maximum concentration of 0.58 ng/L (Waihuka Stream). E1 was measured at a 
concentration above the suggested PNEC of 3 ng/L in two streams, at 4.2 ng/L in the 
Waihuka Stream and 3.3 ng/L in a tributary of Toenepi. 
Because steroid estrogens can act additively, Young et al. (132) suggested a ‘toxic 
equivalents’ approach for assessing water samples containing mixtures, with a maximum 
acceptable value of 1, based on the following equation:  
Equation 7.1:
[17 -ethynylestradiol]
0.1
α [17 -estradiol]
1
β
+
[estrone]
3+  
Using this equation, total estrogens in Waihuka Stream measured 1.98, exceeding the 
suggested maximum value of 1. Total estrogens measured 1.1 in the tributary of Toenepi 
Stream, also exceeding the suggested maximum value of 1. Values derived for all other 
streams remained below 1, but were 0.5 or above at locations in the Waikakahi and 
Toenepi Streams. This approach indicates potential for adverse effects in these streams in 
intensive dairying catchments. 
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A PNEC for 17α-E2 has not been developed as there is insufficient in vivo data. Although 
this is the predominant steroid in dairy wastes, it was not prevalent in the stream 
samples, possibly due to its lower persistence compared to E1. Concentrations were less 
than 1 ng/L in all stream samples and based on its lower potency compared to 17β-E2, its 
presence alone is unlikely to result in adverse effects. The presence of 17α-E2 would, 
however, increase the total exposure to steroid estrogens due to additive effects, and if 
incorporated into Equation 7.1, depending on the derived PNEC, may result in 
exceedance of a total estrogen concentration of 1. 
The streams sampled in the Waikato Region are considered representative of the streams 
throughout the region, with flows ranging from a few L/s to 32 m3/s. However, as each 
stream was sampled only once, this data can be considered no more than a snapshot of 
the concentration of steroid estrogen and estrogenic activity at one time. Sampling in the 
Waikato Region was undertaken during an exceptionally dry period, when seepage of 
steroids through soil can be expected to be lower than during frequent rainfall and 
saturated soil conditions. Although in-stream dilution would be larger under high flow 
conditions, sampling in the Toenepi Stream suggests this may be outweighed by the 
increased load of steroids entering the stream, through either overland flow, seepage or 
increased discharge from treatment ponds. As in-stream concentrations were close to 
proposed PNECs, it is likely that under wet-weather conditions the PNECs would be 
exceeded, suggesting potential for adverse effects in fish. 
7.4 CONCLUSIONS 
Estrogenic activity and steroid estrogens were widespread in the waterways studied 
within dairy catchments, particularly in the intensively farmed Waikato Region.  
Estrogenic activity was measurable in 83% of streams and in 75% of groundwater 
samples, albeit at low levels. E1 was the predominant steroid measured in the streams, in 
spite of its lower concentration in dairy effluents compared to 17α-E2, presumably due to 
more rapid degradation of 17α-E2 in aquatic environments. 
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E1 and estrogenic activity were also measured in a stream receiving a municipal sewage 
discharge and in streams with grazing in the catchment. This suggests that while dairy 
land use may be a major risk factor for estrogen pollution of waterways in rural areas, 
other estrogen sources should not be ignored. 
Estrogenic activity and steroid concentrations were within the range measured 
internationally in agricultural and particularly dairying catchments. Under baseflow 
conditions, direct discharges of dairy effluent to waterways may be the most important 
source of the steroids. However, limited data collected under high flow conditions 
suggests that higher concentrations may be measured during periods of heavy rainfall 
and floods, possibly due to overland runoff of steroids in soil. 
The data collected indicate potential for adverse effects on fish in two of the streams 
studied where the estrogen concentrations measured exceeded PNECs. These PNECs 
were also approached in another two streams. The results suggest that further research, 
including in vivo testing, is warranted to assess whether or not these concentrations are 
having an adverse effect on stream biota.  
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Chapter 8:  Final Conclusions 
8.1 OVERVIEW 
The previous chapters have each presented the main conclusions of the research described 
within them. This chapter aims to integrate the findings of each chapter in a short 
discussion of potential implications, assess whether the research objectives have been met, 
present the key findings of the research, and suggest recommendations for further 
research. 
8.2 IMPLICATIONS FOR AQUATIC BIOTA OF DSE 
DISCHARGES TO LAND AND WATER 
8.2.1 Water 
The presence of residual steroid estrogens in dairy effluents following treatment poses a 
risk to aquatic receiving environments. A comparison of estrogen concentrations and 
estrogenic activity in treated DSE and in STP effluents (Table 8.1) demonstrates the 
importance of these wastes as sources of estrogen pollution. 17β-E2 concentrations are 
typically much higher in the treated DSE than in STP effluents, with the mean 
concentration of 17β-E2 in the DSE samples 20-fold higher than the mean in STP effluents 
worldwide. The estrogenic activity of DSE was also much higher than STP effluents, 
except where measured using the ERBA. As discussed in Chapter 3 and 5, higher EEQ is 
expected when using ERBA, as this also measures antagonists. 
The volume of DSE discharge to water is typically much lower than volumes of STP 
effluent. The farms examined in this study discharged between 8 and 15 m3/day of 
treated effluent, much less than the maximum limits of 2,000-310,000 m3/day for the NZ 
STP effluents. Despite the lower volume, in many cases treated DSE is discharged into 
minor streams or farm drains that provide low dilution. Furthermore, in catchments 
where dairy is the predominant land use, the cumulative effects of numerous discharges 
result in higher in-stream concentrations and an increase in the potential for adverse  
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Table 8.1: Free estrogens and estrogenic activity in dairy effluents discharging to waters compared with Sewage Treatment Plant effluents (mean ng/L (range)). 
  Steroid estrogen concentrations (ng/L)  Dilution   Bioassay   
  E1 17α-E2 17β-E2  required a  EEQ used  Ref. 
Dairy effluents b 
 
240 (5.2-720) 330 (0.69-880) 61 (0.30-310) 
 
78 (<1-310) 
 
109 (3.2-670) E-Screen 
 This 
study 
NZ STP effluents            
Pukete (NZ)  T c ND d T  -  BQL e ERBA  (40) 
Taupo (NZ)  84.7 9.5 14.8  28  32 ERBA  (40) 
Temple View (NZ)  19.0 T ND  6  22 ERBA  (40) 
NZ & Australia  NM NM NM  -  <4–6.4 ERBA  (56) 
International STP effluents          
Australia  24 (3.1-39) NM 3.8 (0.05-6.3)  8 (<1–13)  0.60 (0.03-2.2) YES  (45) 
Canada  17 (1-96) NM 1.8 (0.2–14.7)  6 (<1-32)  50 (ND-106) ERBA  (240) 
Germany  1.5 (<0.1–70) NM 0.55 (<0.05–15)  0.55 (<1-23)  1.6 (0.2–7.8) E-Screen  (201,241) 
Netherlands  3.4 (<0.3-11) <0.4 <0.8  1.1 (<1-4)  ND-2.2 ER-CALUX  (166) 
Japan  12 (ND – 180) NM ND (ND-11)  4 (<1-60)  NM NM  (88) 
Mean ± std. dev.  15 ± 15 NM 3 ± 3  3  NM NM  (159) 
Notes: a Maximum dilution required to reduce median steroid concentrations to below suggested PNECs for E1 (3 ng/L) and/or 17β-E2 (1 ng/L) (132). b Mean (range) 
of data for sites discharging to water. c Trace concentrations detected (below quantitation limit). d Not detected. e Below quantitation limit. 
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effects in aquatic biota. Stream sampling in the Waikato Region demonstrated widespread 
potential for elevated concentrations of estrogens in waterways receiving effluents.  
8.2.2 Land 
Land disposal of DSE is favoured in most regions to reduce impacts of nutrients on 
waterways. In most cases, effluent is immediately irrigated directly onto paddocks with 
no form of treatment. Raw effluents are likely to contain E1-3S, which binds to soil much 
more weakly than free estrogens do (242). There is therefore potential for E1-3S to be 
transported in runoff to surface waters or to leach through soil into groundwater. Thus, 
E1-3S may serve as a reservoir for estrogen contamination, which can be subsequently 
hydrolysed into E1 in favourable conditions. 
The free estrogens have greater potential to sorb to soil than the sulfate conjugates and 
should therefore be retained in the soil. Despite this, free estrogens have, in fact, been 
measured in soil drainage water (233). DSE has high concentrations of dissolved organic 
carbon and colloidal organic carbon. This is thought to enhance the transport of free 
estrogens through soil and result in lower sorption than predicted from soil testing in the 
laboratory (233,234). The current trend in New Zealand towards larger and more 
intensive dairy farming may increase the loads of estrogens applied to land.    
Estrogens have also been detected in runoff after application of dairy wastes to land (243). 
There may be increased potential for steroids in runoff where effluent is irrigated near 
waterways or results in ponding, common occurrences in New Zealand (244-246) despite 
regulations to the contrary. Furthermore, estrogens deposited diffusely during grazing, a 
route not examined during this research, may enter waterways through runoff during 
high rainfall events. Any increase the amount of estrogen deposited diffusely due to 
increases in dairy cattle numbers and /or increases in the proportion of dairying within a 
catchment will likely increase the concentrations entering a waterway through runoff. 
Anaerobic pond treatment increased the aqueous estrogen concentrations compared to 
raw effluent. On some Waikato farms, effluent is irrigated from pond systems. The use of 
holding ponds (RT ≥ 3 days) is increasing in the Canterbury region due to regulatory 
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pressure. These ponds, likely to be anaerobic due to the high organic loading of DSE, will 
increase the aqueous concentrations of free estrogens prior to irrigation. 
As aerobic and facultative ponds greatly reduced the concentrations of estrogens in the 
effluent, the ideal disposal method for DSE would appear to be anaerobic treatment to 
cleave conjugated estrogens, aerobic pond treatment to reduce concentrations, then 
disposal via irrigation onto land. 
8.3 THESIS OBJECTIVES REVISITED 
The overall aim of this thesis was to establish whether dairy farming is a contributor of 
steroid estrogens to NZ’s aquatic environment. There were four specific objectives and the 
outcomes related to each of these are discussed in the following sections. 
Objective 1: To develop a method to analyse steroid estrogens and conjugated 
estrogens in dairy shed effluents and environmental samples. 
A GC-MS method was developed through improvements on a previously developed 
method. The method incorporated SPE extraction, clean-up on aminopropyl and florisil 
sorbents and through GPC, derivatisation to trifluoroacetates then analysis by GC-MS. 
Isotopically-labelled standards were used for quantitation and the overall method 
detection limit was 0.8 ng/L for free estrogens in DSE samples, comparable to previously 
published methods. This method was applied to the analysis of 17β-E2, 17α-E2 and E1 in 
dairy effluents and environmental water samples at the ng/L level and over a 
concentration range of several orders of magnitude. The robustness of the method was 
further demonstrated through its application to the analysis of extracted samples of dairy 
effluent solids. 
An LC-MS method was developed to analyse sulfate conjugates using LC-IT-MS in SRM 
mode. This provided suitable sensitivity for the analysis of dairy effluent samples, which 
contain conjugated estrogens at higher concentrations, but did not provide the sensitivity 
to analyse environmental water samples, where concentrations are expected to be much 
lower. Methods based on enzyme hydrolysis and solvolysis were also evaluated but poor 
recovery was achieved for standards and results for dairy effluent samples conflicted with 
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LC-MS results. Detection limits for the glucuronide conjugates were not satisfactory and 
these compounds could not be accurately measured in the DSE samples. Co-eluting 
compounds in the DSE samples interfered with the quantitation of 17β-E2-3S. The 
conjugated estrogens 17α-E2-3S and E1-3S were reliably measured in a number of raw 
and treated DSE samples with method detection limits of ~15 ng/L. 
Objective 2: To determine the levels of estrogens in dairy effluents by chemical 
analysis and compare results with those generated using biological assays. 
Steroid estrogens and estrogenic activity were examined in DSE samples from 18 different 
farms collected at two different periods in the milking season. Steroid estrogens were 
detected in all DSE samples collected with 17α-E2 measured at the highest concentrations. 
The results also demonstrated that DSE has high estrogenic activity with a median EEQ of 
46 ng/L using the E-Screen assay. Estrogenic activity measured using the E-Screen assay 
showed generally good agreement with the results from chemical analysis. For most 
samples, the majority of the activity measured in the assay could be attributed to 17α-E2, 
17β-E2 and, to a lesser extent, E1. Selected samples were also tested using ERBA and two-
hybrid yeast assays to corroborate estrogenic activity and confirmed that activity was 
mediated through the estrogen receptor. 
Objective 3: To assess whether estrogens are removed in treatment systems used for 
dairy effluent prior to discharge to waterways. 
Analysis of samples collected from the exit point of DSE oxidation pond treatment 
systems (Chapter 4) indicated that estrogens were present after treatment. More detailed 
investigations of two systems, a commonly used two-pond system and a newer Advanced 
Pond System, indicated that estrogens initially increased in concentration then reduced 
significantly through each system. Between 63% and 99% of total estrogens were removed 
from the particulate and aqueous phases. The estrogenic activity reduced by up to 89% in 
the aqueous phase. Despite these large reductions, residual steroid estrogens and 
estrogenic activity remained in the final effluent of both treatment systems and was 
discharged into receiving waters. 
Final conclusions 
160  
Objective 4: To investigate the presence of steroid estrogens and estrogenic activity in 
aquatic receiving environments of dairy catchments. 
Steroid estrogens and estrogenic activity were widespread in streams and in 
groundwater, with measurable estrogenic activity in 83% of stream samples and 75% of 
groundwater samples. E1 was the predominant steroid measured; at up to 3.3 ng/L. 
Estrogenic activity and steroid concentrations were within the range measured 
internationally in agricultural and particularly dairying catchments. The results indicated 
potential for adverse effects on fish in two of the streams studied where the estrogen 
concentrations measured exceeded PNECs. 
8.4 KEY RESEARCH FINDINGS 
The key findings of the research were: 
 Steroid estrogen concentrations were elevated in dairy shed effluents and were 
dominated by the steroid 17α-E2. Despite the lower potency of this compound 
compared to 17β-E2 and E1, results from the E-Screen showed that it contributed a 
significant proportion of the overall activity from DSE due to the much higher 
concentrations. Conversely, results obtained using a two-hybrid yeast assay 
indicated that 17β-E2 and E1 caused the majority of measured activity. This was due 
to relative differences in the potencies of E1 and 17α-E2 in each in vitro assay. As 
potencies differ from in vitro to in vivo assays, in vivo testing will be required to 
determine the true significance of 17α-E2 to cause adverse effects in aquatic biota. 
 Much higher EEQs were measured in the two-hybrid yeast assay based on a fish 
estrogen receptor (medER). This may be due to the presence of estrogenic 
compounds not measured in this study, such as phytoestrogens or mycoestrogens. 
If this assay better reflects the effect in exposed fish, the E-Screen assay may 
underestimate the potential effects in aquatic environments. 
 Conjugated estrogens were measured in several raw effluent samples, at 
concentrations that were similar to the concentrations of free estrogens. In 
particular, E1-3S (13-180 ng/L) was present at similar concentrations to free E1 in 
those samples (10-480 ng/L). Although the conjugated estrogens demonstrated only 
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weak activity in the E-Screen assay, their presence is of importance as they can 
degrade to the highly active free estrogens. Conjugated estrogens therefore 
represent a significant source of estrogens that has previously been neglected.  
 Enzymolysis and solvolysis methods provided inconsistent results. Recovery was 
poor for the pure compounds. Furthermore, in some cases, the free estrogen 
produced from cleavage was different to that in the parent conjugate form. 
 In this study, free estrogens were measured at relatively high concentrations in the 
solids phase of DSE. This may be due to the much higher content of solids in these 
wastes compared to sewage influent and effluent, and perhaps due to the practice of 
acidification of samples. Most studies internationally have focussed purely on the 
aqueous phase of wastewater samples. Future studies of wastes with high solids 
content should bear this in mind and, if centrifuging and/or filtering samples, 
measure both particulate and aqueous phases. 
 Steroid estrogens were not completely removed by currently used DSE treatment 
systems. Steroid estrogen concentrations and estrogenic activity increased during 
anaerobic treatment, due to either desorption processes or hydrolysis of conjugated 
forms. Aerobic treatment appears to be the most important step to decrease estrogen 
concentrations in DSE effluent. Residual concentrations in the treated effluent are 
typically higher than reported concentrations in sewage effluents. 
 Steroid estrogens were detected in several waterways in predominantly dairying 
catchments, and were highest in a minor stream receiving a direct discharge of 
treated dairy effluent. Steroid estrogens (17β-E2, 17α-E2 and E1) were all detected in 
at least one waterway. Most waterways demonstrated measurable estrogenic 
activity. Concentrations of E1 and 17β-E2 were above proposed PNECs in two 
streams and approached this value in two others. Potential exists for higher 
concentrations in these streams under different environmental conditions. 
 Steroid estrogens and estrogenic activity were also detected in groundwater in an 
intensive dairying catchment. This suggests that the steroids have potential to leach 
through soils when applied to land either as dairy effluent, or diffusively during 
grazing. 
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8.5 RECOMMENDATIONS FOR FUTURE RESEARCH 
The method developed in this study was not sensitive enough to allow quantitation of 
glucuronides. Further work should be undertaken to improve the quantitation method for 
this group of compounds to enable their measurement in raw DSE samples. It is likely 
that they do not survive long in these samples, due to the rich microbial environment; 
however, this needs to be confirmed by laboratory batch tests of DSE samples spiked with 
glucuronides. 
One of the major findings of this research was that 17α-E2 dominated the steroid profile of 
effluents and had a major contribution to the overall estrogenic activity of samples. There 
is currently little information on the fate and effects of 17α-E2. It has been suggested that 
it may degrade to E1, which may be more a potent estrogen that 17α-E2. Furthermore, at 
this stage, there are no published studies evaluating the effects of 17α-E2 in vivo and no 
guidelines for maximum safe concentrations in aquatic environments. Future research 
should be applied to elucidating these questions, given the importance of dairy effluents 
as a source of estrogens, particularly in New Zealand. 
As estrogens were not completely removed in the DSE treatment systems studied, the 
efficacy of existing treatment systems needs to be improved. Further research into the 
current mechanisms of removal in these systems, incorporating a mass balance approach 
and examining bottom sludges from the ponds, would provide much needed information 
to improve the systems and further reduce the concentrations of estrogens in the final 
effluent discharged into waterways. 
Stream samples collected under flood conditions contained higher concentrations of 
steroid estrogens than those under baseflow conditions, suggesting that runoff or sub-
surface leaching may be a more important route in some catchments than direct 
discharges. Further sampling under wet-weather conditions, including sampling of 
runoff, may assist in identifying the processes of steroid transport. This may be 
particularly important in ephemeral streams, where all the water is sourced from runoff. 
Alternatively, passive samplers could be deployed in streams within dairy catchments, to 
provide an integrated estimate of exposure to steroid estrogens. 
  
 
REFERENCES 
 
 
 
 
 
 
 
   163 
References 
 
(1) Tyler, C. R.; Routledge, E. J. Pure Appl. Chem. 1998, 70, 1795-1804. 
(2) Purdom, C. E.; Hardiman, P. A.; Bye, V. J.; Eno, N. C.; Tyler, C. R.; Sumpter, J. P. Chem. 
Ecol. 1994, 8, 275-285. 
(3) Sumpter, J. P.; Jobling, S. Environ. Health Perspect. 1995, 103, 173-178. 
(4) Harries, J.; Sheahan, D. A.; Jobling, S.; Matthiessen, P.; Neall, P.; Routledge, E. J.; Rycroft, 
R.; Sumpter, J. P.; Tylor, T. Environ. Toxicol. Chem. 1996, 15, 1993-2002. 
(5) Harries, J. E.; Sheahan, D. A.; Jobling, S.; Matthiessen, P.; Neall, P.; Sumpter, J. P.; Tylor, T.; 
Zaman, N. Environ. Toxicol. Chem. 1997, 16, 534-542. 
(6) Jobling, S.; Nolan, M.; Tyler, C. R.; Brighty, G.; Sumpter, J. P. Environ. Sci. Technol. 1998, 32, 
2498-2506. 
(7) Sumpter, J. P. Toxicol. Lett. 1995, 82/83, 737-742. 
(8) Soto, A. M.; Justicia, H.; Wray, J. W.; Sonnenschein, C. Environ. Health Perspect. 1991, 92, 
167-173. 
(9) Desbrow, C.; Routledge, E. J.; Brighty, G. C.; Sumpter, J. P.; Waldock, M. Environ. Sci. 
Technol. 1998, 32, 1549. 
(10) Routledge, E. J.; Sheahan, D. A.; Desbrow, C.; Brighty, G. C.; Waldock, M.; Sumpter, J. P. 
Environ. Sci. Technol. 1998, 32, 1559. 
(11) Norris, D. O.; Carr, J. A. Introduction to Endocrinology. In Endocrine disruption: biological 
bases for health effects in wildlife and humans; Norris, D. O., Carr, J. A., Eds.; Oxford 
University Press: New York, 2006; p 477. 
(12) IPCS. Global assessment of the state-of-the-science of endocrine disruptors; International Program 
on Chemical Safety, World Health Organisation, 2002. 
(13) Fotsis, T. J. Steroid Biochem. 1987, 28, 215-226. 
(14) Fotsis, T.; Adlercreutz, H. J. Steroid Biochem. 1987, 28, 203-212. 
(15) Panter, G. H.; Thompson, R. S.; Beresford, N.; Sumpter, J. P. Chemosphere 1999, 38, 3579-
3596. 
(16) D'Ascenzo, G.; Di Corcia, A.; Gentili, A.; Mancini, R.; Mastropasqua, R.; Nazzari, M.; 
Samperi., R. Sci. Total Environ. 2003, 302, 199-209. 
(17) Garverick, H. A.; Erb, R. E. J. Anim. Sci. 1971, 32, 946-956. 
(18) Erb, R. E.; Randel, R. D.; Mellin, T. N.; Estergreen Jr, V. L. J. Dairy Sci. 1968, 51, 416-419. 
(19) Mellin, T. N.; Erb, R. E.; Estergreen, V. L. J. Anim. Sci. 1966, 25, 955-961. 
(20) Mellin, T. N.; Erb, R. E. J. Dairy Sci. 1965, 48, 687-700. 
(21) Mathur, R. S.; Common, R. H. Poult. Sci. 1969, 48, 100-104. 
(22) Sanderson, J. T. Toxicol. Sci. 2006, 94, 3-21. 
(23) Gillesby, B. E.; Zacharewski, T. R. Environ. Toxicol. Chem. 1998, 17, 3-14. 
(24) Guillette, L. J. Environ. Health Perspect. 2006, 114, 9-12. 
(25) Colborn, T.; vom Saal, F. S.; Soto, A. M. Environ. Health Perspect. 1993, 101, 378-384. 
References 
164  
(26) Vos, J. G.; Dybing, E.; Greim, H. A.; Ladefoged, O.; Lambre, C.; Tarazona, J. V.; Brandt, I.; 
Vethaak, A. D. Crit. Rev. Toxicol. 2000, 30, 71-133. 
(27) Hertz, R. The estrogen problem - retrospect and prospect. In Estrogens in the Environment II 
- Influences on Development; McLachlan, J., Ed.; Elsevier Science Publishing Co., Inc.: New 
York., 1985. 
(28) Petrovic, M.; Eljarrat, E.; López de Alda, M. J.; Barceló, D. Anal. Bioanal. Chem. 2004, 378, 
549-562. 
(29) Gutendorf, B.; Westendorf, J. Toxicology 2001, 166, 79-89. 
(30) Fang, H.; Tong, W.; Perkins, R.; Soto, A. M.; Prechtl, N. V.; Sheehan, D. M. Environ. Health 
Perspect. 2000, 108, 723-729. 
(31) Leusch, F. D. L.; van den Heuvel, M. R.; Chapman, H. F.; Gooneratne, S. R.; Eriksson, A. M. 
E.; Tremblay, L. A. Comp. Biochem. Physiol., Part C: Toxicol. Pharmacol. 2006, 143, 117-126. 
(32) Soto, A. M.; Sonnenschein, C.; Chung, K. L.; Fernandez, M. F.; Olea, N.; Serrano, F. O. 
Environ. Health Perspect. 1995, 103, 113-122. 
(33) Johnson, A. C.; Williams, R. J.; Matthiessen, P. Sci. Total Environ. 2006, 362, 166-178. 
(34) Blok, J.; Wosten, M. A. D. Source and environmental fate of natural oestrogens; Association of 
River Waterworks - RIWA, 2000. 
(35) Lange, I. G.; Daxenberger, A.; Schiffer, B.; Witters, H.; Ibarreta, D.; Meyer, H. H. D. Anal. 
Chim. Acta 2002, 473, 27-37. 
(36) Calvert, C.; Smith, L. W.; Wrenn, T. R. Poult. Sci. 1978, 57, 265-270. 
(37) Knight, W. M. Estrogens administered to food-producing animals: environmental 
considerations. In Estrogens in the Environment; McLachlan, J., Ed.; Elsevier North Holland 
Inc.: New York, 1980; pp 391-402. 
(38) Colborn, T.; Dumanoski, D.; Myers, J. P. Our stolen future: are we threatening our fertility, 
intelligence, and survival?: a scientific detective story; Dutton: New York, 1996. 
(39) Raman, D. R.; Williams, E. L.; Layton, A. C.; Burns, R. T.; Easter, J. P.; Daugherty, A. S.; 
Mullen, M. D.; Sayler, G. S. Environ. Sci. Technol. 2004, 38, 3567-3573. 
(40) Sarmah, A.; Northcott, G.; Leusch, F.; Tremblay, L. Sci. Total Environ. 2006, 355, 135-144. 
(41) Furuichi, T.; Kannan, K.; Suzuki, K.; Tanaka, S.; Giesy, J. P.; Masunaga, S. Environ. Sci. 
Technol. 2006, 40, 7896-7902. 
(42) Fine, D. D.; Breidenbach, G. P.; Price, T. L.; Hutchins, S. R. J. Chromatogr. A 2003, 1017, 167-
185. 
(43) Hutchins, S. R.; White, M. V.; Hudson, F. M.; Fine, D. D. Environ. Sci. Technol. 2007, 41, 738-
744. 
(44) Shappell, N. W.; Billey, L. O.; Forbes, D.; Matheny, T. A.; Poach, M. E.; Reddy, G. B.; Hunt, 
P. G. Environ. Sci. Technol. 2007, 41, 444-450. 
(45) Williams, M.; Woods, M.; Kumar, A.; Ying, G. G.; Shareef, A.; Karkkainen, M.; Kookana, R. 
S. Endocrine disrupting chemicals in the Australian riverine environment: A pilot study on 
estrogenic compounds; Land & Water Australia, 2007. 
(46) Hanselman, T. A.; Graetz, D. A.; Wilkie, A. C. J. Environ. Qual. 2004, 33, 1919-1923. 
(47) Hanselman, T. A.; Graetz, D. A.; Wilkie, A. C.; Szabo, N. J.; Diaz, C. S. J. Environ. Qual. 
2006, 35, 695-700. 
(48) Zheng, W.; Yates, S. R.; Bradford, S. A. Environ. Sci. Technol. 2008, 42, 530-535. 
References 
  165 
(49) Lorenzen, A.; Hendel, J. G.; Conn, K. L.; Bittman, S.; Kwabiah, A. B.; Lazarovitz, G.; Masse, 
D.; McAllister, T. A.; Topp, E. Environ. Toxicol. 2004, 19, 216-225. 
(50) Houlbrooke, D. J.; Horne, D. J.; Hedley, M. J.; Hanly, J. A.; Snow, V. O. N. Z. J. Agric. Res. 
2004, 47, 499-511. 
(51) Statistics New Zealand. Agricultural Production Statistics 2003; Department of Statistics New 
Zealand, 2004. 
(52) Statistics New Zealand. 2002 Agricultural Production Census; Department of Statistics New 
Zealand, 2003. 
(53) Statistics New Zealand. Agricultural Production Statistics (Final): June 2007; Department of 
Statistics New Zealand, 2008. 
(54) Statistics New Zealand. 2006 Census; Department of Statistics New Zealand, 2007. 
(55) Langford, K. H.; Lester, J. N. Fate and behavior of endocrine disrupters in wastewater 
treatment processes. In Endocrine disrupters in wastewater and sludge treatment processes; 
Birkett, J. W., Lester, J. N., Eds.; Lewis Publishers: Boca Raton, FL, 2003; pp 103-144. 
(56) Leusch, F. D. L.; Chapman, H. F.; van den Heuvel, M. R.; Tan, B. L. L.; Gooneratne, S. R.; 
Tremblay, L. A. Ecotoxicol. Environ. Saf. 2006, 65, 403-411. 
(57) Belfroid, A. C.; Van der Horst, A.; Vethaak, A. D.; Schafer, A. J.; Rijs, G. B. J.; Wegener, J.; 
Cofino, W. P. Sci. Total Environ. 1999, 225, 101-108. 
(58) Isobe, T.; Shiraishi, H.; Yasuda, M.; Shinoda, A.; Suzuki, H.; Morita, M. J. Chromatogr. A 
2003, 984, 195-202. 
(59) Adler, P.; Steger-Hartmann, T.; Kalbfus, W. Acta Hydrochim. Hydrobiol. 2001, 29, 227-241. 
(60) Labadie, P.; Budzinski, H. Environ. Sci. Technol. 2005, 39, 5113-5120. 
(61) Mouatassim-Souali, A.; Tamisier-Karolak, S. L.; Perdiz, D.; Cargouet, M.; Levi, Y. J. Sep. Sci. 
2003, 26, 105-111. 
(62) Gentili, A.; Perret, D.; Marchese, S.; Mastropasqua, R.; Curini, R.; Di Corcia, A. 
Chromatographia 2002, 56, 25-32. 
(63) Yamamoto, A.; Kakutani, N.; Yamamoto, K.; Kamiura, T.; Miyakoda, H. Environ. Sci. 
Technol. 2006, 40, 4132-4137. 
(64) Stuer-Lauridsen, F.; Kjølholt, J.; Høibye, L.; Hinge-Christensen, S.; Ingerslev, F.; Hansen, 
M.; Andersen Krogh, K.; Andersen, H.; Halling-Sørensen, B.; Hansen, N.; Køppen, B.; 
Bjerregaard, P.; Frost, B. Survey of Estrogenic Activity in the Danish Aquatic Environment; 
Danish Environmental Protection Agency, 2005. 
(65) Isobe, T.; Serizawa, S.; Horiguchi, T.; Shibata, Y.; Managaki, S.; Takada, H.; Morita, M.; 
Shiraishi, H. Environ. Pollut. 2006, 144, 632-638. 
(66) Matejicek, D.; Houserova, P.; Kuban, V. J. Chromatogr. A 2007, 1171, 80-89. 
(67) Zacharewski, T. R. Environ. Sci. Technol. 1997, 31, 613-623. 
(68) Kinnberg, K. Evaluation of in vitro assays for determination of estrogenic activity in the 
environment; Danish Environmental Protection Agency, 2003. 
(69) Scrimshaw, M. D.; Lester, J. N. Anal. Bioanal. Chem. 2004, 378, 576-581. 
(70) Soto, A. M.; Maffini, M. V.; Schaeberle, C. M.; Sonnenschein, C. Best Pract. Res. Clin. 
Endocrinol. Metab. 2006, 20, 15-33. 
(71) Kuiper, G. G. J. M.; Carlsson, B.; Grandien, K.; Enmark, E.; Haggblad, J.; Nilsson, S.; 
Gustafsson, J.-A. Endocrinology 1997, 138, 863-870. 
References 
166  
(72) Murk, A. J.; Legler, J.; van Lipzig, M. M. H.; Meerman, J. H. N.; Belfroid, A. C.; Spenkelink, 
A.; van der Burg, B.; Rijs, G. B. J.; Vethaak, D. Environ. Toxicol. Chem. 2002, 21, 16-23. 
(73) Tremblay, L.; Van der Kraak, G. Aquat. Toxicol. 1998, 43, 149-162. 
(74) Burnison, B. K.; Hartmann, A.; Lister, A.; Servos, M. R.; Ternes, T.; Van Der Kraak, G. 
Environ. Toxicol. Chem. 2003, 22, 2243. 
(75) Akahori, Y.; Nakai, M.; Yamasaki, K.; Takatsuki, M.; Shimohigashi, Y.; Ohtaki, M. Toxicol. 
in Vitro 2008, 22, 225-231. 
(76) Molina-Molina, J.-M.; Escande, A.; Pillon, A.; Gomez, E.; Pakdel, F.; Cavaillès, V.; Olea, N.; 
Aït-Aïssa, S.; Balaguer, P. Toxicol. Appl. Pharmacol. 2008, 232, 384. 
(77) Wang, S.; Huang, W.; Fang, G. Z.; Zhang, Y.; Qiao, H. Int. J. Environ. Anal. Chem. 2008, 88, 
1-25. 
(78) Ingerslev, F.; Halling-Sørensen, B. Evaluation of Analytical Chemical Methods for Detection of 
Estrogens in the Environment; Danish Environmental Protection Agency, 2003. 
(79) Kuster, M.; López de Alda, M. J.; Rodriguez-Mozaz, S.; Barceló, D. Chapter 2.6 Analysis of 
steroid estrogens in the environment. In Comprehensive Analytical Chemistry: Analysis, fate 
and removal of pharmaceuticals in the water cycle; Petrovic, M., Barceló, D., Eds.; Elsevier: 
Amsterdam, 2007; Vol. 50, pp 219-264. 
(80) López de Alda, M. J.; Barceló, D. Fresenius Journal of Analytical Chemistry 2001, 371, 437-447. 
(81) Kuster, M.; López de Alda, M. J.; Barceló, D. Estrogens and progestogens in wastewater, 
sludge, sediments, and soil Volume 2. In Emerging organic pollutants in waste waters and 
sludge; Barceló, D., Ed.; Springer-Verlag: Heidelberg, 2005; Vol. 5.0. 
(82) Richardson, S. D. Anal. Chem. 2007, 79, 4295-4324. 
(83) Voulvoulis, N.; Scrimshaw, M. D. Methods for the determination of endocrine disrupters. 
In Endocrine disrupters in wastewater and sludge treatment processes; Birkett, J. W., Lester, J. N., 
Eds.; Lewis Publishers: Boca Raton, FL, 2003; pp 59-101. 
(84) Spengler, P.; Körner, W.; Metzger, J. W. Environ. Toxicol. Chem. 2001, 20, 2133-2141. 
(85) Ternes, T. A.; Stumpf, M.; Mueller, J.; Haberer, K.; Wilken, R.-D.; Servos, M. Sci. Total 
Environ. 1999, 225, 81-90. 
(86) Ingrand, V.; Herry, G.; Beausse, J.; de Roubin, M. R. J. Chromatogr. A 2003, 1020, 99-104. 
(87) Labadie, P.; Budzinski, H. Anal. Bioanal. Chem. 2005, 381, 1199-1205. 
(88) Komori, K.; Tanaka, H.; Okayasu, Y.; Yasojima, M.; Sato, C. Water Sci. Technol. 2004, 50, 93-
100. 
(89) Ternes, T. A.; Andersen, H.; Gilberg, D.; Bonerz, M. Anal. Chem. 2002, 74, 3498-3504. 
(90) Ferguson, P. L.; Iden, C. R.; McElroy, A. E.; Brownawell, B. J. Anal. Chem. 2001, 73, 3890-
3895. 
(91) Croley, T. R.; Hughes, R. J.; Koenig, B. G.; Metcalfe, C. D.; March, R. E. Rapid Commun. Mass 
Spectrom. 2000, 14, 1087-1093. 
(92) Petrovic, M.; Eljarrat, E.; López de Alda, M. J.; Barceló, D. J. Chromatogr. A 2002, 974, 23-51. 
(93) Reddy, S.; Iden, C. R.; Brownawell, B. J. Anal. Chem. 2005, 77, 7032-7038. 
(94) Gomes, R. L.; Birkett, J. W.; Scrimshaw, M. D.; Lester, J. N. Int. J. Environ. Anal. Chem. 2005, 
85, 1-14. 
References 
  167 
(95) Koh, Y. K. K.; Chiu, T. Y.; Boobis, A.; Cartmell, E.; Lester, J. N.; Scrimshaw, M. D. J. 
Chromatogr. A 2007, 1173, 81-87. 
(96) Schlüsener, M. P.; Bester, K. Rapid Commun. Mass Spectrom. 2005, 19, 3269-3278. 
(97) Okayasu, Y.; Komori, K.; Yasojima, M.; Suzuki, Y. In Technology 2005 2nd Joint Specialty 
Conference for Sustainable Management of Water Quality Systems for the 21st Century: Working 
to Project Public Health, Water Environment Federation, 2005; pp 291-297. 
(98) Ternes, T. A.; Kreckel, P.; Mueller, J. Sci. Total Environ. 1999, 225, 91-99. 
(99) Hoffmann, B.; Pinho, T. G. d.; Schuler, G. Exp. Clin. Endocrinol. Diabetes 1997, 105, 296-303. 
(100) Finlay-Moore, O.; Hartel, P. G.; Cabrera, M. L. J. Environ. Qual. 2000, 29, 1604-1611. 
(101) Yang, C. J.; Wu, L. S.; Tseny, C. M.; Chao, M. J.; Chen, P. C.; Lin, J. H. Asian-Australasian J. 
Anim. Sci. 2003, 16, 1254-1260. 
(102) Isobe, N.; Nakao, T. Anim. Sci. J. 2005, 76, 203-207. 
(103) Huang, C. H.; Sedlak, D. L. Environ. Toxicol. Chem. 2001, 20, 133-139. 
(104) Richardson, S. D. Anal. Chem. 2008, 80, 4373-4402. 
(105) Ferrer, I.; Thurman, E. M. TrAC, Trends Anal. Chem. 2003, 22, 750-756. 
(106) Ardrey, R. E. Liquid Chromatography - Mass Spectrometry: An Introduction; John Wiley & Sons 
Ltd: West Sussex, 2003. 
(107) Boyd, R. K. Rapid Commun. Mass Spectrom. 1993, 7, 257-271. 
(108) Willoughby, R.; Sheehan, E.; Mitrovich, S. A Global View of LC/MS: How to solve your most 
challenging analytical problems; 1st ed.; Global View Publishing: Pittsburgh, 1998. 
(109) Reddy, S.; Brownawell, B. J. Environ. Toxicol. Chem. 2005, 24, 1041-1047. 
(110) Lerch, O.; Zinn, P. J. Chromatogr. A 2003, 991, 77-97. 
(111) López de Alda, M. J.; Barceló, D. J. Chromatogr. A 2000, 892, 391-406. 
(112) Benijts, T.; Dams, R.; Gunther, W.; Lambert, W.; De Leenheer, A. Rapid Commun. Mass 
Spectrom. 2002, 16, 1358-1364. 
(113) Hájková, K.; Pulkrabová, J.; Schůrek, J.; Hajšlová, J.; Poustka, J.; Nápravníková, M.; 
Kocourek, V. Anal. Bioanal. Chem. 2007, 387, 1351-1363. 
(114) Reemtsma, T.; Quintana, J. B. Analytical methods for polar pollutants. In Organic Pollutants 
in the Water Cycle; Reemtsma, T., Jekel, M., Eds.; Wiley-VCH: Weinheim, 2006; pp 1-40. 
(115) Hill, E. N.; Leonard, T. W.; Whittle, R. R. In 
http://www.freepatentsonline.com/EP1464650A2.html; (US), B. L. I., Ed., 2004. 
(116) Reepmeyer, J. C.; Brower, J. F.; Ye, H. J. Chromatogr. A 2005, 1083, 42-51. 
(117) Waters. Oasis Applications Notebook; Waters Corporation, 2005; pp 10-11. 
(118) Rütters, H.; Möhring, T.; Rullkötter, J.; Griep-Raming, J.; Metzger, J. O. Rapid Commun. 
Mass Spectrom. 2000, 14, 122-123. 
(119) Burkhardt, M. R.; ReVello, R. C.; Smith, S. G.; Zaugg, S. D. Anal. Chim. Acta 2005, 534, 89-
100. 
(120) Berek, D. Interactive properties of polystyrene/divinylbenzene and divinylbenzene-based 
commercial chromatography columns. In Column handbook for size exclusion chromatography; 
Wu, C.-S., Ed.; Academic Press: San Diego, 1999; pp 445-458. 
References 
168  
(121) Bruessau, R. General characterization of gel-permeation chromatography columns. In 
Column handbook for size exclusion chromatography; Wu, C.-S., Ed.; Academic Press: San 
Diego, 1999; pp 429-444. 
(122) Sjovall, J.; Vihko, R. Acta Chem. Scand. 1966, 20, 1419-1421. 
(123) Tikkanen, M. J.; Adlercreutz, H. Acta Chem. Scand. 1970, 24, 3755-3757. 
(124) Rao, P. N.; Purdy, R. H.; Williams, M. C.; Moore, J. P. H.; Goldzieher, J. W.; Layne, D. S. J. 
Steroid Biochem. 1979, 10, 179-185. 
(125) Vihko, R. Acta Endocrinol. 1966, 52, 1-67. 
(126) Williams, M. C.; Helton, E. D.; Goldzieher, J. W. Steroids 1975, 25, 229-246. 
(127) Kolodziej, E. P.; Harter, T.; Sedlak, D. L. Environ. Sci. Technol. 2004, 38, 6377-6384. 
(128) Kolodziej, E. P.; Sedlak, D. L. Environ. Sci. Technol. 2007, 41, 3514-3520. 
(129) Stanford, B. D.; Weinberg, H. S. J. Chromatogr. A 2007, 1176, 26-36. 
(130) Lee, H.-B.; Peart, T. E.; Svoboda, M. L. J. Chromatogr. A 2005, 1094, 122-129. 
(131) Kolpin, D. W.; Furlong, E. T.; Meyer, M. T.; Thurman, E. M.; Zaugg, S. D.; Barber, L. B.; 
Buxton, H. T. Environ. Sci. Technol. 2002, 36, 1202-1211. 
(132) Young, W.; Whitehouse, P.; Johnson, I.; Sorokin, N. Proposed predicted no effect concentrations 
(PNECs) for natural and synthetic steroid oestrogens in surface waters; Environment Agency, 
2002. 
(133) Kang, J.; Hick, L. A.; Price, W. E. Rapid Commun. Mass Spectrom. 2007, 21, 4065-4072. 
(134) Hanselman, T. A.; Graetz, D. A.; Wilkie, A. C. Environ. Sci. Technol. 2003, 37, 5471-5478. 
(135) de Mes, T. Z. D.; Kujawa-Roeleveld, K.; Zeeman, G.; Lettinga, G. Water Sci. Technol. 2007, 
56, 15-23. 
(136) Thorpe, K. L.; Cummings, R. I.; Hutchinson, T. H.; Scholze, M.; Brighty, G.; Sumpter, J. P.; 
Tyler, C. R. Environ. Sci. Technol. 2003, 37, 1142-1149. 
(137) Silva, E.; Rajapakse, N.; Kortenkamp, A. Environ. Sci. Technol. 2002, 36, 1751-1756. 
(138) Körner, W.; Spengler, P.; Bolz, U.; Schuller, W.; Hanf, V.; Metzger, J. W. Environ. Toxicol. 
Chem. 2001, 20, 2142-2151. 
(139) Thorpe, K. L.; Gross-Sorokin, M.; Johnson, I.; Brighty, G.; Tyler, C. R. Environ. Health 
Perspect. 2006, 114, 90-97. 
(140) Jin, S.; Yang, F.; Liao, T.; Hui, Y.; Xu, Y. Environ. Toxicol. Chem. 2008, 27, 146-153. 
(141) Houtman, C. J.; Booij, P.; van der Valk, K. M.; van Bodegom, P. M.; van den Ende, F.; 
Gerritsen, A. A. M.; Lamoree, M. H.; Legler, J.; Brouwer, A. Environ. Toxicol. Chem. 2007, 26, 
898-907. 
(142) Hashimoto, S.; Ueda, Y.; Kurihara, R.; Shiraishi, F. Environ. Toxicol. Chem. 2007, 26, 279-286. 
(143) Körner, W.; Hanf, V.; Schuller, W.; Kempter, C.; Metzger, J.; Hagenmaier, H. Sci. Total 
Environ. 1999, 225, 33-48. 
(144) Leusch, F. D. L.; Chapman, H. F.; Körner, W.; Gooneratne, S. R.; Tremblay, L. A. Environ. 
Sci. Technol. 2005, 39, 5781. 
(145) Rasmussen, T. H.; Nielsen, J. B. Biomarkers 2002, 7, 322-336. 
References 
  169 
(146) American Public Health Association Standard methods for the examination of water and 
wastewater; 21st ed.; American Public Health Association, American Water Works 
Association and Water Environment Federation: Washington, DC, 2005. 
(147) Payne, J.; Jones, C.; Lakhani, S.; Kortenkamp, A. Sci. Total Environ. 2000, 248, 51-62. 
(148) Coldham, N. G.; Dave, M.; Sivapathasundaram, S.; McDonnell, D. P.; Connor, C.; Sauer, M. 
J. Environ. Health Perspect. 1997, 105, 734-742. 
(149) Routledge, E. J.; Sumpter, J. P. Environ. Toxicol. Chem. 1996, 15, 241. 
(150) Legler, J.; Jonas, A.; Lahr, J.; Vethaak, A. D.; Brouwer, A.; Murk, A. J. Environ. Toxicol. Chem. 
2002, 21, 473-479. 
(151) Johnson, A. C.; Sumpter, J. P. Environ. Sci. Technol. 2001, 35, 4697-4703. 
(152) Dairying and the Environment Committee. Managing Farm Dairy Effluent; Revised and 
updated edition 2006 ed., 2006. 
(153) Mellin, T. N.; Erb, R. E. Steroids 1966, 7, 589-606. 
(154) Mellin, T. N.; Erb, R. E.; Estergreen, V. L. J. Dairy Sci. 1965, 48, 895-902. 
(155) Mostl, E.; Choi, H. S.; Wurm, W.; Ismail, N.; Bamberg, E. Br. Vet. J. 1984, 140, 287-291. 
(156) Longhurst, R. D.; Roberts, A. H. C.; O'Connor, M. B. N. Z. J. Agric. Res. 2000, 43, 7-14. 
(157) LIC. New Zealand Dairy Statistics 2006-2007; Livestock Improvement Corporation Limited, 
2007. 
(158) Khanal, S. K.; Xie, B.; Thompson, M. L.; Sung, S.; Ong, S. K.; van Leeuwen, J. Environ. Sci. 
Technol. 2006, 40, 6537-6546. 
(159) de Mes, T. Z. D.; Zeeman, G.; Lettinga, G. Rev. Environ. Sci. Bio/Technol. 2005, 4, 275-311. 
(160) Rutishauser, B. V.; Pesonen, M.; Escher, B. I.; Ackermann, G. E.; Aerni, H. R.; Suter, M. J. F.; 
Eggen, R. I. L. Environ. Toxicol. Chem. 2004, 23, 857-864. 
(161) NZSFA. AgVetLink Issue 56; New Zealand Food Safety Authority, 2006. 
(162) Hartmann, N.; Erbs, M.; Wettstein, F. E.; Hoerger, C. C.; Schwarzenbach, R. P.; Bucheli, T. 
D. J. Agric. Food Chem. 2008, 56, 2926-2932. 
(163) Scudamore, K. A.; Livesey, C. T. J. Sci. Food Agric. 1998, 77, 1-17. 
(164) Lauren, D. R.; Jensen, D. J.; Smith, W. A. N. Z. J. Crop Hortic. Sci. 2006, 34, 63-72. 
(165) Lauren, D. R.; Smith, W. A.; Di Menna, M. E. N. Z. J. Crop Hortic. Sci. 2007, 35, 331-340. 
(166) Vethaak, D.; Rijs, G. B. J.; Schrap, S. M.; Ruiter, H.; Gerritsen, A. A. M.; Lahr, J. Estrogens 
and xeno-estrogens in the aquatic environment of the Netherlands: Occurrence, potency and 
biological effects; Dutch National Institute of Inland Water Management and Waste Water 
Treatment (RIZA) and the Dutch National Institute for Coastal and Marine Management 
(RIKZ), 2002. 
(167) Raman, D. R.; Layton, A. C.; Moody, L. B.; Easter, J. P.; Sayler, G. S.; Burns, R. T.; Mullen, 
M. D. Transactions of the ASAE 2001, 44, 1881-1888. 
(168) Nelson, J.; Bishay, F.; van Roodselaar, A.; Ikonomou, M.; Law, F. C. P. Sci. Total Environ. 
2007, 374, 80-90. 
(169) Hickey, C. W.; Quinn, J. M.; Davies-Colley, R. J. N. Z. J. Mar. Freshw. Res. 1989, 23, 569-584. 
(170) Craggs, R. J.; Tanner, C. C.; Sukias, J. P. S.; Davies-Colley, R. J. Water Sci. Technol. 2003, 48, 
291-297. 
References 
170  
(171) Craggs, R. J.; Sukias, J. P.; Tanner, C. T.; Davies-Colley, R. J. N. Z. J. Mar. Freshw. Res. 2004, 
47, 449-460. 
(172) Andersen, H. R.; Kjolholt, J.; Hansen, M.; Stuer-Lauridsen, F.; Dueholm Blicher, T.; 
Ingerslev, F.; Halling-Sorensen, B. Degradation of Estrogens in Sewage Treatment Processes; 
Danish Environmental Protection Agency, 2004. 
(173) Kinney, C. A.; Furlong, E. T.; Zaugg, S. D.; Burkhardt, M. R.; Werner, S. L.; Cahill, J. D.; 
Jorgensen, G. R. Environ. Sci. Technol. 2006, 40, 7207-7215. 
(174) al-Alousi, L. M.; Anderson, R. A. Steroids 2002, 67, 269-275. 
(175) Nakajima, D.; Kageyama, S.; Shiraishi, F.; Kamata, R.; Nagahora, S.; Takahashi, S.; Ogane, 
J.; Ohtani, Y.; Horiuchi, T.; Watanabe, M.; Hamane, T.; Yamane, K.; Haraguchi, K.; Jinya, 
D.; Kadokami, K.; Goto, S.; Tatarazako, N.; Shiraishi, H.; Suzuki, N. J. Environ. Chem. 2007, 
17, 453-460. 
(176) Selvarajah, N. In Tertiary Treatment Options for Dairyshed and Piggery Wastewaters; Mason, I. 
G., Ed.; Department of Agricultural Engineering, Massey University: Massey University, 
Palmerston North, 1996. 
(177) MAF Policy. Dairy shed wastewater treatment ponds; Ministry of Agrciulture and Fisheries, 
1994. 
(178) Sukias, J. P. S.; Tanner, C. C.; Davies-Colley, R. J.; Nagels, J. W.; Wolters, R. N. Z. J. Agric. 
Res. 2001, 44, 279-296. 
(179) Schäfer, A. I.; Mastrup, M.; Jensen, R. L. Desalination 2002, 147, 243-250. 
(180) Houghton, E.; Grainger, L.; Dumasia, M. C.; Teale, P. Org. Mass Spectrom. 1992, 27, 1061-
1070. 
(181) Leyssens, L.; Van Puymbroeck, M.; Raus, J. Analyst 1998, 123, 2643-2644. 
(182) de Mes, T. Z. D.; Kujawa-Roeleveld, K.; Zeeman, G.; Lettinga, G. Water Sci. Technol. 2008, 
57, 1177-1182. 
(183) Ren, Y. X.; Nakano, K.; Nomura, M.; Chiba, N.; Nishimura, O. Water Res. 2007, 41, 3089-
3096. 
(184) Ying, G. G.; Kookana, R. S. Environ. Sci. Technol. 2003, 37, 1256-1260. 
(185) Dytczak, M. A.; Londry, K. L.; Oleszkiewicz, J. A. Water Environ. Res. 2008, 80, 47-52. 
(186) Lee, H. B.; Liu, D. Water, Air, Soil Pollut. 2002, 134, 353-368. 
(187) Sarmah, A. K.; Northcott, G. L. Environ. Toxicol. Chem. 2008, 27, 819-827. 
(188) Layton, A. C.; Gregory, B. W.; Seward, J. R.; Schultz, T. W.; Sayler, G. S. Environ. Sci. 
Technol. 2000, 34, 3925-3931. 
(189) Colucci, M. S.; Bork, H.; Topp, E. J. Environ. Qual. 2001, 30, 2070-2076. 
(190) Ying, G. G.; Kookana, R. S.; Dillon, P. Water Res. 2003, 37, 3785-3791. 
(191) Bonin, J. L.; Simpson, M. J. Environ. Toxicol. Chem. 2007, 26, 2604-2610. 
(192) Ying, G. G.; Kookana, R. S. Environ. Toxicol. Chem. 2005, 24, 2640-2645. 
(193) Czajka, C. P.; Londry, K. L. Sci. Total Environ. 2006, 367, 932-941. 
(194) Lin, A. Y. C.; Reinhard, M. Environ. Toxicol. Chem. 2005, 24, 1303-1309. 
(195) Jurgens, M. D.; Holthaus, K. I. E.; Johnson, A. C.; Smith, J. J. L.; Hetheridge, M.; Williams, 
R. J. Environ. Toxicol. Chem. 2002, 21, 480-488. 
References 
  171 
(196) Zhang, Y.; Zhou, J. L.; Ning, B. Water Res. 2007, 41, 19-26. 
(197) Cameron, K. C.; Rate, A. W.; Noonan, M. J.; Moore, S.; Smith, N. P.; Kerr, L. E. Agric., 
Ecosyst. Environ. 1996, 58, 187-197. 
(198) Sarmah, A. K.; Northcott, G. L.; Scherr, F. F. Environ. Int. 2008, 34, 749-755. 
(199) Longhurst, R. D.; O'Connor, M. B.; Bremner, K.; Matthews, L. N. Z. J. Agric. Res. 2000, 43, 
501-507. 
(200) O'Connor, J. C.; Cook, J. C.; Marty, M. S.; Davis, L. G.; Kaplan, A. M.; Carney, E. W. Crit. 
Rev. Toxicol. 2002, 32, 521-549. 
(201) Karbe, L.; Ternes, T.; Wenzel, A.; Hecker, M. Estrogens, xenoestrogens and effects on fish 
in German waters. In Estrogens and xenoestrogens in the aquatic environment: an integrated 
approach for field monitoring and effect assessment; Vethaak, D., Schrap, M., Voogt, P. d., Eds.; 
Society of Environmental Toxicology and Chemistry (SETAC): Pensacola (Fl), 2006; pp 365-
406. 
(202) Houtman, C. J.; Van Houten, Y. K.; Leonards, P. G.; Brouwer, A.; Lamoree, M. H.; Legler, J. 
Environ. Sci. Technol. 2006, 40, 2455-2461. 
(203) Jones, P. A.; Baker, V. A.; Irwin, A. J. E.; Earl, L. K. Toxicol. in Vitro 1998, 12, 373-382. 
(204) Schoonen, W. G. E. J.; Joosten, J. W. H.; Kloosterboer, H. J. J. Steroid Biochem. Mol. Biol. 1995, 
55, 423-437. 
(205) Burkhardt-Holm, P.; Segner, H.; Burki, R.; Peter, A.; Schubert, S.; Suter, M. J. F.; Borsuk, M. 
E. Chimia 2008, 62, 376-382. 
(206) Sun, Q.; Deng, S.; Huang, J.; Shen, G.; Yu, G. Environ. Toxicol. Pharmacol. 2008, 25, 20-26. 
(207) Terasaki, M.; Shiraishi, F.; Nishikawa, T.; Edmonds, J. S.; Morita, M.; Makino, M. Environ. 
Sci. Technol. 2005, 39, 3703-3707. 
(208) Shiraishi, F.; Okumura, T.; Nomachi, M.; Serizawa, S.; Nishikawa, J.; Edmonds, J. S.; 
Shiraishi, H.; Morita, M. Chemosphere 2003, 52, 33-42. 
(209) Balaguer, P.; Francois, F.; Comunale, F.; Fenet, H.; Boussioux, A.-M.; Pons, M.; Nicolas, J.-
C.; Casellas, C. Sci. Total Environ. 1999, 233, 47-56. 
(210) Segner, H.; Navas, J. M.; Schafers, C.; Wenzel, A. Ecotoxicol. Environ. Saf. 2003, 54, 315-322. 
(211) Van den Belt, K.; Berckmans, P.; Vangenechten, C.; Verheyen, R.; Witters, H. Aquat. Toxicol. 
2004, 66, 183. 
(212) Snyder, S. A.; Villeneuve, D. L.; Snyder, E. M.; Giesy, J. P. Environ. Sci. Technol. 2001, 35, 
3620-3625. 
(213) Aerni, H. R.; Kobler, B.; Rutishauser, B. V.; Wettstein, F. E.; Fischer, R.; Giger, W.; 
Hungerbuhler, A.; Marazuela, M. D.; Peter, A.; Schonenberger, R.; Vogeli, A. C.; Suter, M. 
J. F.; Eggen, R. I. L. Anal. Bioanal. Chem. 2004, 378, 688-696. 
(214) Kortenkamp, A.; Altenburger, R. Sci. Total Environ. 1998, 221, 59-73. 
(215) Folmar, L. C.; Hemmer, M. J.; Denslow, N. D.; Kroll, K.; Chen, J.; Cheek, A.; Richman, H.; 
Meredith, H.; Grau, E. G. Aquat. Toxicol. 2002, 60, 101-110. 
(216) Sumpter, J. P. Acta Hydrochim. Hydrobiol. 2005, 33, 9-16. 
(217) Furuichi, T.; Kannan, K.; Glesy, J. P.; Masunaga, S. Water Res. 2004, 38, 4491-4501. 
(218) Soto, A. M.; Calabro, J. M.; Prechtl, N. V.; Yau, A. Y.; Orlando, E. F.; Daxenberger, A.; 
Kolok, A. S.; Guillette, L. J.; le Bizec, B.; Lange, I. G.; Sonnenschein, C. Environ. Health 
Perspect. 2004, 112, 346-352. 
References 
172  
(219) Nichols, D. J.; Daniel, T. C.; Edwards, D. R.; Mooe, P. A.; Pote, D. H. J. Soil Water Conserv. 
1998, 53, 74-77. 
(220) Nichols, D. J.; Daniel, T. C.; Moore, P. A.; Edwards, D. R.; Pote, D. H. J. Environ. Qual. 1997, 
26, 1002-1006. 
(221) Shore, L. S.; Correll, D. L.; Chakraborty, O. K. Relationship of fertilization with chicken 
manure and concentrations of estrogens in small streams. In Animal waste and the land-water 
interface; Steele, K. F., Ed.; Lewis Publishers: Boca Raton, 1995; pp 155-162. 
(222) Matthiessen, P.; Arnold, D.; Johnson, A. C.; Pepper, T. J.; Pottinger, T. G.; Pulman, K. G. T. 
Sci. Total Environ. 2006, 367, 616-630. 
(223) Peterson, E. W.; Davis, R. K.; Orndorff, H. A. J. Environ. Qual. 2000, 29, 826-834. 
(224) Orlando, E. F.; Kolok, A. S.; Binzcik, G. A.; Gates, J. L.; Horton, M. K.; Lambright, C. S.; 
Gray, L. E.; Soto, A. M.; Guillette, L. J. Environ. Health Perspect. 2004, 112, 353-358. 
(225) Irwin, L. K.; Gray, S.; Oberdorster, E. Aquat. Toxicol. 2001, 55, 49-60. 
(226) Parkyn, S.; Matheson, F.; Cooke, J.; Quinn, J. Review of the Environmental Effects of 
Agriculture on Freshwaters; National Institute of Water & Atmospheric Research Ltd, 2002. 
(227) Ministry for the Environment. Environment New Zealand 2007; Ministry for the 
Environment, 2007. 
(228) Parliamentary Commissioner for the Environment. Growing for good: Intensive farming, 
sustainability and New Zealand's environment; Parliamentary Commissioner for the 
Environment, 2004. 
(229) Wilcock, R. J.; Monaghan, R. M.; Quinn, J. M.; Campbell, A. M.; Thorrold, B. S.; Duncan, M. 
J.; McGowan, A. W.; Betteridge, K. N. Z. J. Mar. Freshw. Res. 2006, 40, 123-140. 
(230) Ministry for the Environment "Clean streams accord: Snapshot of Progress - 2006/2007," 
Ministry for the Environment, 2008. 
(231) Close, M.; Dann, R.; Ball, A.; Pirie, R.; Savill, M.; Smith, Z. J. Water Health 2008, 6, 83-98. 
(232) Swartz, C. H.; Reddy, S.; Benotti, M. J.; Yin, H.; Barber, L. B.; Brownawell, B. J.; Rudel, R. 
Environ. Sci. Technol. 2006, 40, 4894-4902. 
(233) Kjaer, J.; Olsen, P.; Bach, K.; Barlebo, H. C.; Ingerslev, F.; Hansen, M.; Halling-Sorensen, B. 
Environ. Sci. Technol. 2007, 41, 3911-3917. 
(234) Casey, F. X. M.; Ocluor, P. G.; Hakk, H.; Larsen, G. L.; DeSutter, T. M. Soil Sci. 2008, 173, 
456-467. 
(235) Gadd, J. B. An investigation of the sources and occurrence of environmental estrogens in the 
Waikato River; MSc, University of Auckland: Auckland, 2000; p 182. 
(236) Beard, S. "Waikato River Water Quality Monitoring Programme: Data Report 2007," 
Environment Waikato, 2008. 
(237) Pawlowski, S.; Ternes, T. A.; Bonerz, M.; Rastall, A. C.; Erdinger, L.; Braunbeck, T. Toxicol. 
in Vitro 2004, 18, 129-138. 
(238) Bewsell, D.; Monaghan, R. M.; Kaine, G. Environ. Manage. 2007, 40, 201-209. 
(239) Mortensen, G. K.; Strobel, B. W.; Hansen, H. C. B. Chemosphere 2006, 62, 1673-1680. 
(240) Servos, M. R.; Bennie, D. T.; Burnison, B. K.; Jurkovic, A.; McInnis, R.; Neheli, T.; Schnell, 
A.; Seto, P.; Smyth, S. A.; Ternes, T. A. Sci. Total Environ. 2005, 336, 155-170. 
(241) Korner, W.; Spengler, P.; Bolz, U.; Schuller, W.; Hanf, V.; Metzger, J. W. Environmental 
Toxicology and Chemistry 2001, 20, 2142-2151. 
References 
  173 
(242) Scherr, F. F.; Sarmah, A. K.; Di, H.; Cameron, K. C. In 2nd Australian Symposium on 
Ecological Risk Assessment and Management of Endocrine Disrupting Chemicals (EDCs), 
Pharmaceuticals and Personal Care Products (PPCPs) in the Australasian Environment; CSIRO, 
Land & Water: Canberra, Australia, 2007. 
(243) Dyer, A. R.; Raman, D. R.; Mullen, M. D.; Burns, R. T.; Moody, L. B.; Layton, A. C.; Sayler, 
G. S. In ASAE Annual International Meeting: Sacramento, California, 2001. 
(244) Thompson, G. "The compliance status of dairy effluent discharges to land in the 
Canterbury region for the 2006/2007 season," Environment Canterbury, 2007. 
(245) Smart, J. "Dairyshed effluent survey 2007/2008 report," Marlborough District Council, 
2008. 
(246) Northland Regional Council "Annual monitoring report 2005-2006," Northland Regional 
Council, 2006. 
(247) Hawke, R. M.; Summers, S. A. N. Z. J. Agric. Res. 2006, 49, 307-320. 
(248) Di, H. J.; Cameron, K. C.; Silva, R. G.; Russell, J. M.; Barnett, J. W. N. Z. J. Agric. Res. 2002, 
45, 235-244. 
(249) Hawke, R. M.; Summers, S. A. N. Z. J. Agric. Res. 2003, 46, 339-346. 
References 
174  
 
  
  
 
APPENDICES 
 
 
 
 
 
 
 
 
  
Appendices 
 175 
Appendix A: DSE composition 
DSE composition varies due to differences in volumes of wash-down water used, feed 
type and quality, and the time of year (247). Further differences are observed with timing 
and depth of sampling (39). The composition of the DSE samples collected from the 
Waikuku catchment was at the lower end of the range observed throughout New Zealand 
for farm dairy effluents (Table A.1). 
Table A.1: Composition of DSE from Waikuku catchment (all data mg/L). 
 Total 
Suspended 
Solids 
Total Organic 
Carbon 
Total Kjeldahl 
Nitrogen 
Total 
Phosphorus 
Wku1 4080 1330 203 41.5 
Wku2 3290 1390 246 51.2 
Wku3 2110 1030 138 29.4 
Wku4 1430 690 149 23.5 
Wku5 1790 1630 180 40.2 
Wku6 2980 854 184 32.2 
Average 2610 ± 1010 1150 ± 360 183 ± 39 36 ± 10 
NZ Literature a     
Mean b 9400 ± 3200 2700 ± 830 205 ± 45 65 ± 20 
Range c 400 – 52,000 700 - 6550 80 – 506 † 21 - 123 
Raman et al. (39) NM NM 589 ± 364 106 ± 11 
Hutchins et al. (43) 718 576 185 30.3 
Notes: a Data from (156,176,248,249) and references therein. b Weighted mean of means ±  std deviation of 
means. c Range in mean concentrations.    
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Appendix B: Stream Sampling Locations and Catchment 
Characteristics 
 
Table B.1: Stream sampling locations and catchment characteristics. 
 Sampling location 
DSE discharges 
in catchment No. of stock in catchment 
Stream Name Easting Northing 
Total area 
of 
catchment 
(ha) 
Area of 
dairy 
land use 
(ha) 
No. 
dairy 
farms 
No. to 
water 
No. to 
Land 
Dairy 
cattle 
Beef 
cattle Pigs Deer Sheep 
Mangakawaru Stream 2710239 6401370 4038 353 64 6 18 24220 215 0 0 41 
Mangaorongo Stream 2709123 6335547 12766 7821 135 17 47 51242 1286 75 1 1964 
Mangapiko Stream 2716693 6354091 13624 8126 131 4 66 45439 1411 414 0 125 
Matatoki Stream 2741272 6439828 815 156 15  0 3726 366 1 0 220 
Mellsops Drain 2723552 6343266 245 106 5  0 2013 17 3 0 0 
Owairaka Valley Stream 
tributary 2730797 6340322 NA a NA 1 0 1 NA NA NA NA NA 
Owairaka Valley Stream 2730824 6340174 4771 2720 33  6 14517 574 4 15 20 
Piako River 2735138 6392078 39227 23323 354 31 158 445742 2598 5967 156 629 
Pokaiwhenua Stream 2750104 6345734 1178 696 26 1 7 7298 50 0 0 10 
Puniu River 2711431 6349998 51907 21981 299 15 111 150790 2928 52 15 5417 
Toenepi Stream 2735192 6385475 1493 1118 18 8 10 4529 NA NA NA NA 
Waihou River 2749435 6402794 110294 47158 769 35 381 263484 3218 401 1 1279 
Waihuka Stream 2713216 6337419 391 376 10 3 3 4034 28 0 0 0 
Notes: a Data not available. 
 
 
